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Diary 
Evening meetings will be held at the RPS, 1 Lambeth 
High Street, on Mondays, starting with refreshments at 
5.00 pm, unless otherwise stated. 
Monday 12 May 2014 
'The Apothecary in Medieval and Early Modem Society' 
by Dr Pat Cullum, Head of History, Huddersfield 
University. Lambeth, 5.30 pm. 
Monday 7 July 2014 
Visit to Royal Holloway University of London, Egham, 
Surrey TW20 OEX. Archives and picture gallery. Details 
later. 
Monday 6 October 2014 
'Galen' by Emeritus Professor Vivian Nutton, UCL 
Centre for the history of medicine. Lambeth, 5 .30 pm. 
Wednesday 12 November 2014 
'~icholas Culpeper' by Dr Barry Strickland-Hodge. 
Jomt meeting at Aston University, Birmingham. 
Theft from RPS Museum November 2013 
BSHP President Briony Hudson and Honorary Secretary 
Peter Homan attended a meeting on 20th January 2014 to 
discuss issues arising from the recent theft from the 
Royal Pharmaceutical Society Museum. Martin Astbury, 
RPS President, chaired the discussion. Also present were 
Helen Gordon, RPS Chief Executive, Simon Redman, 
Director of Finance and Resources, Catherine Duggan, 
Director of Professional Development and Support, Ruth 
Wakeman, Head of Professional Support, Neal Patel, 
Head of Corporate Communications, and John Betts, 
Keeper of the Museum Collections and BSHP 
Committee member. 
It was confirmed that the investigation into the incident 
is still ongoing and active, and that additional security 
measures have been put into place in response to 
immediate issues raised. The discussion particularly 
focussed around lessons to be learnt that could inform the 
plans currently being made for the new RPS headquarters 
near Tower Bridge. The President also thanked BSHP for 
its ongoing support for the Museum. 
Bumby Memorial Bursary 2014 
The bursary for 2014 was awarded to Eliz.abeth Nally, a 
5th year medical student at Imperial College London for 
a paper on 'Itching for a Solution: making topical steroids 
a standard treatment for eczema'. The paper will be 
presented at the 2014 Annual Spring Conference in 
Birmingham. 
The bursary was awarded from a fund in memory of 
Dr Juanita Bumby, former history researcher, president 
ofBSHP and editor of the Pharmaceutical Historian. 
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Edward Joseph Shellard -
A Phenomenal Pharmacognosist: 
Part 2 
Peter J Houghton1 and J David Phillipson2 
11nstitute of Pharmaceutical Sciences, Kings 
College London, Franklin Wilkins Building 
2 Centre for Pharmacognosy and Phytotherapy, 
Department of Pharmaceutical and Biological 
Chemistry, UCL School of Pharmacy, 29-39 
Brunswick Square, London WC1N 1/:\X 
An outline of Joe Shellard's career has been presented in 
Part 11. He joined the School of Pharmacy, Merchant 
Venturers Technical College, later the College of 
Technology, Bristol, as a lecturer in 1946. In 1957 he was 
appointed as a lecturer in Pharmacognosy at the 
Department of Pharmacy, Chelsea College, London, and 
he retired in 1978. During his time at Chelsea he was 
promoted to Senior Lecturer, then Reader and finally 
Professor in 1970. When he retired he was Assistant 
Head of the Pharmacy Department at Chelsea College. In 
Part 2 we present some of the contributions that he made 
to Pharmacognosy and Pharmacy, including his research 
into the alkaloids of Mitragyna species, his role as an 
External Examiner, his overseas connections and visits, 
his presentations to pharmaceutical and scientific 
conferences, his committee work, his respect for his 
teacher Dr Tommy Wallis and his activities in retirement. 
Mitragyna Alkaloids 
Joe Shellard's main area of research in the 17 years from 
1961-1978 was concerned with the alkaloids of Mitragyna 
species (Rubiaceae). Nearly 100 original research papers 
and review articles were published and lectures presented 
dealing with some 43 alkaloids isolated from 10 species2"°. 
The question that must be asked is, why Mitragyna? His 
interest was aroused whilst he was at the Bristol School of 
Pharmacy prior to his Chelsea College days. Arthur 
Hereward Millard, Director of the Botanic Gardens, Kuala 
Lumpur, Malaya, was a former member of staff when the 
School was at Bath and he knew Joe. In 1959 when he 
visited Chelsea College he told Joe about the use of the 
leaves of the tree Mitragyna speciosa Korth. as an opium 
substitute. 
In 1960 Arnold Beckett returned from Kumasi in Ghana 
with a supply of leaves that contained alkaloids. He 
arranged for Albert Tackie, a lecturer from the School of 
Pharmacy, Kwame Nkrumah University, Kumasi, to work 
on these leaves under his supervision for the degree of PhD. 
Joe took samples of this plant material to the Herbarium, 
Royal Botanic Gardens Kew, where they were identified as 
Mitragyna stipu!osa (DC) O.Kuntze. Previous 
investigations had been made by other researchers into the 
alkaloids of Mitragyna speciosa known as 'biak: biak:' in 
Malaya and 'kratom' in Thailand. Joe discovered that 
Albert Tackie was also working on Mitragyna speciosa and 
that this plant material had been sent to him by his friend 
AH Millard, but had been delivered to Arnold Beckett. 
Smith, Kline and French, the US pharmaceutical company 
were interested in this species and they were also financing 
some of Arnold Beckett's research. SKF discovered that the 
major alkaloid mitragynine had analgesic activity similar to 
codeine but further investigation revealed toxicity in animal 
tests. When SKF had no further interest in Mitragyna, 
alkaloids they allowed Arnold Beckett to publish a paper on 
the alkaloids of Mitragyna speciosa with Joe Shellard as 
co-author7. When AH Millard learned this he was most 
upset because he had previous bad experience with 
scientists from SKF. 
Beckett, Shellard and Tackie presented their early results 
on the alkaloids of Mitragyna stipulosa at the British 
Pharmaceutical Conference in 1963.8 David Phillipson 
commenced research on the alkaloids of Mitragyna 
parvifo!ia (Roxb.) Korth. from India and Mitragyna, 
rotundifolia (Roxb.) 0 Kuntze from Burma in 1961 under 
the supervision of Joe Shellard. Their early results were 
presented at the 23rd Congress of Pharmaceutical Sciences 
ofFIP held in Munster, Germany, in 1963.9,10 
When the Mitragyna research commenced progress was 
limited because of the lack of chromatographic separation 
of the constituent alkaloids. Joe obtained a novel kit for 
spreading thin layers of adsorbents such as silica gel or 
alumina on to glass plates. This novel technique of thin 
layer chromatography (TLC) not only enabled Tackie and 
Phillipson to separate the alkaloids rotundif oline and 
rhynchophylline, which had been previously isolated by 
crystallisation, but also to demonstrate that crude extracts 
contained complex mixtures of at least 12 different 
alkaloids. This technique was used to separate other 
alkaloids and had a dramatic effect on the progress of the 
research. Within a few years gas liquid chromatography 
(GLC) and high performance liquid chromatography 
(HPLC) also became available for further separations to be 
made. The process of determining the chemical structures 
was greatly aided by the evolution of physico-chemical 
analytical techniques including nuclear magnetic resonance 
spectrometry (NMR) and mass spectrometry (1:iS). '!he 
combination of these techniques led to the 1solat1on, 
characterisation and determination of the chemical 
structures of a whole series of novel alkaloids. SKF donated 
mitragynine mother liquors in kilogram quantities, which 
provided a useful source of many alkaloids. The Mitragyna 
research group expanded particularly wi~ Payom 
Tantivatana and Dhavadee Ponglux from Thailand, who 
both subsequently became professors at Chulalongkom 
University, Bangkok, and postdoctoral workers such as 
Calvin Lee and Bill Trager from the USA. 
As the research continued a whole series of closely 
related indole alkaloids with heteroyohimbine and oxindole 
structures were isolated and the focus of the investigation 
turned to studies of their configurational and 
conformational structures. When Peter Houghton join~ 
the group he also registered for a PhD . under Joe s 
supervision. He discovered that in some ~1es ~e young 
leaves contained heteroyohimbine alkal01ds which were 
absent from the mature leaves. This led to speculation about 
the biosynthetic pathways involved in the fonnation of 
these alkaloids. Studies on the alkaloids of Mitragyna 
parvifolia leaves, stem bark and root bark collected 
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monthly over a 12 month period led to a hypothesis about 
the pathways involved, and radioactive feeding 
experiments indicated that the heteroyohimbines were the 
precursors of the oxindoles. Although research on 
Mztragyna alkaloids has now ceased at Kings College 
London (Chelsea College was merged with Kings College 
London in 1984) there is still interest in the UK because the 
leaves of Mitragyna speciosa are available for 
'recreational' purposes giving rise to concern about health 
risks to users. 
External Examiner in Pharmacognosy 
fu 1953, while at Bristol, Joe was appointed as an Examiner 
in Phannacognosy by the Pharmaceutical Society of Great 
Britain and this added to his status as a teacher of 
Phannacognosy. Several years later he became Chainnan 
of the Board of Examiners in Pharmacognosy for the 
Phannaceutical Society and this brought him into 
collaboration with CW Maplethorpe who chaired the 
Society's Education Committee. They made changes to the 
Phannacognosy syllabus, cutting down on the botanical 
aspects of medicinal plants and introducing chemistry. Joe 
was able to visit his former colleagues at Bristol as an 
external examiner. As the years passed he acted as an 
external examiner to a number of Schools of Pharmacy in 
the UK including Bath, Bradford, Brighton, Bristol, 
Cardiff, Manchester, Nottingham and Sunderland. These 
duties added to his busy schedule, particularly in the June-
July period when he would frequently have to visit more 
than one School. 
As he became more and more recognised as a teacher 
and a researcher he became external examiner to a number 
of overseas universities including Dublin (Eire), Kumasi 
(Ghana), lbadan and Ile Ife (Nigeria), Khartoum (Sudan), 
andDar-es-Salaam (Tanzania). During all of these visits he 
strove to improve the Pharmacognosy syllabus and 
encouraged university staff in their teaching and research. 
He also helped by suggesting the names of potential 
visiting staff as well as inviting individuals to spend some 
time at the Department of Pharmacy, Chelsea College. As 
examples, whilst at Kumasi, Ghana, in 1961 he suggested 
that Dr Talalaj from Warsaw be appointed as a temporary 
lecturer to improve teaching and research in Pharma-
cognosy. He also took the opportunity to collect samples of 
Mitragyna leaves for research. In 1971 he was at Ibadan, 
Nigeria, and when he arrived he was informed that 
Professor Said, Head of the School of Pharmacy, had been 
killed in a road accident and, as no examination papers had 
been set, Joe had to set theory and practical examination 
papers. The School was short-staffed and he arranged for 
his Chelsea colleagues Dr Georgina Jolliffe and her 
husband Dr Geoffrey Jolliffe, a physical chemist, to be 
seconded to the Ibadan School of Pharmacy for a period of 
3-6months. 
Overseas visits 
In 1957 Joe had met Dr Bogdan Karminski, a lecturer in 
Pharmacognosy at the Faculty of Pharmacy, Warsaw, 
Poland, while he was visiting the School of Pharmacy, 
Brunswick Square, London, and they became finn friends. 
Joe was interested in Pharmacognosy teaching and 
research in Poland and he learned about their use of 
medicinal plants. Joe invited Dr Karminski to Bristol where 
he was attending a special dinner arranged to thank Joe and 
Sylvia for their efforts on behalf of the British 
Pharmaceutical Conference held at Bristol in 1957. 
In 1959 he received an invitation from Professor Deryng, 
via Dr Karminski, to spend a month in the Pharmacognosy 
Department, Faculty of Pharmacy, Warsaw. The Faculty 
was in a new building and all of the Pharmacognosy staff 
was active in teaching and research. They were in the 
process of preparing a Microscopical Atlas of Crude Drugs 
based on camera lucida drawings. This was the first such 
atlas to be prepared since the one produced in Germany by 
Professor Koch in 1906. The Pharmacognosy laboratories 
were all fitted out for microscopical and chemical work and 
each member of staff had their own office and was engaged 
in phytochernical research. Joe visited Dr Lutomski, 
director of the Medicinal Plant Research Institute at Poznan 
and Herbapol where there were plantations of medicinal 
plants specially cultivated for their high quality and yield. 
At this time there was no pharmaceutical industry in Poland 
and synthetic medicinal drugs were not readily available. 
The contrast to Britain was considerable and Joe was 
inspired to fight for Pharmacognosy as an important subject 
in the UK. 
Ten years later he returned to Poland where he gave a 
series of research lectures at Warsaw, Poznan and Krakow. 
In 1970 he was elected as an Honorary Member of the 
Polish Pharmaceutical Society and his certificate was 
presented by the Polish Ambassador at the London 
Embassy. Mr WM Darling, President of our 
Phannaceutical Society and Mr DF Lewis, Secretary and 
Registrar, were present as guests. Also present at this 
glittering occasion was one of the authors of this article 
(JDP) and his wife. Never before, or since, have they seen 
so much alcohol presented for consumption. An 
international symposium 'Progress in the Field of Plant 
Drugs' was held at Poznan in 1970 and Joe gave a plenary 
lecture entitled 'Present and future trends in the scientific 
study of plants throughout the world'. The Slovakia 
Pharmaceutical Society held a symposium on Pharma-
ceutical Analysis in the same year and Joe was an invited 
speaker. He presented other research lectures in a number 
of Eastern European countries including Bucharest 
(Romania), Sofia (Bulgaria) and Budapest (Hungary). 
In 1975, Joe was invited to visit the office of the Polish 
Cultural Attache in London and was faced with a series 
of questions about his relationship with the Warsaw 
Medical Academy. It subsequently became apparent that 
he was being awarded a Doctorate honoris causae. The 
honorary degree was conferred in Warsaw in June 1975. 
His contribution to teaching and research in Pharma-
cognosy in Eastern Europe was also recognised by him 
being made an Honorary Member of the Pharmaceutical 
Societies of Bulgaria, Hungary and Poland. 
His use of TLC for the separation of the constituents of 
medicinal plants brought him into contact with Professor 
Egon Stahl of Saarbrucken University and Joe gave 
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several lectures at Saarbrucken. As his reputation grew he 
received invitations to lecture in a number of European 
countries including Belgium, France, Germany, Hungary, 
Italy, Netherlands, Norway, Spain, Sweden and 
Switzerland. Inevitably invitations to lecture came from 
even further abroad including Egypt, Turkey, Iraq, India, 
Sri Lanka, Malaysia, Singapore and Thailand. Wherever he 
went he made strong links and invited many scientists to 
visit him at Chelsea College. 
Conference presentations 
Joe went to many pharmaceutical conferences, including 
the British Pharmaceutical Conferences and congresses of 
FIP, and as the Mitragyna research progressed he 
frequently contributed scientific papers. His inc~ation w~ 
to prefer FIP because there was more mterest m 
Pharmacognosy. He was often accompanied by Dougie 
Harrod and the venues included Austria, Czechoslovakia, 
France, Germany, Netherlands, Poland and Sweden. He 
organised a botanical excursion for the Medicinal Plants 
Section at a London FIP Congress. They visited Burnham 
Beeches and had a reception held by the Lord Mayor of 
Oxford. The day concluded with a dinner at Chelsea 
College. In 1976 he was elected as the Vice President of the 
Medicinal Plants Section of FIP and he was the President 
from 1980to 1984. 
He gave lectures at the majority of the UK Schools of 
Pharmacy and to local branches of the Pharmaceutical 
Society. By the time that he retired he had given more than 
50 local branch lectures. There were also meetings of 
Pharmacy teachers and Pharmacy students where he 
lectured and he always took an active part in their 
discussions. In addition he was invited to lecture to other 
scientific groups including the Society for Analytical 
Chemistry, Society for Chemical Industry, Phytochemical 
Society, National Council for Careers for Women, 11 
Osteopaths, and Naturopaths. He also organised several of 
his own symposia on the application of chromatographic 
techniques and in 1967 he was invited to submit an article 
to the prestigious scientific journal Nature12• As an active 
member and also one time chairman of the Hounslow 
Branch of the Pharmaceutical Society he was at the centre 
of all of their activities. When Parke-Davis was based at 
Hounslow he had the opportunity to meet with industrial 
colleagues and he persuaded the company to donate an 
annual prize for the best student specialising in 
Pharmacognosy at Chelsea College. In 1966 he was invited 
to give the annual Parke-Davis lecture to the Hounslow 
Branch. 
A Committee Man 
Joe was a member of many committees throughout his 
academic career and he was a powerful advocate for those 
matters that he supported. He was a formidable opponent in 
any debate. In 1953 he was an active member of the 
Association of Teachers in Technical Institutes (ATTI) at 
Bristol and he became chairman of the local ATTI at 
Chelsea College. He was active in 1965 at the joint 
discussions between theATTI and theAUTwhen Chelsea 
College was changing from a Technical College to 
university status. 
By 1960 he was recognised as a teacher and researcher 
in Phannacognosy and this led to him joining the 
Phannacognosy Committee of the Pharmaceutical Society 
and also the British Pharmaceutical Codex Revision 
Committee. He prepared detailed memoranda on the 
Pharmacognosy syllabus for CW Maplethorpe, chainnan 
of the Education Committee of the Pharmaceutical Society 
and this led to the formation of a small committee of 
pharmacognosists including Bill Court, Ken Fell, Frank 
Fish, and Betty Jackson , with Joe as chairman. They 
reorganised the Phannacognosy syllabus for the BPhann 
degree and included phytochemistry and chromatography. 
They also prepared a booklet on the identification of 
powdered plant drugs to help undergraduates in their 
practical examinations and this cut down the amount of 
memory required on their characteristic features. 
The Medicines Control Agency (MCA) was established 
by the government under the Medicines Act 1968 an~ ~e 
wording of the Act appeared to put an end to the practlsmg 
of Herbal Medicine. Pressure was exerted by members of 
both Houses of Parliament and Mr A Charnings was invited 
to set up a group of experts to advise the MCA on medicinal 
plants. Joe became a member of this committee that also 
included Mr F Fletcher Hyde, President of the National 
Institute of Medical Herbalists (NIMH), and professors Jim 
Fairbairn and JM Rowson. The committee met many times 
during the 1970s until a report was p~ared 
recommending that a Herbal Products Advisory 
Committee be established. Mr Chamings proposed that the 
British Herbal Medicines Association (BHMA) should 
prepare a British Herbal Pharmacopoeia (BHP) that would 
lay down standards for medicinal plants. Joe. became 
heavily involved in the preparation of the BHP which ~e 
out in several parts until a complete volume was p~blished 
in 1983.13 A fully revised version and a Compendium was 
published in 1992.14,15 He also organised se~eral short 
courses to train those interested in evaluatlng herbal 
material. · f 
Joe was also active in committees of the Univers_1ty ? 
London and was chairman of the Board of Studies m 
Pharmacy and of the Higher Degrees ~mmittee. ~t 
Chelsea he chaired the Refectory Comnuttee and ~ 
required treading a careful line between the students 
demands for cheap meals and the need for the re~ectof)'. to 
break even in its :finances. In turn this led to him bemg 
appointed to the College Financ~ Commi~, a In:ov_e : 
helped to reorganise the allocatlon of funding within 
Department of Pharmacy. 
Dr TE Wallis . 
Joe always held Dr TE (Tommy) Wallis, his P~annr 
cognosy teacher 1934-6, in the hi~est regard. In his ~ ft 
days at Bristol when he prepared his fn:st research pape bis 
was Tommy Wallis ~t. helped ~ to redraft also 
manuscript and to subrrut 1t for publica1:10n. Tommy f 
helped him in his early research at Chelsea and was ?: 0 
his examiners for the degree of PhD. Joe orgar1:1s } 
function at Chelsea College to mark the occasi~~6~ Tommy's 85th birthday in December f 
Phannacognosists from many of the UK . Schoo! ie 
Pharmacy came for a birthday lunch and contnbuted 
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Figure 1. British phannacognosists presenting a 
television set to Tommy Wallis on the occasion of his 
90th birthday, 1966. 
presentation of a silver salver, a 5 year diary and an 
autograph album signed by those present Five years later 
the celebrations were continued and Tommy was given a 
TV set. On this occasion Tommy gave a lecture, complete 
with slides, to staff, students and guests from other Schools 
of Pharmacy. Joe organised a further party for Tommy's 
95th birthday and after lunch Tommy was presented with 
an armchair from British Pharmacognosists. He died, aged 
96, in March 1973, and two of his former students, 
Professors Jim Fairbairn and Joe Shellard, read eulogies at 
Figure 2. Joe Shellard and Tommy Wallis on the 
occasion of his 90th birthday, 1966. 
the funeral service. 
Joe also submitted 
obituaries to the 
Pharmaceutical 
Journal, Chemist and 
Druggist and 
Chemistry in Britain 
(Figures 1,2). 
Retirement 
Joe retired in 1978 
but continued to be 
busy throughout his 
final year. He took 
an active part in the 
Pharmacy Lecturers 
Conference at 
Brighton 
Polytechnic. He was 
involved in the 
appointment of Dr 
Michael Newton as 
the new Professor of 
Pharmaceutics and persuaded Norman Bisset to take 
over as Assistant Head of the Chelsea College 
Department of Pharmacy. He gave two special lectures to 
3rd year BPharm students at the School of Pharmacy, 
Brunswick Square. His term as External Examiner at the 
University of Bath ended and at a special dinn~r his 
former colleague, DA Norton, made a presentation to 
him. In June he went again to Nairobi as an External 
Examiner. 
The Principal of Chelsea College, Professor David 
Ingram and his wife invited Joe and Sylvia to their home 
for a special dinner in July. On the 24th of July there was 
a presentation ceremony for Joe at the Colleg~. ~peeches 
and presentations were made by the Pr:inc1pal, Dr 
Georgina Jolliffe and Cyril Maplethorpe, chairman of the 
Figure 3. Joe Shellard receiving a retirement gift from Dr 
Georgina Jolliffe, Dr Peter Hylands, Dr Peter Houghton, 
and Professor Norman Bisset, 1978. 
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Education Committee of the Pharmaceutical Society. On 
the following day he was the guest of the Pharmacy 
Students Association. The week ended with a lunch with 
his Pharmacognosy colleagues (Figure 3). 
In September he and Mr Harrod attended the FIP 
Congress at Cannes and made a special excursion to La 
Mortola, the Hanbury Botanical Garden in Ventimiglia, 
Italy. He donated all of his scientific books to the Faculty 
of Pharmacy, Hanoi, Vietnam. 
His last day at Chelsea College was 30th September, 
1978. Among the many tributes made to him was one that 
brought tears to his eyes. It was written by his colleague 
Professor Bill Hunter, head of Pharmaceutical Chemistry 
and this small excerpt is pertinent: 
He took over a small, traditionally orientated Phannacognosy 
Department and in 21 years transfonned it to one of the best 
equipped and well known in the countly. In the process he 
himself was to become known throughout the phannaceutical 
world as one of the most famous and respected personalities. No 
scientific subject could have wished for a more devoted or more 
passionate champion, whether lecturing on bis own research or 
arguing with characteristic fervour for material or financial 
support ... Ali of this does not add up to what I have called the 
unique Shellard style. The only comparison I can make is to 
Figure 4. Georgina Jolliffe presenting Joe Shellard with 
a picture of a cricket match, his favourite sport, on his 
80th birthday, 1993. 
Figure 5. Joe Shellard giving a lecture in tribute to 
Dave Phillipson on his retirement at The School of 
Pharmacy, University of London, 1994. 
Aneurin Bevan, the oratory, the lapses into his native accent, the 
flashing eye, the ready wit, the courage and denunciation of cant 
or hypocrisy, all these we shall lose and our communal life will 
be the poorer for it. We shall miss his tireless efforts on our 
behalf, his ability to stimulate and to infi.uiate his colleagues. 
Above all we shall miss his understanding and appreciation of 
the real issues that are often buried beneath layers of 
circumstance and expediency. 
After such a busy career it would not have been 
surprising to learn that Joe Shellard relaxed into an easier 
lifestyle. Nothing could be further from the truth. He 
wrote a series of articles entitled 'A History of British 
Pharmacognosy, 1842-1980' for the Pharmaceutical 
Journal, 16 also collected into a soft backed fonnat as a 
private publication17 with a foreword by Desmond 
Lewis, fonner Secretary and Registrar of the 
Pharmaceutical Society of Great Britain. There are nine 
separate articles and they include accounts of the Materia 
Medica Museum and Herbarium of the Pharmaceutical 
Society, the life and work of Jonathan Pereira, Daniel 
Hanbury, EM Holmes, Henry George Greenish, and TE 
Wallis. He also took up painting each morning and many 
of his colleagues and friends have been delighted to 
receive one of his pictures. 
When he had been retired for nine years he was invited 
by Professor Lutomski, Director of the Institute of 
Medicinal Plants, Poznan, to present a lecture at their 
40th anniversary celebrations in 1987. Years previously 
in 1970 he had given a lecture at their international 
symposium entitled 'Research on Medicinal Plants 
throughout the World' and a paper 'Present and future 
trends in research in medicinal plants and crude drugs in 
Great Britain' was published in Herba Polonica. 18• In his 
1987 lecture he summarised the research taking place in 
British Schools of Pharmacy by pharmacognosists 
including NG Bisset, G Blunden, FJ Evans, PJ 
Houghton, PJ Hylands, ID Phillipson and MF Roberts. 
Although he had been retired for 9 years he still kept a 
keen interest in the research of British pharmacognosists. 
A lunch at Kings College London to celebrate Joe's ~Oth 
birthday in 2003 was organised by Professor Bob Hider, 
Head of School of Biomedical and Health Science. 
Tributes were paid to him by three of his former 
colleagues and although he claimed that he had not 
prepared a speech, he entertained the assembled ~es!5 
with his usual great humour. Joe never lost interest m his 
favourite subject, Pharmacognosy, or in his fellow 
pharmacognosists (Figures 4,5) and he died on the 10th 
June 2010 aged 96. 
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The relationship between the 
expeditions of the Heroic Age of 
Antarctic Exploration and drug 
companies 
Dr HR Guly FRCP, FCEM 
Retired consultant in emergency medicine 
Derriford Hospital, Plymouth, PL6 8DH ' 
The main supplier of drugs and medical equipment to the 
British and Australian Antarctic expeditions of the 
Heroic Age was Burroughs Wellcome and Co 
(BW &Co). This paper discusses the relationships 
between the expeditions of Scott and Shackleton and 
BW &Co and also discusses some of the other companies 
that supplied drugs or used the names of the expeditions 
in their advertising. 
Introduction 
The main supplier of drugs and medical equipment to 
both of Robert Scott's and all three of Ernest 
Shackleton's Antarctic expeditions was Burroughs 
Wellcome and Co (BW&Co). They also supplied the 
Scottish and Australian expeditions, Roald Amundsen, 
the Southern Cross expedition, the Morning (the ship that 
relieved the Discovery in 1903 and 1904) and 
expeditions to many other places including the Arctic, 
Africa and Mount Everest. 
The drugs themselves and the types of medicine chests 
and cases supplied are described in previous papers in 
this series. 
From the founding of its business, BW &Co had 'made 
a special feature of studying medical and surgical 
requirements for expeditions to tropic and arctic and 
other trying climates, especially for the use of explorers, 
journalists and other travellers ... ' 1 and they supplied 
these drugs and other medical equipment in their 
medicine chests and cases. These medicine chests 
became established as emblematic of the company2 and 
the expeditions that used their cases were much quoted in 
BW &Co's advertising literature. This paper discusses the 
relationships between BW &Co and the expeditions. 
BW&Co's medical cases for travellers 
While the concept of a medicine chest was by no means 
new, BW&Co's formulation of drugs in tablets and 
compressed bandages meant that their chests were more 
compact than previous ones. The idea of the chest seems 
to have been Silas Burroughs': 
These cases ... would I believe be the means of introducing 
our goods more acceptably[,] rapidly & profitably to the 
medical profession & public, and at the same time with less 
expense to ourselves than any other means. Every chemist 
would be willing to keep one of each sort of case on his 
counter together with copies of the books for sale. Such a case 
in [the] bands of each doctor & chemist . . . would spread our 
goods over the world in a hurry greatly to our credit & profit.2 
BW&Co's interest in travel and the traveller's medical 
chest has, I believe, several elements. Firstly Sir Henry 
Wellcome was personally interested in travel and had 
travelled to Ecuador, where he searched for cinchona, 
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and Sudan and he had a personal friendship with the 
explorer, Henry Morton Stanley. He also saw the benefits 
of travel for his business: 
Exploration had the potential to open up more markets 
for their products and, outside medicine, he noted that 
'many of the most invaluable discoveries came as by-
products of an explorer's achievement', for example the 
northern whale fishery was discovered during a search 
for the North West Passage.3 Explorers also assisted him 
in building his collection of medical objects.4 
Others have reached different conclusions. 
Commercial opportunities were, of course, greater in the 
colonies rather than the Antarctic and comments such as 
'the medicine chest goes hand in hand with the advance 
of civilisation. The conquest of disease and the battle 
against ignorance and superstition are fought along the 
same frontiers5 have been used to paint the extreme view 
that marketing medicine chests to travellers to the tropics 
was 'to preserve white European bodies against the 
vagaries of a highly racialized tropical climate' and was 
'scientific racism' by upholding 'the western belief in a 
hierarchy of civilizations, with the west - particularly 
Britain - at the summit. '6 
Lastly, of course, he used these connections with 
explorers for advertising. 
Use of the expeditions in BW&Co 
advertising 
Many of the expedition medical chests and cases were 
lent and, on their return, became part of the Wellcome 
Collection. These 'were featured as tools of travel and 
exploration within company brochures and through their 
display at international trade fairs. The objects therefore 
became part of campaigns to build and advertise 
BW &Co as a global company'4 and Johnson says that 
'the chests eventually became as famous as the explorers 
who used them, going on tour, with their own history and 
stories of adventure. '6 
Another of Sir Henry Wellcome's interests was the 
history of medicine and BW &Co produced a number of 
small books which combined brief histories of medical 
topics with advertising of their products to the medical 
profession. 
At least five of these7,8,9,10,11 described the medicine 
chests supplied to Antarctic, Arctic and other expeditions 
and included testimonials from the explorers and their 
doctors. From the Discovery Expedition, Dr Edward 
Wilson wrote: 
Though there was but Little serious illness on the 'Discovery' 
during the recent Antarctic expedition, the 'Tabloid' 
preparations and the cases were put to a fairly rigorous test, 
not only in the ship but on the various sledge journeys that 
were undertaken during which they experienced 
temperatures as low as 68°F below zero, and much rough 
handling, without any loss of efficiency and usefulness. 
Certain of the 'Tabloid' Ophthalmics were freely used for 
snow blindness, and were found to be most convenient. 
Sir Clements Markham (president of the Royal 
Geographical Society) and Drs Reginald Koettlitz and 
George Davidson (medical officer to the relief ship 
'Morning') also provided testimonials, as did Ernest 
Shackleton and Dr Eric Marshall from the Nimrod 
expedition.7 From later expeditions testimonials were 
provided by Roald Amundsen, Ernest Shackleton (from 
the ITAE), Frank Wild (Quest expedition)12 and the 
doctors of the Terra Nova expedition. 13 They continued 
to support arctic and Antarctic exploration and also used 
a testimonial from Richard Byrd12 who led five US 
expeditions between 1928 and 1956. 
BW &Co also used their Antarctic connection in 
advertising their products to non-medical travellersl4 
(Figs 1 and 2). 
i;.-::~'TAIBHLOID' BRAND 
Medical Equipments 
have been supplied to ev.ery important expedition of recent years, 
including the Stanley, Nansen, Peary, Jackson, National 
Anwctic, and Scottish National Antarctic Expeditions, and 
were extensively used in the South African and o!,her campaigns. 
1'a. 9 -T.\Wt.Of'1J' 8'u4 M&Dtcrl'& CNUT, ,.._ fll ,..... ... .._ 
o.tad.e ............ •JW X ~- XIJ(. W...,.. al'*'-:.._ ........... .. 
The chest illustrated abo\"e is invaluable for c:araftn 'l'Od: 
and base dep3ts, being compact, complete and portable. 'The 
contents are unaffected by heat, cold or damp and me 
always ready for instant use. Cases to suit an requiremen.ts 
in any pan of the world are issued in a variety of sizes. 
Elltilffl.u ,,-,. or lll••trflt-' JIil 
a.11d /•II putlC11/a•1 ,.,,t tNI r,qt1ut. 
Btruoucrns WE.LLCOWE AND Co., LONOON, SYDNEY, CAPB 'IO'lfll 
£x ... 
[To I= lad p. of-""· 
Figure 1. Advertisement in Royal Geographical Society. 
Hints to Travellers Scientific and General: vol 2. London: 
Royal Geographical Society, 1906: vii (ref 14). 
Arrangements with expeditions . 
The benefits of this were not of course, one-sided as 
expeditions look to compani;s of all sorts to provide 
food, equipment and medical supplies cheaply or even 
for free. 
Church says that one of the things that differentia~ 
BW &Co from other drug companies was their marketmg 
and actively seeking orders from doctors and 
pharmacists, rather than waiting for orders to arrive 15 and 
they were certainly pro-active in approaching e.xplorers 
to provide the drugs and equipment for expedibOOS. A 
report (presumably to a superior within the company) 
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Figure 2. Advertisement for Burroughs Wellcome 
showing various situations in which a Tabloid medicine 
chest would be useful. 
Reproduced by permission of the W ellcome Trust. 
shows that the day after the announcement of the 
Endurance expedition, BW &Co approached Shackleton: 
Following the announcement in the 'Daily' papers of 30th 
December 1913, I ... interviewed Sir Ernest Shackleton ... 
respecting the order for his medical supplies. 
Shackleton obviously wanted to use BW &Co 's products 
but also realised that BW &Co needed his custom as the 
report continues: 
Sir Ernest immediately asked if we were going to give the 
medical equipment to him - I said I had not come prepared 
with an answer to that request, but presumed he would be 
willing to entrust his equipment with us on the same 
condition as before ... [ie supply J the entire medical 
equipment at cost ... Sir Ernest said ... "I know who to go to 
for the various items of my equipment when the time arrives 
and Burroughs Wellcome & Co. for medical supplies is a 
household word", but as he is requiring further funds he is 
looking forward for most of his equipment being supplied 
gratis.16 
The final agreement was set out in a letter to Frank Wild, 
Shackleton's deputy: 
We understand that you will kindly regard our finn as the sole 
suppliers of your medical equipment. In view of this we shall 
have great pleasure in loaning to you free of charge, a 
regulation case of surgical instruments, and also a specially 
designed Aluminium Outfit for the party who are making the 
march from the Weddell to the Ross Seas (It being 
understood that you will be kind enough to return these two 
cases to us on your return to England for our Historical 
Museum); that you will let us have a report on the medical 
equipment signed by yourself; and that if you write a book 
upon the Expedition you will be good enough to mention that 
we were the sole suppliers of the medical section of your 
equipment, in return for which we will supply the balance of 
the surgical and medical equipments packed in convenient 
size portable cases, at cost.17 
I have not found the agreements with the other 
expeditions but the letter above implies that the 
agreement for the Endurance expedition was going to be 
the same as that for Nimrod. The arrangements for Scott's 
Terra Nova expedition were similar, as there is a letter 
from BW &Co emphasising: 'We draw to your attention 
the fact that it is the entire medical equipment, and all the 
photographic chemicals'18 and a letter from the company 
to Henry Wellcome that states that Scott 'has accepted 
our offer [to supply the complete medical equipment] on 
the conditions proposed, namely that we are the only firm 
to supply his medical and surgical equipment ... ' 18 As 
further evidence of Sir Henry Wellcome's interest in the 
expeditions, he also made a personal donation of 200 
guineas (£210) towards this expedition. 19 They also 
supplied photographic equipment, veterinary drugs and 
chemicals for Dr Atkinson's bacteriology, protozoology 
and helminthology and they supplied veterinary drugs to 
the Australian expedition. 
When William Spiers Bruce (the leader of the Scottish 
expedition) was planning a second Antarctic expedition 
for 1912 (which never happened), BW&Co wrote to him 
saying: 'we trust that if you decide upon leading an 
Expedition to the Antarctic regions you will not forget 
our application to be allowed to supply your medical 
equipment. ' 20 
The company also made an unplanned contribution to 
Shackleton's ITAE. Shackleton left England in August 
1914 with many unpaid bills and in December of that 
year BW &Co were chasing an unpaid bill of 
£235.18s.Od.21 Shackleton's solicitors replied that due to 
the start of the First World War, 'a considerable sum of 
money which had been promised ... was not forthcoming 
[and that] the funds at present .. . do not permit [them] to 
meet liabilities in full.' 22 £63.13s.6d was paid in July 
191523 and eventually, once news of Shackleton's 
shipwreck and rescue reached England, the remainder of 
the bill was written off.24 
BW&Co imply that they 'hedged their bets' over the 
Scott-Amundsen race to the South Pole writing: 
'incidentally, both Amundsen and Scott carried 'Tabloid' 
Outfits. So, whichever one of them had won, the 
'Tabloid' Equipment would have been first at the South 
Pole as at the North Pole'25 (they had also supplied 
Peary). However, they would not have known that 
Amundsen was planning to reach the South Pole, as 
when his expedition set out it was bound for the Arctic. 
Other drug companies 
BW&Co would supply other drug company's products 
(presumably when they had no equivalent). Thus Dr 
Levick asked for, and was supplied with, Trilactine 
(manufactured by Martindale's).26 Despite BW&Co 
wanting exclusive rights to supply medical equipment, 
this did not always happen. Doctors might take their own 
drugs. On the Nimrod expedition Dr Eric Marshall took 
a supply of 'Forced March' (Kola compound) which was 
not part of the formal sledging medical kit. This is 
described elsewhere.27 However, this was a BW &Co 
product (and, later, was part of the official list of drugs for 
the Endurance and Terra Nova expeditions). 
Roald Amundsen obtained drugs from both Norway 
and from BW&Co: 'A chemist in Christiania [Oslo] 
supplied all the necessary medicines as a contribution, 
carefully chosen, and beautifully arranged '28 but 'The 
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Figure 3. Testimonial form Sir Clements Markham 
reproduced in Anon. The Evolution of Antiseptic Surgery. 
London: Burroughs Wellcome & Co, 1910: 114.33 
medical stores for sledging were given by a London firm. '29 
The Australian expedition obtained its drugs from 
BW &Co but its surgical instruments from Allen and 
Hanbury.30 
Despite Dr Koettlitz saying, in a testimonial, 'the medical 
equipment of the Discovery ... was entirely supplied by 
Messrs Burroughs Wellcome & Co ... '9 this was not true 
as he also obtained drugs from other sources. The British 
Medical Journal said that 'The medicines, mostly in the 
form of tabloids and palatinoids, are kept in locked 
cupboards '31 and in an interview Dr Reginald Koettlitz said 
that the main medical outfit was supplied by BW &Co but 
that 'in addition I took a few of Oppenheimer's Palatinoids, 
which also proved thoroughly successful. '32 Sir Clements 
Markham said that the entire medical equipment for the 
Discovery expedition was supplied by Burroughs 
Wellcome and that 'the few other drugs and preparations 
taken with the Expedition were only supplied for purposes 
of experiment, and, in no way can be regarded as part of the 
medical equipment'33 (Fig. 3). 
Palatinoids consisted of 
two convex disks of soluble jujube containing the purest 
drugs obtainable of powder or liquid, without the addition of 
excipient unless the local effect of the medicament would be 
either corrosive or extremely poisonous. Palatinoids are 
easily swallowed, accurate in dosage and keep indefinitely. 
All drugs usually taken as powders, pills or cachets are 
supplied in this portable and elegant forrn .34 
They were used particularly for drugs which were 
unpalatable to take or which denatured on exposure to the 
air. In the words of an advertisement: 
Palatinoids preserve the drugs from contact with the atmosphere, 
are not stamped into a concrete mas.s or bound up with insoluble 
material as are tablets and pills. They are as economical in price as 
the best tablets or the best pills. 35 
require cases or hampers to pack them in before being taken 
away. '36 This does not imply small quantities. 
Oppenheimer used this letter from Koettlitz to advertise 
their products36 to non-medical travellers only a few pages 
from the BW&Co's own advertisement in the same bookl4 
(Fig. 4). This cannot have pleased BW &Co and is probably 
the reason for their insistence on exclusive rights in 
subsequent British expeditions. 
Surveys of the huts used by the explorers have also shown 
medicinal products not supplied by Burroughs Wellcome. I 
have described some of these elsewhere.37 
The ITAE Ross Sea Party also took Hean's Essence or 
Heenzo, a patent cough medicine. This only seems to have 
been used in Australia and New Zealand so must have been 
taken from there. Advertisements for this (Fig. 5) carry a 
testimonial from Ernest Wtl.d and Ernest Joyce and quote 
Shackleton (who would not have used it, as the Endurance 
did not visit Australia or New Zealand) as saying 'I am 
informed that they found the remedy of value under the 
exceedingly severe conditions experienced in the Ross Sea. '38 
Other advertisements were phrased to imply that he himself 
used it: 'Heenzo is the remedy for colds, about which Sir 
Ernest Shackleton and members of his exploration party 
wrote in terms of high praise. '39 In its advertising, the 
company used testimonials from a variety of famous 
:n 
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~ 
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up with Insoluble material as are 
CLOSEO. tablets and pills. OPU. 
They ore H eco11omlc:al In pri~ as the but tableto or the bell pllil. 
They are used to-day In all quvtcr~ of the world. 
S11rre:oa H. P . T .• H.M •. 5. ••Torch, '' .Sydney, writes :-
.. l ,Yu much 1urpri1ed to hear from ray fathtr, IDlpt'-1.or-Gcneral Ale.under 
Turnt,uU, R.N., that you hove o~ beard from me ...,.pec:llllC the l'IJ&Unolda fOQ 
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by ••perts .sultablc for all parts of die World. 
Award«lonlyOOLDMEOAL. INTERNATIONAL MEDICAL CONORESS. 
OPPENHEIMER, SON tl CO., Ltcl., 
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Although Koettlitz says that he took a 'few' Palatinoids, 
he is quoted as saying to the company 'we have many of 
your products on board which have not been used' and 
offered to sell them back but warned that 'they would 
Figure 4. Advertisement in Royal Geographical Society. Hints 
to Travellers Scientific and General: volume 2. London: Royal 
Geographical Society,1906: xv.36 
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Survivors over six millennia: 
Essential oils 
Malcolm E Brown MPhil PhD 
MRPharmS MCPP 
Beccles, Suffolk 
Introduction 
Medicaments and pharmaceutical adjuncts seldom 
remain for millennia. The numbers of index entries 
between the 17th and the early 21 st centuries, in the most 
authoritative hard-copy British information source ( e.g. 
Martindale) in use during nine separate years: 1633 
(Gerard),' 1793 (Brookes),2 1890 (Squires),3 1908 
(Squires),4 1952 (Capper),5 1958 (Capper),6 1968 
(Todd),7 1982 (Reynolds)8 and 2011 (Sweetman)9 were 
counted. The increase was astonishing: approximately 
27-fold. Information in Figure 1 illustrates that. 10 
This provides evidence of an explosion of knowledge 
especially over the last two generations. It follows, if 
'importance' is measured by the fraction of the whole 
body of knowledge available in that particular year, that 
any one entry in 2011 is only 'worth' about a twenty-
seventh of that in 1633. So entries that do survive become 
more 'valuable'. Moreover, I have witnessed that many 
entries in the British National Formulary on my 
registration as a pharmacist in 1968 had disappeared, 
been superseded, in the BNF used on my retirement in 
2010. When those perspectives are expanded to 
millennia, the very few medicaments that do survive 
matter greatly. They include opium and fragrant 
materials. 
Human bodies can still suffer severe pain; that is a 
medical emergency. Opium-related medicines remain 
our strongest analgesics so the survival of opium is easily 
explained. But why have essential oil-related materials 
survived? This article will focus upon the liquid fragrant 
materials called 'essential oils' and tentatively offer one 
explanation for their survival. 
Oils are hydrophobic liquids, unlike fats that are solid 
at room temperature. Essential oils include conc-
entrated volatile aromatic compounds from plants. They 
are the intensely scented 'oil of' the plant from which 
they were extracted, such as clove. Each specific oil 
smells of their particular plant. Today we know that 
perceived odour results from one or more 
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empirical chemicals that have an odour. Their molecules 
are sufficiently volatile to transport in air by diffusion into 
the olfactory system in the upper nose. Smell builds 
slowly in a 'crescendo' and then slowly decreases, over a 
period of seconds to hours, and is not 'instant' such as 
sight, hearing, touch or proprioception (internal feelings 
of pain or balance). In general the chemicals must have 
molecular weights over 300; that is co-related with 
(comparatively) low boiling points; they vary from about 
160° to 270° C. Their odoriferous ingredients typically 
include alcohols, aldehydes, esters, ketones or terpenes. 
They have boiling points, generally above that of water 
but below that of the comparatively odourless fixed oils 
that contain mainly triglycerides. For example olive oil 
boils at 300°C; its main ingredient, oleic acid, boils at 
360°C. Although at room temperature, the essential oils, 
by definition, are liquid, their odoriferous ingredient(s) 
may be solid. Illustrations of volatile oils of historical 
pharmaceutical importance are shown in Figure 2. 
Figure 2: Essential Oils, illustrative odoriferous 
ingredients and boiling points 
Oil One odoriferous ingredient 
Name Boiling point 
oc 
Aniseed Anethole 234 
Bergamot Linalyl acetate 220 
Clove Eugenol 254 
Dill Carvone 231 
Juniper Camphene 159 
Orange or Limonene 176 
lemon 
Lavender Camphor 204 
Rose P-Damascenone 274 
Peppermint Menthol 212 
Thyme Thymol 232 
Pine Terpineol 2 19 
Smelly molecules (odourivectors) directly contact 
odour receptor nerves that are a direct extension of the 
comparatively nearby brain. One suggestion is that the 
specific nerve fires if the odourivector's molecule fits 
into the olfactory nerve as a key in a lock. There are about 
thirty types of anosmia (partial odour 'blindness') and 
that may suggests that about thirty types of odour 
receptor may exist. One type, for example could be a 
hemispherical socket for a spherical camphor-smelling 
molecule. 11 But there may be a smaller number of basic 
primary odours correlating to odour receptors for each, 
much as the spectrum of perceived colours in visible 
light is generated by the activation of three primary 
Pharrn Hist (Lond) 2014; 44 (1): 13 
colour receptors. In 1949, Amoore suggested a 
stereochemical theory requiring seven primary odours, 
for example, include floral, minty, musky, 
camphoraceous, ethereal, pungent and putrid. 12 Olfactory 
nerves function in parallel with nerves of taste in the 
mouth with their specific 'lock' receptors for particular 
tasty 'keys'. To perceive smells (and tastes) the brain 
mingles input from smell and taste. Interestingly, the 
odoriferous molecules of menthol also act on receptors 
for cold; they lower the threshold for firing. This explains 
why menthol-containing dentifrices feel fresh and 
tingle. 13 When the olfactory bulb detects an odour, it 
signals the cerebral cortex and sends a message directly 
into the limbic system, where we feel, lust and invent. 
That part of the brain is so ancient that we share it with 
lizards. Unlike other senses, smell needs no interpreter. 
Once perceived the effect is immediate and requires no 
thought or translation and cannot be censored. Sound and 
vision that we experience in short-tern memory seem to 
quickly fade and become inaccessible but smells induce 
intense nostalgia. 
Perfume is liquid memory. 14 Whenever I smell a rose 
on an evening after rain, I am instantly transported: my 
5-year old self is in my grandmother's garden with roses 
around the door and an air-raid shelter and chickens 
clucking. Whenever I smell gaseous anaesthetic, it 
transports me into being a post-graduate student 
undergoing practical training in hospitals: suddenly, I am 
scrubbing out a large stained porcelain sink with an ether 
soap, bleach and scouring powder suspension. Kipling 
observed in his poem Lichtenberg, 'Smells are surer 
than sights and sounds to make the heart-strings crack.' 
When we add that to smell seeming to wash over us, to 
arrive and leave slowly, no wonder the ancients noticed 
aromatic medicaments, mentioned them in their literature 
and left traces in their artefacts for us to detect. 
Ancient history 
The Mesopotamians lived between the Tigris and 
Euphrates rivers corresponding to modem Iraq, 
Northeastem Syria, Southeastem Turkey and smaller 
parts of southwestem Iran. I can imagine an inquisitive 
Mesopotamian slicing open a sun-warmed ripe orange 
skin with a finger-nail and a spray squirting out, 
illuminated in a sunbeam and, on impulse, sniffing it in. 
An intense pleasing odour from ruptured schizogenous 
glands resulted. That simple pressure technique would 
yield very little essential oil, but it would be a finite 
volume. I further speculate that our adventurer might 
have wanted to collect this liquid pleasure and store to 
enjoy after the orange had lost its scent. 15 What is fact is 
that when we use tools on materials using our bodies, 
particularly our hands, and reflect on what we can do 
(such as fabricating equipment in order to make essential 
oils) intuitive mental leaps happen. 16 This article outlines 
the journey of pharmaceutical artisans and others 
interested in essential oils, from antiquity to today. 
What is known is that the Mesopotamians could 
extract natural plant aromas. Witness from Campbell 
Thompson's Assyrian Prescriptions for Bruises and 
Swellings: 
cedar, cypress, fir-turpentine, pine-turpentine ... lemon ... all 
plant-drugs, all aromatics .. . thou shall put, boil in a small 
copper pan. 17 
We presume their pharmaceutical formulae developed by 
trial and error. Those dense herbal materials on, 
presumably, simmering, became a pharmaceutical 
concoction. As an aqueous solution was being boiled, the 
temperature would have slightly exceeded 1 oo0c at sea 
level. Because of the copper pan, this occurred in the 
copper age: about 4000 BC - six millennia ago. 
There in some evidence that the Mesopotamians 
possessed distillation pots. Perhaps distillation, even if 
unwitting, was achieved. Distillation pots have been 
found in Tepe Gawra, Iraq, dating back to about 3500 BC. 
One double-rimmed earthenware pot is of about 371 
capacity; the double rim allowed about 2L of distillate 
condensed against the lid to be collected. It was the most 
primitive form of the later aludel. Texts mention its 
careful heating and instruct how to keep the heat from 
reaching the rim, the primitive receiver of the distillate. 
However, it is presumed that they did not understand the 
principle of distillation. 1s 
The Egyptians were their geographical neighbours 
from round 3000 BC. The embalmers who attempted to 
preserve cadavers, including against bacterial decay, used 
materials such as initially soda (natron) to dehydrate, then 
pitch, juniper oil (my italics), frankincense and myrrh. 
Many materials were used; the result had a 'strongly 
aromatic aroma' .19 This is important: the first reference to 
an essential oil Quniper) as a specific refined material that 
this present author can find. However, at least one other 
author has a different opinion about Egyptian essential 
oils.20 Presumably perfumes counteracted to some extent 
the stench of decay. Egyptians used perfumes for three 
purposes: embalming, aesthetic during their lives to 
enhance an individual's status and as offerings to 
deities.21 The aromatics diffused upwards to please 
and/or placate the gods. It is probable that priests made 
most of the perfumes; the pursuit was considered 
mysterious: an esteemed art. 
Most essential oils are thought to have been produced 
by a type of enfleurage extraction: the 'most an~q~e 
method of extraction known' . The vegetable matenal 1s 
pressed in plant or animal fat (grease) that absorbs .th~ 
aromatic materiaJ.22 If the technology of the still, to distil 
spirits, mainly alcohol, had diffused from the 
Mesopotamians, perhaps that aromatic grease was then 
washed in alcohol: perfumed alcohol would result. 
Egyptians also used maceration: comminution and 
immersion in hot oils and expression presumably by 
presses.23 
The Ancient Greeks took over and absorbed the 
wisdom of the Egyptians. The Roman historian Pliny 
tells us that the Greeks ( and Romans) flavo~ed both the~ 
sauces and their wines 'with (peppermmt) essence · 
Presumably this refers to some kind of aq~~ous 
decoction or infusion. The ancient Greek phys1c1ans 
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used two species of mint, but some writers doubt whether 
either was the modem peppermint, though there is 
evidence that the Egyptians cultivated M piperita.24 
Modem peppermint is a hybrid of watermint25 and 
spearmint.26 Hippocrates (460-377 BC) included aroma-
therapy massage in his treatment. Rose, violet and lily 
were popular as perfumes; this present author does not 
know whether these were extracted as essential oils. 
The first evidence of distillation is in Alexandria 
around the first century AD.27 An unmistakable drawing 
of a complete 'modem-looking' still, perhaps from 
around the third century AD, is shown in Figure 3. 
"'l'J "P Ki ~'I'~ ,, .... 
}-.r, rti .. 'o 
9~\o -
"'' 
Figure 3. Early still of Zosimus, Alexandria. 27 
In tum, the Romans took over the medicinal wisdom of 
the Greeks; this was part of a wider appropriation of 
knowledge such as much of Greek lore about stars. Some 
Bible experts say mint was among the 'bitter herbs' 
mentioned in Exodus 12:8 and Numbers 9: 11. Mint was 
eaten after meals as a digestive aid. Again this author is 
unable to discern any evidence of an actual volatile oil 
being used. Galen was a Roman physician important 
enough to be selected as the right-hand bearer of the arms 
of the Pharmaceutical Society of Great Britain in 1844. 
After the fall of the Roman Empire, the Arabic empire 
rose. It embraced not only Greek and Roman teachings but 
also those of China and India. The Persian physician 
Avicenna, or Ibn Sina, in Persian (980-1037 AD), the left-
hand bearer of the Society's arms,28 was amongst those 
who made perhaps the most significant advance in 
distillation for essential oils.29 Few people appreciate that 
Avicenna proposed the first law of motion 600 years before 
Newton. 30 At aroundAvicenna's time steam distillation was 
invented: a seminal event for the extraction of essential oils. 
On heating, the two mutually immiscible liquids 
(volatile oil and water) exert their respective vapour 
P~sures, independently, in their mixture; that changes 
With temperature. Total vapour pressure increases (Raoult's 
Law). The mixture starts boiling when the total vapour 
pressure exceeds atmospheric pressure. Many aqueously-
~oluble organic compounds, such as the complex 
nuxtures comprising essential oils, can be so purified at a 
temperature below that of their thermal decomposition. 
Using steam distillation, almost 100% of essential oil of 
high quality and purity can be extracted from botanical 
material.31 
Meanwhile, during the European Dark Ages ( about the 
5th to 15th centuries) monks in monasteries were 
influential in keeping pharmaceutical knowledge alive. It 
might be presumed, on the one hand, that the Crusaders 
were influenced by Arabic techniques and brought back to 
Europe sophisticated steam distillation of volatile oils. On 
the other hand, those ideas might have been be discounted 
as being from Saracens and therefore heathen and 
polluting.32,33 Sometime before 1250, GilbertusAnglicus 
produced the Compendium of Medicine. This author can 
find no reference to essential oils in a partial translation 
although that did acknowledge the benefit of aromatic 
materials for nausea: 
a little aromatic wine will also benefit the patient, and a few 
aromatic seeds chewed in the morning are al o of service.34 
Recipes containing oils are mentioned. Further research 
is required to see if they include essential oil(s), perhaps in 
the more detailed copy archived at the Royal College of 
Surgeons, London.35 That might comprise the first 
documentary evidence of essential oils in Britain. During 
the Black Death in 1348-9, some opinion describes 
contemporary plague doctors as wearing bird-like masks. 
However, more opinion appears to attribute the invention 
of the 'beak doctor' costume to the French physician 
Charles de Lome (1619). Plague doctors wore masks with 
long beaks containing powerful-smelling medicaments, ie 
an early biohazard suit (Fig.4). One essential oil was 
bergamot oil. 
Renaissance onwards 
During the European Renaissance (14th to 17th century) 
one person could no longer know everything. To 
Figure 4. Plague Doctor showing Beal< containing 
essential oil. Engraving by Paul Furst ( 1656) . 
Pharm Hist (Lond) 2014; 44 (1): 15 
discover the secrets of nature, man had to torture it,36 
such as by the violence, the dismemberment, of 
distillation. Paracelsus ( 1493-1541) distilled alcohol 
from wine and considered alchemical process including 
fire a universal way of concentrating the specific 
properties of a substance, although his chemical theories 
are challenging for modem eyes to attempt to 
understand.37 Distillation became well-established. The 
rich houses of England boasted 'still-rooms' where 
servants distilled spirits; servants sweated to prepare 
refined requisites for refined people. In still-rooms 
servants also manipulated 'citrus peel'. 38 Charles 1 st was 
anointed at his coronation in 1626 with a mixture 
including musk, civet, ambergris, flowers of benzoin, 
and oils of orange flowers, roses, cinnamon, jasmine and 
sesame (my italics).39 By the 17th century, nearly all 
classes used cosmetics. An Act of the English parliament 
intended to protect men beguiled ('seduce and betray') 
into matrimony 
by the scents (my italics), paints, cosmetic washes, artificial 
teeth ... incur the penalty ( of) law in force against witchcraft 
... and marriage .. . null and void.40 
Since the 17th century, the scientific method has 
characterised natural science, consisting in systematic 
observation, measurement, and experiment, and the 
formulation, testing, and modification of hypotheses, 
iteratively. Or put colloquially, observe, guess, test and 
propose, again and again.41 Presumably, this will have 
been applied to the production of essential oils by the late 
renaissance. 
From the 19th century, laboratory-based science 
became more dominant. Early teaching at the newly 
established Pharmaceutical Society of Great Britain and 
its examinations were influenced, for example, by 
prestigious German chemical laboratory science.42 
Indeed, in the fourth quarter of the new Society's coat of 
arms was an alembic and receiver, an early apparatus for 
distillation that represented the pharmacists' chemical 
skill. It also symbolised the new drugs, some of which 
were single, pure chemical entities. The tempestuous 
development of organic chemistry helped improve the 
design of stills. Stills, retorts, vacuum evaporators (able 
to function at lower temperatures) and steam boilers 
became commonplace.43 Steam distillation is a method 
for distilling thermolabile compounds. The temperature 
of the steam is easier to control than the surface of a 
heating element, and allows a high rate of heat transfer 
without heating at a very high temperature. This process 
involves bubbling steam through a heated mixture of the 
raw material (e.g. leaves or flowers). Some of the target 
compound will vaporise (in accordance with its partial 
pressure). The vapour mixture is cooled and condensed. 
That usually yields a layer of oil and a layer of water. A 
Florentine receiver may be used to separate this mixture, 
depending on whether the essential oil is less or more 
dense than the watery herbal distillate. The position of the 
tap to drain off the oil is high or low respectively.44 
One notorious appearance of peppermint oil in the 19th 
century was in 1858 when 200 people suffered arsenic 
trioxide poisoning and 20 died in Bradford after eating 
peppermint humbugs. The arsenic was substituted for a 
cheap sugar replacement (' daff': often calcium sulphate) 
by the druggist Charles Hodgson. However, peppennint 
oil had been used in their manufacture. The essential oil 
itself was safe and damaged only by association. 
Recent history 
By the early 20th century in the USA (and presumably 
the UK), ordinary people, non-specialists, undertook 
DIY preparations including dry and steam distillation.45 
In the 1960s, plants from which essential oils were 
derived still mattered. They formed a significant part of 
the Pharmacognosy curriculum for future pharmacists. 
For example, I was examined, while being timed walking 
along a bench offering a row of ten natural products. 
Examples were: anise, cardamom, cassia, chamomile, 
cinnamon, dill, fennel, ginger, nutmeg, and Penang and 
Zanzibar cloves. Identification was required. One mark 
was awarded for each correct answer but any incorrect 
answer lost a mark, so deterring guesses. During one year 
I had glued a sample of each drug on cards by my bedside 
in the hope of memorising their appearance; a boxful, 
well beyond their expiry date, still lurks in the attic._ . 
In the 'peppermint water' case (1998), a baby died m 
the UK after a concentrate was incorrectly diluted. 
Examinations for the assessment of pharmacy pre-
registration students include a section on calculations (no 
electronic calculators allowed) that students must pass 
before registration. . . 
Today, essential oils remain important: a s1gmficant 
article of commerce, globally. One estimate, extrapolated 
from 1989 data, suggests, for example, 12,000 tonnes of 
sweet orange, 4,800 of peppermint, 2,600 of cedar woo'; 
2,100 of eucalyptus, 2,300 of lemon and 2,000 of cl~v~. 
Martindale9 gives information on about 60-70 van~~es 
of essential oil.47 Uses includes pine-smelling dism-
fectants, gripe water, mouthwashes, toothpastes, 
medicine flavourings, toothache applications, arom~-
therapy oils and topical preparations such as kao~ 
poultice that contains 0.05%, thymol ~d 0.05 Yo 
peppermint oil. Peppermint oil 0.2 mL r~mams re_gularl~ 
prescribed for the relief of abdommal colic an 
distension, particularly in irritable bowel S)'.lldrome.48 
Lavender oil may assist relaxation in recovenng cancer 
patients, for example. . It 
The ancient process of enfleurage 1s seldom used: 
now includes extraction by solid odourless fat, washing 
the fat with alcohol and evaporating off that alcohol; the 
essential oil such as jasmine remains. Most flowers 
contain too little volatile oil to undergo the pressing used 
for olive oil. Some odoriferous chemicals are too 
thermolabile even for steam distillation. A more modem 
technique used is dissolving in a solvent such as the 
comparatively inert supercritical carbon dioxide. Carbo~ 
dioxide is a gas in. air at s~dard temperatur: an If 
pressure or a solid ( dry ice) when fr?ze · ed 
the temperature and pressure are both mcreas 
from standard temperature and pressure to be at or above 
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the critical point for carbon dioxide (31 'C and 
72.9 atmospheres or 7.39 MPa) it adopts properties 
between a gas and a liquid: a supercritical fluid. 
Hexane is also used.49 Stainless steel, an innovation from 
World War 1, heavy-duty equipment is required. How 
our Mesopotamian antecedent would have marveled! 
Another insight is that essential oils, from an 
evolutionary viewpoint, are a plant's chemical defences 
against being eaten by herbivores. But we humans have 
had our way with plants. We have ransacked that treasure 
trove of natural products. We have ordered them, 
categorised them in our minds and manipulated them 
with our ever-improving technology. The rage for order 
is a basic human trait, not least amongst scientists. The 
nuclear physicist Schrodinger said that science is 
'necessary but not sufficient'.50 Similarly for pharmacy, 
science is necessary but is not sufficient; pharmacy also 
requires practice, an understanding of history and what it 
is like to subjectively, experientially, live within a human 
body. Volatile oils help us do just that. 
Patients, who have bodies, go to healers and anyone 
professing expertise, to obtain more assured, ordered 
futures: an extraordinary anticipation. In the non-human 
universe, disorder (entropy) tends to increase over time. 
Dropped cups smash into bits: they do not spontaneously 
rejoin; galaxies spread apart as their order fades. 
However, a competent professional reduces disorder in 
patients' lives so (temporally) appearing to 'reverse' the 
otherwise ubiquitous direction of the arrow of entropy. 
Pharmacists achieve this with medicines and proud 
publicity. Today, in encounters with ordinary people, 
community pharmacists display prominently and sell 
profitable aesthetic image enhancers such as perfumes 
and dentifrices - containing essential oil(s). They serve 
clients' hopes and dreams of reverting to youthful norms 
such as glamour. 51 Ancient Egyptian embalmers served 
the extreme hopes of their aristocratic clients, aided by 
juniper oil. The direction of the arrow in this sociological 
interpretation collides with its direction in a dominant 
natural scientific paradigm. This present metaphorical 
explanation conflates the languages of social and natural 
science, arguably doing some violence to each. However, 
those desirable odoriferous portable materials do offer, 
phenomenologically, an entropy-reversing effect that 
users crave. I suggest this is more than a mere play on 
words. Perhaps it explains why essential oils have 
survived for six millennia.s2 
Archeologists ask, "What artefact(s) (of our present 
civilisation) will I (a future archeologist) dig up in a 
hundred years tirne?"53 Essential oils will be present and 
sufficient should have survived for analysis amongst the 
detritus deposited in 2013.54 Suppose that question is 
projected forward: ''What, of the civilisation of just a 
century before, will an archeologist six millennia in the 
future dig up?" 
. What will be among that 81st century detritus? Will it 
mclude toothpaste, or an equivalent formulation, 
containing odoriferous molecules found in essential oil? 
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Wandsworth's Vanishing Hospitals 
Norma Cox 
VVandsworth,London 
Jim Slade wrote in the Wandsworth Historian (Spring 
2012) about the loss of the smaller shops from the streets 
of Putney since the 1950's. 1 These shops have been 
replaced by supermarkets and bars. The article made me 
think about changes that have occurred to the hospitals in 
Merton, Sutton and Wandsworth Area Health Authority, 
where I used to work as a pharmacist. These were: 
Bolingbroke Hospital; South London Hospital for 
Women and Children; St James' Hospital; and St 
George's Hospital, Hyde Park Comer. All these hospitals 
were purpose built. The closure of the hospitals was the 
cause of considerable concern to local people. It was 
argued that it was more efficient to have all of the 
medical expertise on one site, so they were consolidated 
at St George's Hospital, Tooting. The need for hospitals 
had not ceased, in fact with the growing population it had 
increased. 
Bolingbroke Hospital 
The hospital, situated on the comer of Wakehurst Road 
and Bolingbroke Grove (Fig. 1), was a small acute 
hospitaJ.2 In 1977 it had a specialist coronary care unit 
(under the directions of the larger coronary care unit at St 
George's Hospital). In 2008 Bolingbroke Hospital 
became a geriatric hospital and in 2011 it was closed. 
Wandsworth Council bought the derelict hospital to 
ensure it remained in community use.3 Due to its 
splendid architectural features, it was granted Grade II 
listing by English Heritage in 2012.4 In September 2012 
Bolingbroke Hospital became a new academy school. 
It is a handsome redbrick building, built by Young and 
Hall in 1901-1936. It replaced the original hospital on the 
Figure 2. Two tile panels from Bolingbroke Hospital. 
site, which was a mansion house converted to a hospital 
in 1880 by Rev John Erskine Clarke, the vicar of St 
Mary's Battersea, to meet the demand for a hospital in the 
area. 5 The building has many Art Deco features, 
including tiles made by Simpsons of St Martins Lane and 
tile pictures by Carters of Poole.6 The tile pictures in the 
children's' ward show characters from novels by famous 
authors (Fig. 3). There are also 13 panels depicting: 
Humpty Dumpty; Jack and Jill; and Tropical Birds. In 
the entrance lobby to the hospital there is a reception 
booth and a war memorial. From the octagonal hall 
radiate three corridors. The walls are pale green marble 
veneer. And the surrounds of the doors, are dark verde 
marble. The doors have gilt lettering announcing the 
occupant of each room, eg Matron. There was an Annie 
Zunz Ward named after the wife of a German metal 
merchant. She died childless and her heartbroken 
husband left legacies to several London hospitals 
including Bolingbroke to name a ward after his late wife 
and display a plaque to her memory. 7The dispensary was 
in the basement beside the X-ray department. 
South London Hospital for Women and 
Children 
This was an acute hospital at Clapham South. It was the 
vision of two women surgeons, Eleanor Davies-Colley 
and Maud Chadburn, who worked at the New Hospital 
for Women (later called Elizabeth Garret Anderson 
Hospital). There was such a demand at the New Hospital 
that patients were being turned away. A Jetter to The 
Tzmes declared the project was unnecessary and was a 
means for women to force themselves into medicine. 
This comment caused widespread anger, including from 
the suffragette movement. Anonymous donors gave 
Figure 1. Bolingbroke Hospital, Wandsworth SWl 1 6HN. £53,000 and a £40,000 endowment. With these generous 
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Figure 3. South London Hospital for Women SW4. 
donations building was swift. The hospital was designed 
in 1913 by the architect Sir Edwin Cooper. It was 
described as an impressive landmark building and a good 
example of Neo-classical 1920s architecture (Fig. 3). It 
had an all female medical staff. The hospital was opened 
by Queen Mary on 4th July 1916.8 
In 1983 Wandsworth Health Authority deemed the 
hospital uneconomic and the hospital closed to in-
patients in the summer of 1984 and to out-patients on 
15th March 1985. There was a great upset. Staff occupied 
the hospital to force the authorities to change their 
minds.9,IO A baby was born at the hospital even though 
the in-patients had closed. Forty women who had 
barricaded themselves in were forcibly evicted when the 
doors were broken down. A warrant for re-possession of 
the building was served on 17th March 1985. The 
building was secured, medical records and equipment 
removed and the building barricaded up to ensure it 
would not be re-occupied. 11 
Unfortunately the building was not listed by English 
Heritage. There was beautiful wooden panelling and an 
Elizabethan-style staircase. In the out-patients hall there 
was chequered flooring and a beam roof. The dispensary 
was attached to the out-patients hall. There was a 
cloistered rose-garden in the centre of the site which you 
passed on the way to the staff canteen. The fa9ade of the 
hospital was improved by the removal of the awkward 
Figure 4. St James' Hospital, Ealham SW12 8HW. 
ambulance ramp and porch and replaced by an elegant 
flight of stairs with a classical balustrade designed by 
Giles Quarne. Only the fa9ade was preserved while the 
rest of the site became a Tesco store and flats. 
St James' Hospital, Balham 
St James' Hospital, Ealham was also an acute hospital. It 
was built in 1909-1910 by the Wandsworth Board of 
Guardians in Ouseley Road, on the site of the St James 
Road Industrial School, a school for young offenders 
linked with the St James' Branch of Garratt Lane 
Workhouse.12 During World War I, the Infirmary (as it 
was then known) became an auxiliary military hospital 
for the First London General Hospital. In 1920 the 
hospital 's name was changed to St James ' Hospital. In 
1923 and 1926 new nurses accommodation was added 
and in 1930 the hospital was further expanded by the 
LCC. During WW2 flying bombs damaged three wards, 
the boiler house and the laundry. It is said that over 200 
flying bombs fell in this area. In 1948, with the formation 
of the NHS, it was transferred to the Wandsworth 
Hospitals Management committee. 
A new Out-Patient complex, nurses ' accommodation 
and a new Accident and Emergency was added in 1951. 
A Pathe News film clip of 1954 shows the out-patient 
department in use.13 The hospital's architecture can be 
seen as modern and light. I remember the dispensary was 
on ground level. The TV series 'Angels' was filmed in 
the grounds of St James' Hospital at the time. The 
hospital was amalgamated with St George's Hospital in 
1980 and the St James' Hospital was demolished in 1988. 
The land was sold for new housing. 
St George's Hospital, Hyde Park Corner 
St George's Hospital became part of the Wandsworth 
Health Authority in 1977. The original teaching hospital 
was built in 1719 at Lanesborough House and was later 
rebuilt between 1827-1844. The dispensary was in the 
basement and there were underground passages leading 
to it. The wards on the first floor had large windows 
affording an excellent view over Hyde Park. . 
Plans were first drawn up in 1948 to move to the sites 
of the Grove Fever and Fountain Hospitals in Tooting. In 
1973 the building of the new hospital began and in 1 ?76 
St George's Hospital Medical School moved to To~ttn~. 
St George's Hospital started transferring to the site _Ill 
1977. 14 In 1980 St George's Hyde Park Comer closed its 
doors for the last time and became a Hotel in 1991. 
Following its sale in 2001 it was re-named the 
' din 16 Lanesborough Hotel. '5 It is a Grade II listed buil ~- . 
Although it is emotional to close hospitals, medicme 
has advanced significantly since the advent of the ~S. 
It is now more efficient to have all the diagnostics to 
hand, on one site with consultant teams and an attach~ 
medical school. Many conditions can be treated . ID 
· li · which primary care without the need for hosp1ta satton, 
is costly and also adds the risk of infections by 'super-
bugs' . 
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Book Review 
The School of Pharmacy, University of 
London: Medicines, Science and 
Society, 1842-2012 
Briony Hudson in collaboration with Maureen Boylan. 
L~ndon: Academic Press, 2013, pp.xi+214 (hardback, 
pnce: £30.99) ISBN 978-0-12-407665-5 . 
Institutional histories commissioned to commemorate 
particular occasions, such as the anniversary of their 
foundation, all too often turn out to be worthy but 
uninspiring, celebratory but sycophantic, and honourable 
but pretentious. Indeed, some do little more than list the 
su_ccessive achievements of the great and good associated 
with the institution. It is extremely pleasing, therefore, to 
report that this work successfully manages to avoid all 
these tendencies, which is a testament not only to the 
author but also to those who commissioned it. 
. ~s book is much more ilian an institutional history; it 
~s an unportant and scholarly piece of work. It makes an 
~portant contribution to our understanding of the 
history of pharmacy education in Great Britain, with the 
firs_t two chapters especially providing a detailed account 
~f its evolution and its social and political context. The 
title thus rather understates its content. 
The story is told largely in chronological order in seven 
chapters, with a foreword by HRH the Princess Royal, 
the Chancellor of the University of London, and an 
afterword by the former Dean of the School and current 
Vice-Provost for Education at UCL, Anthony Smith. 
Each chapter describes a distinct phase in the School 's 
history and is sub-titled with an apposite quotation. 
Chapter 1 covers the early period from 1841 to 1861 
with Chapter 2 covering that from 1862 to 1895. Chapte; 
3 ~es the story into the twentieth century, covering the 
penod 1896 to 1926, whilst Chapter 4 takes us to beyond 
the Second World War, from 1927 to 1948. The 
remaining three chapters cover the post-war period; 
Chapter 5 from 1949 to 1960, Chapter 6 from 1961 to 
1986, and Chapter 7 the final period from 1987 to 2012. 
Themes which run across most chapters include the 
student experience, the building itself, teaching and 
research. Others include the role of women 
examinations, and relationships with both th; 
Pharmaceutical Society of Great Britain and the 
University of London. Daily life at the School is covered, 
including sports and social activities. There are also 
regular references to developments in pharmaceutical 
education in other parts of the country. The impact of 
both the First and Second World Wars is considered as is 
that of the earlier Crimean War in 1853-6. ' 
At the beginning of each chapter is a list of milestones 
for the period, under six headings; popular culture, 
London life, national news, the wider world, drug 
developments and pharmacy milestones, although for 
some reason pharmacy milestones are omitted from 
Chapter 2 and popular culture from Chapter 5. An 
appendix helpfully provides a chronology of 
pharmaceutical qualifications and courses at the School 
from 1841 to 2012. 
Regular quotations from the students' magazine the 
Square Chronicle, which first appeared in 1912 and 
continued until 1988, provide a regular source of gentle 
humour, vividly illustrating the timeless irreverence and 
humour of the student body which has been a feature of 
the School throughout its history. The study of drugs of 
natural origin is a regular topic of comment. The first 
edition of the Chronicle reported that ' it is rumoured that 
botany lectures are no longer what they were. Gone are 
the days when sponges and calabar beans used to hurtle 
across the theatre ... ' WH Allen wrote in 191 3 that 
'botany lacks the explo iveness of chemistry and its 
entrancing uncertainty. The chemical student mixe 
things in a test tube, applies heat, and hey presto, he is on 
his back with his eye-brows and other face trimmings 
burnt off. ' 
The comfort, or lack of it, of seats in the lecture theatres 
was another recurring feature of student comment. 1n 
1922 the Chronicle fow1d it necessary to offer the 
following advice: 'students, when ordering new suits, 
would be wise in having two or three extra pairs of 
trousers, as the continual shuffling about, trying to find a 
soft spot on a hard seat, does the lower portion of one's 
apparel no great amount of good.' 
Pharmacy generally had an enlightened view of the 
entry of women to the profession, although early 
impressions of this development are enlightening. The 
first lady to attend lectures was Elizabeth Garrett 
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Anderson. Michael Carteighe, who went on to become 
the Society's president, was a student at the School at the 
time. He later described the thoughts of the male students 
at the time about her 
attendance; 'when 
once a lady comes into 
a class she means to 
take prizes, and I am 
afraid to say we were 
selfish enough to think 
of that rather than 
anything else.' 
In 1861 the Council 
passed a formal 
resolution banning the 
attendance of women, 
and m 1868 the 
Society's president, 
G.W. Sandford, 
announced that a new 
member of staff, Mr 
Brady, had agreed to 
deliver an inaugural 
address. 'He would 
probably say 
something about the 
importance of pharmacy' he suggested, but hoped that 
'he would not draw so glowing a picture as to tempt 
ladies into the profession.' Nevertheless, ladies were 
tempted in, and by the time of the first compulsory 
register in 1869 there were 223 female pharmacists. In 
March 1920, almost half the students studying for the 
Major examination at the Square were female. The fears 
of the male students about female students taking all the 
prizes were clearly well-founded; by 1925 there had been 
five female wirmers of the Pereira Medal, seven 
Redwood scholars, five Jacob Bell scholars and no less 
than fifteen female Burroughs scholars. 
On most pages, the core text is surrounded by a large 
variety of other material. There are large font quotations 
on most pages, usually but not always taken from the text 
on the same or an adjacent page. The book is liberally 
sprinkled with mini-biographies of some of the people 
and School alumni who have shaped not only pharmacy 
education in Britain but also the wider profession and 
practice, amongst whom are included the distinguished 
editor of this journal. As well as these boxes an 
assortment of timelines, illustrations, photographs and 
cartoons appear on most pages. For the serious reader 
these are something of a distraction. Which do you read 
or look at first? This reviewer opted to read just the text 
from beginning to end 
first, before going 
back to look at the 
boxes and illustrations. 
At this point of course 
many are no longer in 
context. 
The book is large, 
heavy and rather 
unmanageable when 
not read on a table top. 
It 1s beautifully 
produced, in a 
landscape rather than 
portrait format. The 
publishers clearly 
decided that the main 
market for the book 
was alumni of the 
School and as a coffee 
table adornment. This 
has dictated the style 
and layout of the book. 
The format also dictates the exclusion of detailed notes 
and references; the publishers have opted for a book 
which is only lightly referenced, and neither footnotes 
nor endnotes are provided. A key list of sources is given 
in an appendix at the end, along with suggested further 
reading; however, it is acknowledged that this is not a 
comprehensive bibliography. Regular general references 
to the Pharmaceutical Journal and the Chemist & 
Druggist are given in the text. However, the serious 
researcher may still have some difficulty in tracing the 
exact source of a particular quotation or event mentioned 
in the book. The book is comprehensively indexed. 
The book has been extensively researched, and it is 
written in an engaging and entertaining style. The authors 
and publishers can be truly proud of a job well done. It 
will be of interest not only to past and present studen~ 
and staff of the School but to all those with an interest m 
the history of pharrna~eutical education in particular and 
in the history of pharmacy more generally. 
Dr Stuart Anderson 
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Teaching Pharmacy in Malta 
1676-1990s: Part I 
John Joseph Borg PhD 
Sliema, Malta 
Pharmacy education throughout the centuries has been in 
continuous evolution. It therefore follows that shifts in 
the subjects studied in pharmacy at University are 
expected to parallel the needs of the practice of pharmacy 
at the level of the community and hospital. The course of 
pharmacy in Malta is thought to have started in 1674. 
This two-part article reviews some of the developments 
in Maltese pharmacy education from 1674 to the 1990s 
and tries to tease out trends in pharmaceutical education 
over the centuries. 
The teaching of pharmacy in Malta from 
1676 to 1771 
Grand Master Nicholas Cottoner will always be 
remembered in the history of medicine in Malta for 
establishing the School of Anatomy and Surgery at the 
Holy Infirmary in 167 6. It is also possible that a course of 
pharmacy was established that same year in the School. 
Pointing in this direction is the fact that the first director 
of the School of Anatomy and Surgery, Dr Giuseppe 
Zammit, was also the lecturer in botany. As the first 
person to teach chemistry in the school, he set up a 
botanical garden at his own expense, in the ditch of St 
Elmo, where spece nostrali (native plants) and exotic 
plants were grown to teach chemistry and botany. 1 
Through his extensive research in chemistry, Dr Zammit 
was able to give experimental demonstrations on 
chemical composition and pharmaceutical preparations 
to students during his lectures. 2 These were most 
probably the first teachings on pharmacy based in Malta. 
Among the various chemical and pharmaceutical 
compounds he used to prepare was sodium sulphate, 
which would still, in 1886, be known in Malta as 
Zammit's Salt.3 
One ofZammit's students, Dr Fillippo Cavallini, drew 
up a list of important native medical plants, from which 
pharmaceutical preparations could be made. This list was 
compiled in a book entitled Pugillus Meliteus, seu 
omnium herbarnm in Insula Melita ejusque districtis 
enascentium, which was published in Rome in 1689. 
This book was attributed to Dr Zammit, and was 
described as a written account of his teachings of 
pharmacy and botany during Dr Cavallini 's student years 
at the Medical School.4 
It is generally believed that Zammit, with the help of 
other assistants, lectured in pharmacy, surgery, and the 
Natural Sciences. One of his assistant lecturers was Dr 
Giuseppe Farrugia, his successor as director of the 
School of Anatomy. Unfortunately, Dr Farrugia never 
wrote anything about his daily activities. Dr Zammit's 
notes have also gone missing, and because of this, the 
exact number of professors lecturing at, and students 
attending the course of Pharmacy during the years 1676 
and 1720, are not known. Thus, due to the limit in 
available documentation about the School of Anatomy 
and Surgery throughout this period, little is known about 
medical and surgical education, let alone pharmaceutical 
education. 5 
In 1723 Dr Henin replaced Dr Farrugia as the director 
of the School of Anatomy and Surgery. In 1729 the latter 
post was changed, and the chief pharmacist of the Holy 
Infirmary was appointed instead. Pappalardo claims that 
'this was achieved as a consequence of a set of internal 
disciplinary rules for pharmacy students which were laid 
down on a chirograph on 17 December 1729'. 
These regulations stated that: 
1. Apprentices were not allowed either to leave the premises, 
or absent themselves unnecessarily from any lecture 
regarding their profession. Lectures included practical 
demonstrations and theoretical concepts. 
2. Two apprentices had to be always present at the pharmacy 
of the Holy Infirmary night and day. 
3. A person could practice pharmacy only if he passed the 
final examination in Pharmacy. 
4. After passing the examination no pharmacist could practise 
the profession in Malta and Gozo unless: (i) he did not work 
for six months in the pharmacy of the Holy Infirmary, and (ii) 
obtained the approval of the chief pharmacist of the Holy 
Infirmary. 
5. Anybody breaking these regulations more than twice was 
expelled from the profession and could not be re-admitted.6 
Before being admitted to the course of studies in 
pharmacy, candidates ('perserveranti') had to be 
approved by the chief pharmacist of the Holy Infirmary. 
This approval was determined by the students' 
knowledge and education. These requisites are not 
clearly known; what is certain is that students had to have 
a reading and writing knowledge ofLatin.7 In 1771, two 
years before Grand Master Pinto's death, the School of 
Anatomy and Surgery became part of the Universita 
degli Studi a Malta (University of Malta) under ~e 
Faculty of Medicine and Surgery,8 where lectures ID 
Anatomy, Surgery, and Medicine were given ~y doctors9 
and surgeons. 10 The pharmacy course, for all mtents and 
purposes, was held at the dispensary of the Holy 
Infirmary, and therefore pharmacy students had to attend 
the hospital pharmacy for their education. :i?~Y ~ere 
given on-site experience of day-to-day act1vtt1es ID a 
hospital pharmacy. . . 
After undergoing the course of studies and taking an 
examination, successful candidates were granted a 
Diploma in Pharmacy by the Chief Medical Officer and 
the Medical College, in the Grand Master's name." 
The teaching of pharmacy in Malta in the 
nineteenth century 
During the first two decades of the nineteenth c~ntury, 
students were examined by the protomedicus, who issued 
a certificate of proficiency. 12 On 24 March 18~ 1, ~e 
Medical Council was constituted and the duty of 1ssum? 
these certificates was devolved. This Medical Counc~ 
was the forerunner of the Medical Board found today. 
The Faculty of Medicine and Surgery appointed the 
following professors to instruct pharmacy students 
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during the 1830s: A professor of botany, who was in 
charge of the running of the Botanical Garden, and 
lectured also in natural history and jurisprudence. A 
professor of organic chemistry, practical chemistry and 
materia medica, whose lectures were accompanied as 
often as possible by experiments in the laboratory. 14 
On 19 February 1834, the following notice appeared in 
the Government Gazette: 
The professorship of chemistry is now vacant, the Council of 
the University hereby gives notice, that a concourse will be 
held for filling up the same on Tuesday the 25th instant, and 
on such succeeding days as may be required. 
The Council requests, therefore, such gentlemen, as intend to 
become candidates for the appointment, to call at the office of 
the University any day from the 20th to the 24th instant 
inclusive, between the hours of 8 and 11 in the morning; to 
inscribe their names, and be informed of the conditions of the 
election, as laid down by the regulations of the University. 
University, Valetta, 17th February 1834, 
E. Canonico Rosignaud, Rector.15 
On 25 February 1834, the Medical Council held a 
meeting at the University of Malta, Valletta, to discuss the 
employment of the Pharmacist Giuseppe Fenech and of 
Dr D Aquilina, as instructors of Chemistry at the 
University. The following day, Fenech and Aquilina both 
had to sit for an examination to assess who was the better 
candidate for the job. The question they had to answer 
was one from a set of questions each member of the 
medical college submitted prior to the exam. The 
examination question was then extracted from an urn. 
The examination question the two candidates had to 
answer, in the five hours between 10.30 am and 3.30 pm 
was: "Who discovered morphine? What are the const-
ituents of morphine? Its properties and characteristics? 
What reactions occur with carbonic acid, vinegar, 
solforico idroclorico, vitrico tartarico? What are the 
general characteristics of morphine salts?". The 
pharmacist Giovanni Fenech felt sick during the exam, 
and at 11am asked the Rector to be exempted due to his 
weakness of memory. He was exempted, and only Dr D. 
Aquilina finished the examination. The following day an 
oral examination was held for Dr Aquilina, the only 
candidate left. This oral examination lasted for three 
quarters of an hour. Dr Aquilina was then employed as 
professor of chemistry at the University. l6 
In February 1835, a proposal was made by the Medical 
Council 17 that pharmacy students had to sit for the 
following exams during their course: during the first year, 
chemistry, botany, and natural history; during the second 
year, pharmaceutical chemistry and pharmacognosy; and 
during the third year, pharmacology, practical chemistry 
and botany. This proposal throws some light on how the 
pharmacy course was conducted, and on what pharmacy 
students used to study prior to 1838, when the statute of 
the university established the way in which the course of 
pharmacy had to be carried out. 19 
To be admitted into the course of pharmacy in 1838, 
students had to conform to the educational standards 
required by the Faculty ofMedicine and Surgery. That is, 
they had to present a Diploma as Master of Philosophy 
and Arts obtained from the University, or produce a 
certificate of approval obtained from the Faculty of 
Philosophy and Arts. This certificate was only issued if 
the student passed examinations in Latin, Italian 
literature, English composition, elocution and literature, 
elementary mathematics and physics. If the student did 
not have the above requisites, then he had to sit for an 
examination set by the relative professors of the Faculty 
of Philosophy and Arts, in the presence of the Rector, 
where he had to show proof of his knowledge in the 
subjects mentioned previously. 
In 1838, the course of pharmacy was conducted over a 
two-year period. During the first year, pharmacy students 
had to study natural history, botany, and general 
chemistry; in the second year, they had to study practical 
medicinal botany, pharmaceutical chemistry, and materia 
medica. They also attended the pharmacy and the 
laboratory of the Civil Hospital for practical work but 
they could have also attended private pharmacies. The 
special council of the Faculty of Medicine regulated the 
examinations set, and passing all exams entitled the 
student to obtain his certificate. 20 
On 13 November 1859, a law was passed in Italy to 
regulate all University courses. From that day, pharmacy 
came to be offered as a course in the Faculties of 
Medicine and Surgery, and, as in Malta, it led to a 
diploma. The topics in Italian pharmacy courses were 
similar to the ones studied in the Maltese pharmacy 
course during the nineteenth century. These were: botany, 
chemistry, pharmacy practice and mineralogy. In 1862, 
the Matteucci regulation was passed in Italy, and the 
course of pharmacy was no longer offered by the 
Faculties of Medicine and Surgery. Instead, schools of 
pharmacy were established and the course of pharmacy 
in Italy became a three-year course.21 
For forty-nine years no modifications to the local 
pharmacy course were made, until the promulgation of 
the University statute in 1887, when practical pharmacy 
was introduced in the second year of the course. The 
course was now set as follows: during the first year 
organic chemistry and practical chemistry were studied; 
the aim of these lectures was to give students practice in 
the manipulation of the chemical techniques used in the 
preparation of medicinals. During the second year 
materia medica, medical botany, and practical pharmacy 
were studied. Practical pharmacy had to be carried out at 
the dispensary of the Central Hospital or at any other 
pharmacy approved by the Special Council22 of the 
Faculty of Medicine and Surgery.23 Towards the end of 
the nineteenth century, many books on pharmacy were 
available for purchasing in Malta. Most of them were in 
Italian, but Maltese students attending University had no 
problem understanding them, as certificates in both 
Italian and English Language were required to enter 
University. 
In 1887, students who wished to enter the pharmacy 
course had to have matriculated and passed the 
examinations on the subjects required for admission into 
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the Faculty of Arts. Only candidates who passed the 
examination in the subjects studied during the first and 
second years, before the Special Council of the Faculty of 
Medicine and Surgery, were given the warrant of 
apothecary.24 The last modification in the pharmacy 
course during the nineteenth century occurred in 1889, 
when practical pharmacy was extended over the two 
years of the course. Also, before sitting for their final 
examinations, students had to produce a satisfactory 
certificate of their regular attendance at such a practice.25 
Throughout the nineteenth century students at 
University had to pay for their tuition and also for the 
examinations they undertook. In 1898, regular students 
had to pay 6 pounds per annum for the entire course, and 
a fee of I O shillings per annum for laboratory work; while 
the annual examination fee for courses in the Faculty of 
Medicine and Surgery was of thirty shillings.26 
Authors address: Dr John Joseph Borg PhD, 8, No 40, 
Dingli Court, Howard Str, Sliema, SLM 17 51, Malta. 
Phone: +356 21333072; john-joseph.borg@gov.mt 
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Possible sources of therapeutic 
stone powder from North West 
Europe 
Jan Weertz1, Eis Weertz1 and CJ Duffin2 
1rer Schuur, Netherlands, 2Sutton, Surrey 
Scratch marks on building stones: 
nature and distribution 
The church of Sint Nicolaas, parts of which date back to 
the 13th century, in the Dutch village of Denekamp 
(situated in Twente, near the German/Dutch border), like 
many others in the region, is made of Bentheimer 
Sandstone. A number of deep, parallel vertical grooves 
cut in in the shape of a boat have been scratched into the 
walls of the church (Fig. 1). The Plechelmuskerk in 
Oldenzaal, 1 which dates back to the 12th century, in the 
same region, possesses a 
similar set of strange 
grooves carved into its walls 
(Fig. 2).2 Scratch marks 
such as these on building 
stones, especially those of 
older churches, seem to be a 
phenomenon spread widely 
through the Netherlands, 
Figure 1. (a) Sint Nicolaas 
Church (Denekamp, 
Netherlands); 
(b) scratch marks in the 
Bentheimer Sandstone 
which makes up the walls 
of the church. 
Gennany and Belgium, with further examples also known 
from France and Britain. The background survey 
completed for the preparation of this paper has so far 
documented over 210 sites displaying such scratch marks. 3 
The marks themselves (Fig. 3) can be divided into 
three rough groups: (1) long (15 cm to 30 cm), narrow 
and shallow (circa 3 mm) grooves; (2) shorter (10 cm to 
20 cm long), deeper (up to 5 cm deep) grooves scratched 
in a boat-like shape; (3) spherical hollows (cups or wells) 
measuring up to 1 O cm in diameter and 7 cm deep. 
Figure 2. (a) Plechelmuskerk (Oldenzaal, Netherlands). 
Parts of the church belong to the 12th century; 
(b) scratch marks in the Bentheimer Sandstone which 
makes up the walls of the church. 
Churches and other buildings are usually constructed 
of local building stones which vary in type according to 
the underlying geology, ease of accessibility and extrac-
tion, and physical characteristics. In the area ~der 
consideration, scratches are particularly common m a 
wide variety of Triassic, Cretaceous and Tertiary 
sandstones and soft 'marl' from Limburg and its 
environs. Harder lithologies such as Lower Carboni-
ferous limestones have received limited attention, the 
scratch marks being nearly always small, narrow and 
shallow. 1n a few rare cases, marks have been made in 
igneous rocks: tuffs are consolidated, water-lain_volcanic 
ashes and, being soft, have been worked to give Ion~, 
deep marks as in various sandstones and 'marl' . ~8:5alt 1s 
a hard intrusive rock displaying scratch marks sun1lar to 
those in Lower Carboniferous limestones. 
Most scratch marks have been produced on the external 
walls of churches. The internal walls have also been 
worked in this way, with scratches found on the inner 
surfaces of structural walls, on pillars, near the confessional 
box and beside the font. Outside the church, scratch marks 
have been found on a limited number of gravestones and 
roadside crosses.4 In a few locations they are present on 
smooth natural rock surfaces. At several localities, some 
scratch marks (though, interestingly, not usually all of 
them) have been filled with cement, possibly by church 
authorities seeking to protect the walls. 
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Figure 3. Scratch marks with different morphologies. 
(a) Evangelisch-reformierte Kirche in Veldhausen 
(Germany): cups and grooves with a boat-like shape; 
(b)Abdij inAverbode (Belgium): long, narrow and 
shallow grooves; 
(c) Evangelisch-luth. Kirche in Schtittorf (Germany): 
long, narrow and shallow grooves; 
( d) Sankt Jakobikirche in Goslar (Germany): grooves with 
a boat-like shape; 
( e) Sint Eustachiuskerk in Zichem (Belgium): cups; 
(f) Martinuskerk in Eijsden (the Netherlands): grooves. 
There are some unusually specific choices for the 
locations of some groups of scratches. The sandstone 
castle of Bad Bentheim in Germany has two entrance 
gates with grooves confined to the inner gate. This 
particular wall was chosen because it was shared with a 
small chapel on the other side. SchloBberg Klippen is a 
sandstone outcrop in the German town of Quedlinburg. 
The rocks form the foundations of the SchloBkirche St. 
Servatius. In this case, the rocks of the sandstone outcrop 
are scratched. Why climb up to the church when you can 
gather the stone powder from the same rock type at its 
base? 
Some grooves and cups have been produced on the 
walls of secular buildings, many of which can be shown 
to have had past associations with the church. They have 
also been found in a few old town houses and town gates. 
One interesting secular example is a scratched sandstone 
porch dated to 1618 and attached to a blacksmith's house. 
The blacksmith was a high status profession, members of 
which were considered to be wise men in German 
paganism. 
Scratch mark origins 
A number of different explanations have been given in 
the literature for the origin of the grooves;4 most can be 
refuted, leaving one explanation which we believe to be 
the most plausible: obtaining stone powder for healing 
purposes. 
1. Grinding blades of weapons 
According to this explanation, somewhat loosely rejected 
by some previous authors, knights and other warriors 
ground their weapons on the stones ( such as walls) of 
religious buildings so that they and their weapons would be 
blessed with success in battle and a safe return home. This 
idea is rejected because the depth, boat-like pattern and 
short length of the grooves would have been impossible to 
produce with the blade or edge of a sword, large knife, 
spear, halberd or other similar weapon. Long, narrow and 
shallow grooves would have been difficult to produce in 
this way. Accessibility is also a problem: most grooves are 
located in places where it would have been uncomfortable 
to grind a weapon - the edges of porches, near buttresses or 
just above the ground where grinding a weapon here would 
cause injuries such as grazes or back pain. Furthermore, the 
sharpening of knives and scythes on grindstones produces 
marks which are completely different to the grooves 
described above. 
Scratch marks on British churches, such as those at St 
Dunstan 's Church, Mayfield, East Sussex have some-
times been ascribed to military men sharpening their 
arrows against the wall. It has been asserted that, 
following the Black Death, a law was passed requiring 
men of military age to practice archery on a Sunday 
afternoon. This is rather an overstatement; it is certainly 
true that in the Statutes at Large and of the Chronological 
Index to the Statutes, an Act was passed on 4th February 
1512 requiring that 'All Sorts of Men under the Age of 
Forty Years shall have Bows and Arrows, and use 
Shooting', a law made perpetual in 1514 and restated in 
1541, but large sections were later repealed by Queen 
Elizabeth I. The use of a Sunday for practising does not 
seem to have been stipulated. 
2. Resting weapons against the walls of the church 
This hypothesis suggests that, because weapons were not 
allowed to be taken into church during worship services, 
resting them against the church wall produced scratch 
marks in (long) horizontal rows. This suggests that 
weapons must all have been of the same length and kind 
(i.e. only swords, only spears, only halberds and so on) and 
that the weapons were placed on exactly the same spot each 
time. The trajectories, height and depth of the grooves all 
argue against this explanation. 
3. Playing children . 
It has been suggested that children made the grooves whilst 
at play. Children certainly make scratches in th~ 5?ft 
limestones of Limburg, usually recording graffiti like 
names, figures and sentiments. Children generally lack the 
strength and persistence to produce grooves of the type 
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found on church walls, being distracted by far more 
interesting pursuits than scratching rather nondescript lines. 
4. Weathering 
The results of weathering on rocks are completely 
different to the grooves and cusps described above, 
which are certainly man-made. 
5. Making 'new' fire at Easter by striking or friction 
Certain authors think that the grooves have a religious 
origin; they were created by striking 'new fire' at Easter. 
In Germany this practice is known as 'Samstagsweihe' 
because it took place on the Saturday (Samstag) before 
Easter, probably as a Christianised form of the heathen 
fire-setting in Spring, associated with the beginning of 
the new growing season. In the Easter tradition, certain 
regulations had to be followed: the fire had to be struck 
outside of the church with a stone. 
Sandstone and similar building stones are unsuitable 
for fire-setting in this way. Normally, a steel struck 
against a flint was used to produce sparks (small glowing 
steel fragments) which ignited easily combustible tinder 
(such as dried fungus or carbonized linen) to which was 
then added a fuel such as wood shavings. Blowing on the 
smouldering material encouraged full burning. Tinder-
boxes containing the essential ingredients of this process 
are effectively the predecessors of matchboxes and 
matches. Experiments seeking to replicate this effect 
were unsuccessful as a sufficiently hot and durable spark 
could not be produced against sandstone. The depth of 
the grooves also argues against this interpretation -
fingers and knuckles would be grazed in no time; a fresh 
surface would have been much more suitable. 
It has been suggested that the cups were created by 
frictional means of generating Easter 'new fire'. This 
process requires a fire drill (short stick), one end of which 
is placed in a rough cup-like hollow (usually in a small 
branch) while the other end is placed vertically against a 
small wooden board, firmly hand-held or braced against 
the chest. A fire bow rapidly rotated the drill in both 
directions, producing a glowing carbonised dust which, 
when sufficient, could be used to smoulder the tinder. 
The rough cup-like hollow produced evolves through the 
process to form a diameter of 1-1 Yi cm. 
Applying this scenario to church walls requires 
holding the drill horizontally so that the carbonized dust 
falls to the ground before sufficient is generated to which 
the tinder can be applied. Furthermore, most cups on 
church walls have a diameter greater than 1-1 Y2 cm; some 
are fist-sized. 
6. Projectile impact marks 
On impact, bullets and other projectiles produce (small) 
craters on wall surfaces. Older buildings may show bullet 
impacts from WWII or earlier battles. Projectile impact 
craters are hollows with uneven internal surfaces and 
crumbled edges. Cups that originate from scratching, by 
contrast, have smooth internal surfaces and entire edges. 
7. Scratching healing powder from the stones 
This, the most plausible suggestion, states that peop!e 
created the grooves and cups by scratching the stones ~ 
order to gather a stone powder' used for therapeutic 
purposes 7 against diseases such as the plague and typhoid 
fever. They won the powder not only from church walls 
but also from grave stones and icons. Because the 
powder was won from an ecclesiastical building stone as 
part of a consecrated place of worship its therapeutic 
qualities were deemed, in popular belief, to be fortified 
by its holy association.5 
Therapeutic stone powders 
The production of supposedly therapeutic powders by 
pulverising a variety of geological materials has been 
practised since classical times. The first century Greek 
physician, pharmacologist and botanist, Pedanius 
Dioscorides ( circa 40-90AD), recorded a number of 
fossils, minerals, stones and earths which were used for 
healing purposes in his Materia Medica, written around 
65 AD. 8 A wide range of such materials was summarised 
in Sir John Hill's compendious compilation for his 
History of the Materia Medico in 1751 , including such 
lithologies as jade, pumice, Irish slate, gypsum, clays, 
chalk, marls, and Fuller's earth.9 Powders produced from 
fossil echinoid (sea urchin) spines and belemnites were 
used to treat a wide range of diseases including kidney 
and bladder stones, whilst prehistoric stone axes10 
yielded a powder that was used to treat epilepsy and to 
restore domesticated animals to full health.11 
Amongst the most popular fine-grained sediments 
were a huge variety of medicinal earths excavated from 
many European and Mediterranean countries and often 
stamped with seals of authenticity: the so-called terra 
sigillata. 12 Several types of terra sigillata have a magi~-
medicinal component to their efficacy because of therr 
religious connotations. The extraction o~ ~erra lemnia, a 
widely used and extremely popular medicmal earth from 
Lernnos in the northern Aegean, was highly regulated; 
mining was restricted to a single day througho~t the year 
(August 6th) originally a feast day for Diana, later 
syncretised with St Savi~ur's Day. ~e whole process 
from extraction to stampmg was earned out under the 
· 13 watchful eye of the priestess or clergy, as appropnate. 
An even closer link with Christianity is repre ented by 
Terra Sigillata Melitensis, Maltese sealed earth_. According 
to Maltese tradition, St Paul spent 3 month m a cave at 
Rabat, having been shipwrecked in AD 60 w_hile being 
taken to Rome for trial. In an incident recorded m the Acts 
of the Apostles, St Paul was bitte~ by a '_'iper hjding in a 
woodpile. The locals expected him t~ die, but :when he 
survived with no ill effects they surrrused he rrught be a 
god. The saint brought Christianity to the island and it was 
believed that the rock of the grotto in which he resided and 
preached was imbued with great and holy power. Rock 
was hewn from the walls, reduced to powder, formed into 
cakes, sealed and exported as a powerful medicine used to 
combat a wide range of diseases. 14 
Up until the 1990s the people of Heerle CW?uw 
municipality, Dutch province ofN~rd-Brabai:it), ob~ed 
a wrute sand ('Gertrndiszand'), which was spnnkled m the 
home to discourage vermin such as mice or rats. 1n a 
closely related application, believers. from Prinsenbeek 
village, also in Noord-Brabant, obtamed sand from the 
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church called Onze Lieve Vrouw Tenhemelopneming. 
According to local legend, Saint Gertrude of Nivelles 
(circa 621-659 AD) helped rid the village of rodents 
which were eating the corn. This so-called 'muizenzand' 
(mice sand) was used to protect the harvest against mice 
and rats and Gertrude is worshipped as a patroness 
against these animals. On March 17, the feast-day of the 
saint, 15 consecrated sand from a tub at the back of the 
church could be taken to chase away mice and rats. 
According to legend, a thorn bush grew next to the 
church at Meldert (Belgium) where the staff of the Saint 
Ermelindis (a 6th century Belgian hermitess) was 
planted. Farmers removed earth from the spot and 
applied it to their fields to ensure fertility. 
Gertrudis was also revered in the Belgian village of 
Vorst. She was asked for assistance not only against rats 
and mice, but also to heal wounds on the nose and lips, 
eczema, skin conditions, plague, mental illness and for 
strength when the devil tried to seduce them. Earth from 
the churchyard was used at home as a remedy against 
anything and everything; it is a small step from this 
practice to scratching sand from church walls. 
In the Belgian village of Lembeek, the local Saint 
Veronus (also known as Saint Froon, a grandson of 
Charlemagne who died in 863)16 was said to be able to 
help against conditions such as headaches, meningitis 
and fever. Past pilgrims crept into a pit under the grave of 
the saint where they collected earth in small bags which 
were placed under the head at night in order to ease 
symptoms. The pit was later closed, but pilgrims could 
still obtain bags with earth from the church itself 
Saint Evermarus ( a pilgrim martyred by robbers at 
Rutten in Belgium in 700 AD) is worshipped17 if people 
want to eliminate their headaches. On May 1st (Ever-
marus's Feast Day) earth removed from the Evermarus 
chapel in the Belgian village of Rutten is mixed with food 
and eaten. The chapel itself has flint and limestone walls, 
the latter bearing a number of scratch marks. 
Stone dust is still used for magical and medical purposes 
today. A chapel in the Dutch Limburg village of Sint 
Gerlach is dedicated to the 12th century knight who 
became a Christian hermit and friend of Hildegard von 
Bingen. After his death in around 1170, a number of small 
miracles occurred at his grave. Local people and pilgrims 
began removing soil samples from his grave, believing 
them to possess a special potency. This escalated to a desire 
to possess direct relics, such as bone fragments of the saint. 
The church authorities have since formalised a replacement 
custom in which in a pile of consecrated limestone powder 
(locally called marl) is stored in a hollow beneath the tomb 
of the saint. A small shovel and plastic bags are provided for 
anyone who wants to remove some of the stone dust in 
order to cure sick animals, to mix with corn to deter rats and 
mice, to sprinkle in stables for the well-being of the cattle, 
or even to add to soil to improve crop growth. In another 
example, consecrated earth can still be obtained from the 
cemetery at Hakendover, a Belgian site of medieval 
pilgrimage. Also, the Camillian monastery at Vaals (Dutch 
province of Limburg), now lost, used to sell stone 
powder as a medicine. ls 
Parishioners at Sint Catharinakerk in Montfort (Dutch 
province of Limburg) have special reverence for Saint 
Anthony the Great ( circa 251-356). A long-held tradition 
involves large bins of consecrated sand being stood in the 
church next to a statue of the Saint and made available to 
believers who wanted to sprinkle it in their stables and on 
their fields. The practice is still undertaken today: the 
sand is obtained from local building suppliers and 
blessed by the priest ready for use! 
At Birkheim tiber Kastelaun (Germany) there is an 
altar, the stone powder from which is reputedly beneficial 
for rapid growth in farm animals. Extraction of stone 
powder from the altar became so extensive that its very 
survival was threatened. On being informed that 'normal' 
gypsum could be used for the same purpose, the farmers 
agreed to obtain their powder from other sources. 19 
The use of stone chips and powders was sometimes 
reinforced by the recitation of secular or religious 
charms. Two such German examples are as follows: 
When a spell has been cast on somebody he should go to a 
conciliation cross ( a memorial to somebody who has been 
killed) in the field. There he should walk around the cross 
three times beginning from the left side. While doing this he 
must say the name of the Father, the Son and the Holy Spirit. 
After this he must strike a piece of stone from the cross and 
throw it in running water whilst saying: I throw you in this 
stream so that all sorcery and misfortune stream away and I 
can resist the one who did this to me. 
At the stroke of midnight you should go with a white table-
cloth to a boundary stone that separates three parcels of!and. 
There you should hit three pieces of the stone onto the table 
cloth while saying the name of the Father, the Son and the 
Holy Spirit, and then you must go to running water. You also 
need the urine of a sick person. Make stone powder of the 
three pieces of stone. Put the urine, the powder and some of 
the water from the stream in a glass and let the sick person 
drink of this. As long as the sick person is drinking you 
should say: As certain as Jesus Christ died on the cross, it is 
just as certain that you will not die.20 
It is obvious from the discussion above that stones with 
ecclesiastical and saintly associations have enjoyed a 
long history of popularity as therapeutic materials. The 
consecrated powder worked from church buildings by 
the scratching action of blades along the stone surface 
falls into the same category, but is more the subject of '.1° 
oral folklore tradition than a written one, making details 
rather sparse. 
Powder from church walls 
The use of stone powder from churches was certainly 
already established by the 6th century when Gregory, 
Bishop of Tours (538-594) stated that a little powder 
from the church of Saint Martin was more powerful than 
all the fortune tellers with their senseless tricks;21 even 
scrapings from the gravestones of saints were esteemed 
superior to other medicines. 
Stone dust was used frequently to combat kidney stones 
(urolithiasis) and renal colic, and was mixed with cattle 
fodder.22 Supposedly effective as medicine against m~Y 
diseases, the powder contains mineral nutrients in~luding 
phosphorus, potassium, lime, magnesium and sodium. In 
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certain regions (such as the Odenwald in Gennany) people 
not only scratched stone dust to heal toothaches, headaches 
and diseases of the neck but also to expel warts.23 When 
applied to warts they are reported as disappearing from the 
hands of young girls at night when it was full moon. The 
stone powder could also give relief during teething. 
In Hessen (Germany) and the Grafschaft Bentheim 
(County Bentheim) stone powder was mixed with water 
and then drunk as a healing draught against the plague. 
Thls practice is the origin of the terms 'Pestschaben' and 
'Pestrillen' (plague grooves) for scratch marks on 
churches in these particular areas. 
According to folklore, after scratching powder from 
grooves and cups the collectors ritually blew into the 
hollows to banish the disease. A similar practice 
presently, with some variation, still persists in popular 
belie£ At Overasselt (Dutch province of Gelderland), for 
example, people bring small strips of cloth worn by 
patients suffering from fevers and tie them to an oak tree 
next to a ruin of an old chapel. The people believe that the 
tree takes over the fever so ridding the patient of the 
disease. 
Various farmers healed their animals with sand which 
they had scratched from holy places, as well as spreading 
it on their fields to ensure fertility. Their belief in this 
medicine was absolute; if the animals died or the crops 
failed, they reasoned that the sand has probably been 
applied too late, or that the saints had not been praised 
sufficiently during the process. 24 
Sandstone powder was credited with many miraculous 
properties; in order to ensure full potency the powder was 
to be scratched from the walls during the Twelve Holy 
Nights (Christmastide: December 25th to January 6th). 
Absolute silence was required during the scratching 
process, otherwise the magic powder was rendered 
inactive.25 
In light of the foregoing discussion, one interesting 
possibility is posed by some scratch marks on the face of 
a Sheela Na-gig (a semi-erotic stone carving or corbel on 
the pillars of some Romanesque Norman churches) at ~e 
Church of St Helena in the village of Austerfield m 
Figure 4. A Sheela Na-gig at the top of a pillar in the 
Church of St Helena (Austerfield, Yorkshire, UK). Line 
drawing made from a photograph. Note the scratch 
marks in the facial area. 
Yorkshire (Fig. 4). Considering the erotic nature of 
Sheela Na-gig carvings, and the suggestion by some 
authorities that they might be fertility icons,26 maybe the 
scratches provided a powder for use in reproductive 
conditions - perhaps to counter infertility, amenorrhoea, 
sexually transmitted diseases, pre-partum and post-
partum difficulties as well as problems during childbirth. 
Conclusions 
The therapeutic use of powders derived from a wide 
range of geological materials has a pedigree that extends 
back to classical times. One potential source of such 
powders has received very little attention to date: certain 
building stones used both in secular and especially 
ecclesiastical settings in Germany, Belgium and The 
Netherlands. A superficial examination of churches in 
Britain and France suggests that scratch marks might be 
equally widespread in those countries too. Such buildings 
have systematically scratched surfaces which probably 
provided a supply of therapeutic powders. Stone powd_er 
extracted from church buildings was deemed to have its 
potential healing properties reinforced by its consecrated 
origins. Powders from church building stones represent 
one extreme of a continuum of sources of 'holy' 
materials, ranging from earth obtained from sites of 
pilgrimage to the graves and dwelling places of s~ts. 
Scratching stone powder from church walls still takes 
place today. We have discov~red fresh scratch m~ks27 
alongside older examples, for mstance on a church m the 
German village ofSchadeleben. Their presence might ~e 
related to the local landslip disaster of July 18th 2009, m 
which part of the nearby village of Nachterstedt moved 
downslope into the Concordiasee, a lake developed 
following the cessation of lignite mining in the region. 
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There is no branch of business which might more suitably fill 
a recognised department in the shop of the chemist and 
druggist than the spectacle trade. It is a business which it is in 
the highest degree important should be entrusted to educated 
dealers and the public are as well aware of that fact as are the 
ophthalmic surgeons. 
Although a spectacle dealer did not have to be an 
oculist, it was a good idea to have some knowledge about 
the faults of the eyes that he was correcting. The article 
gives a description of the eye, a brief summary of how it 
works, the ageing process and things that can go wrong 
such as myopia or short-sightedness. It describes concave 
and convex lenses and the benefits of each. It warns 
against the possibility that difficult vision may be due to 
astigmatism and should be ref erred to a 'competent and 
practised person'. 
At this time, measurement of the strength oflenses was 
a numbering system based on their focal distance in 
inches. This was soon to be replaced with dioptres which 
were based on the focal length in metres, a usual range of 
1 to 5. It was suggested that the pharmacist should 
purchase a case of specimen lenses or ' triers', prices 
ranging from £2 or £3 up to £7 or £10. The range of 
spectacles to be stocked was dependent on the amount to 
be invested and the class of the customers he was likely 
to supply. Boxes with a dozen pairs of one quality and 
assorted lens strengths could be supplied by wholesalers. 
The chief stock would be in convex-lensed glasses. A 
folder or case might be included with the more highly 
priced spectacles. In addition a few monocles should be 
stocked. Industrial areas might mean a trade in goggles, 
and seaside resorts might benefit from coloured glasses 
in blue, green or London smoke, the latter being 
generally preferred. Blue was the best for snow-glare. 
So how much profit could be made from spectacles? 
Iron-framed could be purchased at 2s9d per dozen. 
Goggles at 7s per dozen sold at ls6d each. Spectacles 
bought at 20s to 30s per dozen sold at 3s6d, 5s, or 7s6d. 
A good way of keeping the trade together, is to register in an 
indexed book, every transaction, recording the sight of the 
lenses sold to every customer. In cases where satisfaction is 
given, the customer is likely to renew his orders for the sake 
of his own comfort. 
The Tea Trade 
At first glance this seemed a strange option. But tea is a 
herb, we were trained in herbs, so why not sell tea? In fact 
it was a popularly stocked item. The simplest method of 
trading was to purchase ready packed tea in Y.., Yz or 1 lb 
packets, then add a profit margin. The cheaper alternative 
was to buy tea in its original packs imported from China or 
India, and make up his own packets and blends. He should 
have teas to sell at ls6d, 2s, 2s8d, 3s and 3s3d per pound, 
bearing in mind that there was a standard tax of 6d per 
pound. Formulae for blending according to cost were 
suggested: 
To sell at 1/6 (7Yi p) per lb 
lib of China (Moning or Kaisow) siftings 
l lb of Assam broken leaf 
2lbs of mixture ls4d 
ie, 8d per lb and 6d duty gives 1 s/2d cost per lb 
SPECTACLES. 
Iron Frames. Convex Glasses. Assorted Sight.. 
C?mmnn, 21 / per grou. Better ditto, 33/ per gl:'Olia. 
Light Framed ditto, 72/ per grou. 
Steel Frames-
Oommon, 6/ per dozen. l3etter Quality, 10/ per da.n. 
Dilto Light Ball Joint Frame,, 24/ per dozen. 
l>iuo Extra Light Frames, Belt White 01 86/ per dos. 
Pitntuseopic ditto, with Poliahed Edge Oluae., 36/,u fig. l. 
Ditto with lle•t Pebblet, 60/ per dozon. 
Ditto .. Oommon Frame1, 48/ per dozea. 
Ditto with Common Pobblea, Common Framea, 38/ perdm. 
.TAPA.l'D:Sll :l'OLDllB8. 
Common teel, 6/ per dozen. StNI, 7/8 per d n. 
Ditto with Shell 'No .. Pioc , I 0/6 per docen. 
Dit.t.o Grooved Ol&NM, Light Frame, llS/0 per do n. 
Ditto ickel Pl t~ Grooved, Extra Liabt, 38/ per doz n. 
Ditto Beet Panc7 J:iandltd, ISf/ per doun. 
Nickel Plated Folden, Coloured Olu., 38/ per dozen. 
Tortoi-hell ditto, Conv s OltWct , 36/ )?ff do,;en. 
OoLD SP11cuci.u, from 11/ per pau. l>itto u rior, 14/ 
and 21 / per pair. OoLD FuLDllU, bom U /8 pair. 
BlueGlau, 
21 / per 
dozen. 
SXBLETON FOLDERS. 
! Oolour, 
HJ dos. 
12/6 per_dozu. 
Figure 1. Spectacles - Chemist and Druggist Diary 1888. 
THE WELL-KNOWN "LONDON TEAS" 
ABB OJn.T 1,'l'PLrED WllOL' LE DY 
THE GREAT TOWER ST. TEA CO. 
<LI:MITED>. 
Siftings from Fine Tea. • for R t.ail at 114. per lb. 
The London Whole-Leaf Tea. ,, 1,8 ,. 
The London Broken Tea. ,, 1/8 ., 
The London Two-Shilling Tea. ., 2/- ., 
TbeLondonTwo-Shillingindi&nTea,, 21- ,. 
The London A.aaam Broken Te ., 218 ,. 
AND OTHER FINER BLENDS. 
Order a small Sample Parcel, The Qunll t7 nonr del.rtoral ... 
A, HORATIO JONES, " •n•tint DiNCtor. 
Tb• onat Tower 8treet Tea oo. <UmJted>, s• Great 
Tower 8treet, Loudon. a.o. 
Figure 2. Tea supplier - Chemist and Druggist Dimy l 883. 
That is a profit of2d per pound! This gave the cheapest 
blend with siftings and broken leaves. Other formulae used 
whole-leaf tea. 
Tea was wholesaled in chests and half-chests, the weight 
varying between about 96 lbs and 112 lb per chest, 
according to the type of tea. The article advises on the sort 
of quantity that the pharmacist should invest in at the tart 
of his trading. It also points out that the Midlands enjoy 
scented teas such as scented caper and scented orange 
Pekoe. The Midlands also drank green tea, the mo t 
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popular being Moyune Gunpowder. In Ireland they drank 
only Assam tea, so the chemist should not touch Java, 
Japan or Ceylon teas. 
In buying paper in which to wrap the tea, care should be taken 
not to get common paper which smells at all, as many 
experienced men often spoil their tea by using trashy coloured 
paper. Again. in the case of a chemist, the tea should be exposed 
to the air as little as possible, as the smell of the shop would by 
no means improve it. 
The Wine Trade 
Wme could be retailed 'by any shopkeeper who possesses 
a good frontage in a busy street and who has sense enough 
to conceal his ignorance of the subject until experience 
enables him to speak with authority'. There were several 
reasons why chemists should embark upon this trade as 
well as publicans and grocers, the most important being the 
fact that wine is prescribed to invalids and convalescents. 
Who can calculate the probable effects upon the human 
organism of a certain description of liquor like a trader whose 
youth and manhood have been devoted to analysis and 
synthesis? 
It was necessary to find an agent Most of the large 
wholesalers such as Gilbey, the gin people, had filled their 
books with agents in most towns. There were many small 
wholesalers but it was suggested that one should obtain at 
least five quotations. Then thought was needed about 
which products to stock. 
Firstly comes claret, the chink of the future, a wine that ranks 
with bread, meat etc as an article of diet rather than IUXUI)'. 
A void the cheapest and the most expensive as customers may 
prefer to buy expensive clarets from the chateau or a superior 
wine merchant. . . . In the same categoiy as clarets come the 
white wines of Bordeaux which, by ignorant persons are 
occasionally called white claret, a misnomer almost as glaring as 
it would be to speak offemoral bronchitis. 
Burgundy, white and red should be kept in small quantities. It is 
a little fuller in body than claret, and, therefore suitable for use in 
damp and foggy weather. It is a good tonic during the worst 
months: but the unhappy being who drinks it from Januaiy to 
December is laying the seeds of gout, against which the most 
eminent physicians will strive in vain. 
The public knew too much about the prices of good 
champagnes so, just to aid with the festivities, a few cheap 
bottles should be stocked. 
As a pick-me-up a pint of old landed champagne is almost 
unrivalled in the Pharmacopoeia. Its action upon stomach and 
brain is almost instantaneous, especially when the former is not 
loaded by food and when the latter is not loaded by food, and 
when the latter has been injured by alcoholic excesses. 
To chink it at repeated intervals during a heavy repast is an act 
only worthy ofa nation of barbarians, and Nemesis will surely 
follow in the shape of gastritis and general stomachic 
derangements. 
Port is being relegated from polite society to the middle and 
lower orders. In the winter a bottle of fruity port is an excellent 
remedy for a poor person suffering from anaemia. 
Sherry had experienced various fluctuations in the 
market and was not a good bet German wines were 
reasonably popular such as Hock and Moselle. 
The inhabitants of the Rbeingau, where the best Hock is made are 
amongst the most gay, healthful and long-lived members of the 
humanfumily . .. . Diseasesofthekidneyandbladderareunknown. 
It was suggested that Hungarian, Italian, Australian, 
Californian, Greek and other minor varieties had better not 
be held until there was more demand for them. 
Brandy was going through a bad time. The vines of 
Cognac were plagued with Phylloxera. As a result there 
was a lot of counterfeit brandy and the introduction of 
eau-de-vie made from potatoes. Sales were best avoided. 
Petroleum 
My first thought was 'a garage pump outside' , but of 
course in 1882 there were no cars. So what was the 
petroleum trade? 
In 1850, a gentleman named John Young from 
Glasgow took out a patent for the extraction of oil from 
Broxham shale. The heavier elements of this extraction 
were used to lubricate machinery and the lighter elements 
were run off as waste. Young's partner, Meldrum, 
suggested that this lighter oil might be used as a torch in 
collieries and designed a burner in which it could be 
burnt in a suitable wick and chimney. It was named 
paraffin and was a dark, strong-smelling oil. It soon 
started to replace whale oil as a lighting oil. 
The Americans and Canadians had also extracted an oil 
that they had called 'petroleum oil' and were using 
medicinally. They had also distilled oil from coal which 
they had named 'kerosene' which was not as dark or smelly 
as the Scotch version. 
Production rapidly increased and the Chemist and 
Druggist in 1882 commented that: 
There are now unmistakeable signs of exhaustion and prices 
will probably steadily tend upwards, with violent fluctuations 
intervening. 
The price at that time for crude oil was $20 per barrel of 
42 American gallons representing about 2s (1 Op a gallon) 
or 3s a gallon for refined oil. 
Unfortunately Young's patent was only for the 
extraction of oil from shale. The word paraffin had 
previously been used so it could not be patented. As to the 
retailing of petroleum products, there was a Petroleum 
Act that made it necessary to hold a licence, costing Ss 
per year, if the products stored produced an inflammable 
vapour below 73 degrees Fahrenheit. If a licence ~as 
held the storage conditions also had to comply with 
requirements such as the distance from outbuildings, 
limit of stock, drawing off only in daylight and labelled 
with a caution label such as 'dangerous' and the name 
and address of the seller. 
Storage was in coopered barrels. Any sign of damage and 
the contents had to be transferred. The barrels were lined with 
an eighth of an inch of glue which was brittle and could be 
cracked if the barrel was dropped Tanks and containers were 
available for transfer. . 
All petroleum was now being imported from Amenca 
and from the Standard Oil Company, founded by _a 
former bookkeeper named Rockefeller. They had, by_ fair 
means and foul, established a virtual monopoly. Vanous 
products were available: 
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Water-white Crystal Oil ('Wheel brand') - a 
lamp oil that burnt with a very white light about 
twice as brightly as some other oils. 
Lubricating Oils - two types, summer and 
winter. The winter oils would not freeze at 15 
degrees F, as other oils would. Both oils were used in 
collieries, by farmers and in ironworks. They could 
also be used for burning by saturating torches made 
from rope. 
Clear Yellow Oils - were virtually colourless and 
came in two varieties, A and B. A grade was used in 
cotton mills and sewing machines. B grade was a 
heavier oil used in machinery. It was also used, 
lightly perfumed, in hair oils or as a substitute for 
olive oil in the softening of woollen fibres. 
Curriers' Oil - for leather-dressers and saddlers' 
use. It did not dry out or crack. 
Cylinder Oils - for lubricating and rust 
prevention on cylinders used in machinery. 
Spermatine Oils - freezing point of 12 below 
zero. Used by farmers. 
Petroleum Spirit, Naphtha, Benzoline -
solvents with very low flash points. A licence was 
required if stocked. 
And in addition to the sales of oils, the empty barrels 
were very saleable. 
BY H.M.'S ROYAL LETTERS PATENT. 
.... 
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Figure 3. Petroleum - Chemist and Druggist Diary, 1879. backshop or basement. It was necessary to purchase 
machinery to produce the aerated water and also 
machinery to bottle it. Another requisite would be to have 
mains water which should be :filtered. This would be 
through large, plumbed-in carbon or silicon filters. The 
whole set up, including bottles, corks, boxes would have 
cost about £100 which, in those days, would have been a 
considerable investment You would also need to employ 
someone at 25 to 3 5 shillings per week but this could be cut 
down by employing them only in the summer months. It 
was deemed to be a good investment with plenty of scope 
for development, and remember: 
every additional hundred doz.en [bottles] costs less than its 
predecessors. 
Photographic Chemicals 
The year that the article on Auxiliary trades was printed was 
1882. This was only 43 years after Fox Talbot's paper 
presented to the Royal Society when he introduced what 
was called the calotype process. Photography was quickly 
taken up and by the time of the article coated plates were in 
vogue. Along the way some pharmacists had tried their 
hand at processing but little had happened within the 
chemist's trade. We can see from the advertisement that 
c~ernists might stock magic lanterns that would project 
pictures from hand-painted glass slides, but there were no 
adverts for cameras and allied apparatus or chemicals 
although the article does mention a catalogue for specialists. 
It was now suggested that, as most of the chemicals used 
in photography were normal stock items in the pharmacy, 
the chemist should promote these chemicals. They 
included citric acid, ammonium bromide, iodine, 
potassium iodide, potassium bromide, sodium bicarbonate 
and mercuric chloride. Much of the apparatus used would 
be of a scientific nature and would be available from the 
wholesaler and these would be useful add-ons. 
The first advertisements for cameras in the Chemist and 
Druggist appeared in 1886, for tourists, bicyc(j ts, 
tricyclists and others. It is interesting to see that a bicycle 
clip could be had in place of a stand. Presumably this was 
to clip the camera to the bicycle as a stand at that time was 
another name for a tripod And to complete the tock a (j t 
of books were recommended for sale. 
Scientific Apparatus 
Every one qualified to call himself a chemist and druggi l has 
received a certain amount of scientific education and is 
sometimes credited by the public with more knowledge than 
he actually possesses. 
By 1882 science was on many people's minds and 
there were many who sought to experiment at home as 
well as in the laboratory. The main source of apparatus 
were the manufacturers, which was all right if you lived 
in the cities, but difficult on your local high treet. 
And what a good window display - scientific goods that will 
attract and my tify the general public." 
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Figure 4. Scientific apparatus - Chemist and Drnggist 
Diary 1882 
This included various kinds of glass apparatus, Bunsen 
burners, spirit lamps, test-tube stands, retort stands, 
thermometers, coils of insulated wire, batteries, electric 
bells, all items that would withstand the conditions that 
might spoil other stock items. It was suggested that the 
chemist should consider his clientele. Schoolboys would 
probably be the target in most towns and villages unless 
there were scientific institutes. Electricity was not yet on 
mains supply so it was important to stock gas lamps, 
burners and batteries. The article goes on to give a long 
list of items recommended to be stocked 
Homoeopathic Pharmacy 
Homoeopathic medicines are now so extensively used that 
some intelligent equipment for this branch of the medical 
service is almost essential for the chemist and druggist either 
on a large or small scale, according to the possibilities of his 
district. 
Homoeopathy had been invented, or should it be 
discovered, by Dr Samuel Hahnemann and his first book 
on the subject was published in 1806. By 1882 it was 
well developed in Great Britain. 
It was not a great investment to take into stock. The 
manufacturers would supply a showcase full of the most 
popular remedies which could be sold and produce a very 
reasonable profit. It was possible to buy mother tinctures 
in order to medicate your own preparations but it was 
thought unnecessary unless there was a great demand. In 
this case it was suggested that the chemist have a separate 
room just for his homoeopathic work ie preparing 
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Figure 5. Homoeopathic pharmacy - Chemist and 
Drnggist Diary 1888. 
powders, tinctures, globules and pilules and also for 
dispensing prescriptions.. He would need 60 to ~O 
mother tinctures in quantities between 1 and 8 flmd 
ounces (30 to 250 ml) and The Homoeopathic 
Pharmacopoeia to show how they may be prepared. The 
article describes the method of dilution and the strengths 
of tinctures that were produced and gives examples of 
homoeopathic prescriptions. 
Conclusion 
How different is pharmacy today? 130 years lat~~' c~ 
pharmacists make a living by selling those ' tradi~o.nal 
chemist ranges, OTC medicines, ~urgical re9m_s1tes~ 
photographic items and dispensmg prescnptI~ns · 
Perhaps the small shop on the small high street rm~t 
survive but most town centres have malls selling 
everything, with pound-shops undercutting eve~g, 
including OTC medicines. True, the phannac1st ~as 
taken on new roles within the NHS - Non-smoking 
counselling, weight loss advice, MURs etc. But the 
sales? Perhaps we need new entrepreneurs to show us 
new ways to make money. 
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The aim of the present work is to analyse solutions used 
in the past in order to make suggestions for modem 
treatment, thus revising traditional remedies that 
combined with innovative approaches may give rise to 
newer health remedies. In the De Balneis, Michele 
Savonarola from Padua, professor at the University of 
Ferrara and physician at the famous court of Este, 
describes the Patavini Baths and the diseases 
successfully treated in the fifteenth century. The text of 
Michele Savonarola's De balneis, published in 1531 was 
analysed in order to understand medical practices. 
Savonarola's Practica Maior (1560), Gio Andrea Della 
Croce's Chirugia universale (1661), A System of 
Practical Medicine (1840) and Clinica de/ Parigino 
Ospedale di S. Luigi provided essential guidelines in the 
analysis of the diseases described in the document. The 
successfully treated diseases varied and were described 
with meticulous attention: from those of the osteo-
articular apparatus to those of the respiratory system; 
from gastritis to vascular mnemonic-based deficits; pain 
and/or functional limitations of the joints and various 
skin diseases. The analysis led to interesting results not 
only from a historical point of view, but also from the 
clinical, giving important suggestions for the 
development of novel 'optimised' approaches. 
Introduction 
Traditional remedies are an important source of 
suggestions for new remedies. The approaches to health 
described in historic documents, although they are far 
from modem rational approaches, represent the largest 
clinical study ever done by the human being. In recent 
years we have investigated the therapeutic approaches 
used in Ferrara, in particular against the typical illnesses 
of the 19th century. 1 In the present work we focused on 
one of the most popular traditional remedies, 
therrnalism, 2 by studying the earliest report, written in the 
14-15th century by Michele Savonarola, an eminent 
scientist and researcher and author of De Balneis, a 
treatise about thermalism. For the first time, the ancient 
acknowledged properties of Euganean thermae [spas] 
have been revised in the light of current knowledge. 
Man has known the use of mineral substances for 
therapeutic purposes for thousands of years. Greeks, 
Egyptians, Babylonians and other civilisations knew the 
virtues of thermal waters. Philostratus (2nd-3rd century 
AD) in the Heroicus recalls that many wounded from the 
Trojan War were subjected to thermal treatments at the 
Baths, known as the Baths of Agamemnon ,near Smyrna, 
which had warm mineral waters.3 But it was during the 
Roman Empire that a great impetus was given to the 
thermae, with the development of several stations within 
the Empire. A tradition continued later at the court of 
Charlemagne in Aachen, albeit with an obscure period, 
and then again in the 14th century with the recovery of 
the ancient baths. This latter period in history, with 
Savonarola, was investigated in the present work. It was 
only later on that the name of the town Spa in Belgiwn 
became synonymous with hot springs, maybe by 
derivation from the Latin word spagere (to scatter, 
sprinkle, moisten) or as an acronym from the newly 
coined Latin phrase 'salus per aquam' (health through 
water). 
The Euganean thermalism 
The Bagni Patavini, Padua's baths, are located a few 
kilometres southwest from the city. They were renowned 
from ancient timesand known since the Iron Age by 
Paleoveneti (the indigenous people), as cited by many 
Latin writers. 
Over the centuries the nobles and wealthy went to take 
advantage of the balneotherapy in the beautiful area of 
Colli Euganei, a group of hills of volcanic origin. 
The nearby Padua University, founded in 1222, 
already had in the Middle Ages renowned researchers 
like Pietro d'Abano, Jacopo and Giovanni Dondi, 
Michele Savonarola and Bartolomeo da Montagnana, 
and afterwards other famous therrnalists. 
Savonarola's De Balneis 
Salvatore Mandruzzato (1758-1837), professor from 
1801 at the University of Padua (chair A/le Terme di 
Abano, at Abano's spa) in Dei bagni di Abano4 was the 
first to report on Savonarola's 1440 writings in 
Forensium copiosus numerus ex omnibus Jtaliae, ac 
Germaniae partibus ad sanando corpora non mediocri 
cum aviditate veniunt (the baths were frequented by 
foreigners from Italy and Germany). Michele Savonarola 
(1384?-1462?), physician from Padua and grandfather of 
the very famous monk Girolamo Savonarola, was 
professor at the University ofFerrara and physician of the 
Este court. He discussed the virtues of therrnalism in Italy 
in the book De balneis et thermis naturalibus omnibus 
Jtaliae, an incunabulwn printed in Ferrara by Andrea 
Belfort, a French proto-typographer.5 Savonarola was the 
first to mention 'seven baths ' (the total nwnber existing 
at the time). 
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In De Balneis for the first time Abano was recognised 
as Ebano. In Menguzzato's opinion, Ebano derived from 
the Hebrew term aben and eben, stone. 
Several editions of the Savonarola's De Balneis were 
printed in Italy and abroad, also as a section of Practica 
canonica. De Balneis looks at the whole Italian territory; 
however Savonarola came from Padua. He declared his 
obvious preference, giving precedence to the Euganean 
baths. 
Et cum saepe mentem revolverem an extranea domesticis 
anteponendo forent: id mihi honestius esse vedebatur, extraneis 
domestica praefeni debere. Qua ex re cum Patuus siin: de 
balneis in comitatu Paduano a me prius agendum erit ... 
He wrote about the seven baths near Padua: De balneis 
Ebani; De balneis Santi Petri; De balneis Domus nouae · 
De balneis Montis Groti; De balneis Seti Bartolomei; D~ 
balneis Sancte Elene;and De balneis Orthoni mantis (in 
Italian Abano, San Pietro, Casa Nuova, Montegrotto, San 
Bartolomeo, Sant'Elena, Monte Ortone ). 
At first, Savonarola wrote in De Balneis Ebani that the 
seven Euganean baths can be traced back to remote 
antiquity. 
Veriun cum ex ipsis septem quae in comitato habentur, illud 
antiquis scripturis inveniam, quod apud nos de Ebano 
nominatur. Iuxta illud Lucani. 
He mentions the verses of the Latin poet Lucanus 
~ero'.s contemporary, that wrote about Aponus, Aban~ 
(m Lib. VIl v. 193 Frafaglia's war). While sitting on the 
hill of ~bano (which means smoky), Caius Cornelius, 
a~gur (mterpreter of omens) in Padua prophesied the 
victory of Caesar in the war with Pompeus. 
Euganeo si vera fides memorantibus augur: Colle sedens 
aponus terris ubi fumiger exit." 
Since antiquity the Euganean baths were well known 
for their special virtues, as underlined by the meaning 
held in its name: 
De balneis mantis Grotti, sive potius Aegrotorum. Mons est 
ad Occidens Aegrotorum, a veteribus nostris sic nominatus: 
quondam his in temporibus amenitate loci aegrotantes ad 
balnea illi proxima proficiscentes ad eum perambulandum 
trahebantur. 
. Aegrotus means 'the sick' in Latin, Mons Aegrotorum 
1s the mountain of the sick, also attracted by the amenity 
of the place (amenitate loci). 
The sources 
!he text of Michele Savonarola's De balneis6 published 
m 1531 was analysed in order to understand the proposed 
medical practices. 
Savonarola's Practica Maior7(1560), Gio Andrea 
Della _Croce's ~~irugia universale8 (1661), A System of 
Practzcal Medzcme9 (1840) and Clinica de/ Parigino 
Ospedale di S. Luigi (Dermatological Division of St. 
Louis Hospital in Paris) ossia Trattato completo de/le 
Malattie de/la pelle10 (Treatise of skin diseases) were 
used~ es~ential guidelines in the analysis of the diseases 
descnbed m the document. Particular attention was given 
to dermatology in view of our specific research interests. 
The seven baths described by Savonarola will be 
indicated either complete or with abbreviations: De 
b~lneis Ebani, Abano (E); De balneis Santi Petri, San 
Pietro (SP); De balneis Domus nouae, Casa Nuova 
(DN);_ De b~lneis Montis Groti, Montegrotto (MG); De 
balnezs Sctz Bartolomei, San Bartolomeo (SB)· De 
balneis Sancte Elene, Sant'Elena (SE) and De b~lneis 
Orthoni mantis, Monte Ortone (OM). 
Virtues of the Euganean baths 
The Euganean thermal treatments currently have a 
proven benefit for the joints, pain syndromes, muscular 
~troph~ and rehabilitation programs after trauma, 
mcluding fractures and surgery. Moreover, the particular 
chemical composition of the water can help the 
resolution of chronic inflammatory processes. This water 
comes from the Lessini Mountains in theAlpine foothills. 
After reaching a depth of 2000-3000 metres, it flows 
underground through the limestone rock being enriched 
with minerals. Finally it reaches the Euganean hills (of 
volcanic origin), where it flows out on the surface at a 
temperature of nearly 80°C. The water is classified as 
salso-bromo-iodine thermal water. 
Over the centuries this water's properties were 
carefully studied at the University of Padua. They tried to 
exploit all the water sources of the territory, such as the 
sulphurous water that emerged in Costa (Arqua Petrarca, 
Padua), for example. 
Archduke Rainer Joseph of Austria, a Viceroy of the 
Kingdom of Lombardo-Venetia, and his wife were at S. 
Elena della Battaglia spa in 1827. The sulphurous 
mineral spring of Costa was much appreciated by the 
Archduke. The Raineraine was recommended in the 19th 
century for treatment of scrofula. 1 In De Balneis many 
and various virtues are described for different diseases. 
The interpretation was still that of the ancient medicine, 
based on humoral theories. 
Savonarola's treatise for each bath is detailed, but it is 
not easily understandable on certain points. In particular 
we found difficulties in clarifying dermatological terms. 
There is no reference for the words' meanings, and at first 
the terms are unclear. The source of the terms goes back 
to the ancient Arabic, Latin and Greek medicine. 
Vulnera et ulcera (E,SP,MG,SB), gancrenae (E) are 
easily translatable (injury, ulcer and gangrene). In other 
cases a more exhaustive study is required for impetigo (E), 
scabies (E,SB,SE), serpigo (E,SE), herpes aesthiomenes 
(E), bothor (MG), panrrus morpheae (MG), albaras 
(MG,SE), sanguinei violacei, apostemata iunctarum, 
verrucae pendentes, duritia (MG) and maculae corporis 
supe,ficiales (SE). After several attempts the interpretation 
proposed is listed in Tables I-VI. See Figures 1-6. p. 41.) 
The use of the St. Louis Hospital Treatise is a necessary 
guide for a deeper understanding of the described 
diseases. In its text wonderful tables are depicted. 
Alibert10 reported the terms used in the ancient medicine 
for each disease. Also commonly used by other authors: 
Serpigo, impetigo are Arabic, Latin and Greek te~; 
albaras, bothor are Arabic terms; Herpes aestiomenes 1s 
identified as Paracelso's lupus vorax. 
Except for Sant'Elena, all the baths were near Abano. 
San Pietro is a 'mile' away, Casa Nuova, towards the 
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Table I. De Balneis Ebani e Sancti Petri. Rub. L II 
[Illness cured in Abano and San Pietro baths]. 
catarrho frigido [chronic bronchitis with little or no 
phlegm production (dry cough)] & humido 
[acute, chronic or infectious bronchitis with 
phlegm production (wet cough)] 
tinnitui & sibilationis antiquis [tinnitus (whistles and 
hiss in the ear/ rhythmic noises) hearing loss 
up to deafness] 
dolori capitis antiquo [headache] 
habentibus pectus humiditate plenum ac frigiditate 
laesum [acute, chronic or infectious bronchitis 
(pneumonia , pleuritis)] 
stomacho humido [ulcerative gastritis, secretary 
gastritis] 
hydropisim habentibus [fluid retention caused by 
hormonal, cardiac or renal imbalances] 
doloribus articulorum [arthralgia] 
podagrae [gouty arthritis] 
fracture restauratione [healing of bone fractures] 
Vulnera [wounds] & u/cera [plagues and ulcers] 
Ulceribus corrosiuis [traumatic ulcers, diabetic foot 
ulcers] & ambulatiuis [leg ulcers, traumatic 
ulcers, pressure ulcers], gancrenae [ischemic 
gangrene], herpeti esthiomeno [Herpes 
genitalis (HSV-2), already defined by 
Paracelsus as "Lupus Vorax'') ] 
serpiginem [Herpes Zoster with a dermatomal 
distribution (Figure 1, Tav.6)] & impetiginem 
[impetigo caused by Staphylococcus aureus] 
scabiem ulcerosam [scabies complicated by 
scratching and superinfections (Figure 2, 
Tav.55)] 
carbunculis [swelling (pimples or abscesses) and 
ulcers] 
Table II. De balneis Domus nouae. Rub III 
[Illness cured in Casa Nuova baths]. 
Cachexia Cachexia 
Hydrope, Hydropsy 
Paralysi Palsy 
south, is a half-mile from Abano (a Roman mile, milia 
passuum - a thousand steps, where each pace or stride 
was two steps - about 1480 metres or 1617 yards). Even 
if they are close to one another, the properties of the 
waters are often very different anyway. Sant'Elena, 
however, is seven miles from the city. According to 
Savonarola, the various thermal bathhouses were able to 
promise significant benefits for treatment of the 
osteoarticular, neurologic, respiratory, digestive and 
renal-vascular apparatus, including also dermatologic 
diseases, especially the aesthetic. Abano and San Pietro 
have similar properties (Table I). 
About Sancti Bartolomei baths (Table IV) Savonarola 
wrote: 
Unde meo cum consi/io vir quidam Feltrensis nomine 
Petraca qui nodositatem ac duritiem in genu habebat [ ... ] Et 
inventum est in libris quondam Estensem Marchionem a 
podagra curatum [ ... ] et dominus Aquileiensis Cardinalis 
lotus contractus. 
That is, important people were successfully cured, 
such as an Este marquise (podagra), a cardinal from 
Aquileia (osteoarticular apparatus). Petraca is not the 
well known and famous poet Petrarca, who lived in 
Arqua, the Euganean town. Petrarca is not Feltrensis, 
from Feltre. It could not be the 'meo cum consilio, under 
my advice' by Savonarola, as they were not 
contemporaries. 
Dermatological properties are reported for all these 
baths, except from the Domus nouae and Orthonis 
Montis baths (Tables II and VI). Montis Groti e Sancte 
Elenae baths (Tables III and V) are characterised in 
particular for their application to the aesthetic field. 
Principal applications of thermalism to dermatological 
conditions range from teenage acne, all forms of eczema, 
psoriasis, rosaceous acne to all forms of allergic 
dermatitis. The use of mineral water, which aids tissue 
reconstruction, has also proved particularly effective in 
the treatment of skin lesions such as burns. 11 
Scientific aspects related to the use of 
thermal mud 
There is evidence that in prehistoric times, the Nean-
derthal Homo erectus, imitating the behaviour of 
animals, which instinctively roll around in the mud to 
benefit from it, were using earth mixed with water to heal 
wounds, relieve irritation, clean and protect the skin. 
This practice has been documented in various 
historical periods, from Mesopotamia to ancient Egypt, 
where special mixtures of water and clay were used to 
improve anti-inflammatory applications of muds. 
In ancient Greece, we find the first classification in the 
work of Hippocrates and Aristotle, of mud and earth for 
healing, applied in the form of poultices to achieve 
antiseptic goals, for the treatment of skin problems, to 
help wound healing and to remove the poison from 
snakebites. 
The practice of using therapeutic mud baths became of 
great importance in Roman times, as evidenced by 
several documents, including the Natura/is Historia of 
Pliny the Elder, which describes the properties of mud of 
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Table III. De balneis Montis Grotti. Rub 1111 
[Illness cured in Montegrotto baths]. 
catarro humido [acute, chronic or infectious 
bronchitis with phlegm production (wet cough)] 
Sibilo tinniti, surditati ex causa frigida venienti 
[tinnitus , deafness resulting from degenerative 
causes (otosclerosis)] .. . 
do/ores descensiones humiditatum [arthrosis] 
capitis dolori antiquo [headache] 
memoriam . . . non ex aetate deperditam [loss of 
memory due to vascular impairment (but not to 
deqenerative causes)l 
pectus ab humiditatibus liberat ... asthmaticis 
[improvement of productive cough and asthma] 
... 
stomach um laxant .. . stomach um frigidum 
[ulcerative aastritis and atroohic aastritisl 
hydropisi [hydropsy] 
nervos mundificant ... in paralysi .. . spasmi sedant 
.. . epilepticis [central and peripheral 
neurological disorders (epilepsy, paresis)] 
Vulnera [wounds] & ulcera [plagues and ulcers] 
corporis superficiem a bothor [cradle cap, 
seborrheic dermatitis (candidiasis of oral and 
enteral mucosa are not mentioned)] 
ulceribus ma/is antiquis [inveterate ulcers] 
sanguineis violaceis [ecchymosis (subcutaneous 
bleeding), sarcomas (Figure 3, Tav.58)] 
Pannos [all other skin blemishes (superficial, flat, 
sine materia , and with a slow evolution) (Figure 
4, Tav.59)] 
Morfeae & albaras [vitiligo or other skin diseases 
with achromic cutaneous blemishes (Pityriasis 
alba, Pityriasis versico/or, Candida albicans 
etc.) (Figure 5, Tav.61)] 
apostematibus iunctarum [chronic tophaceous gout, 
characterized by nodular masses of uric acid 
crystals (tophi) most commonly found in hands 
and feetl 
duritiis [callosity], verrucis pendentibus [outgrowths] 
volcanic origin. The traditional use continued through the 
Middle Ages, being reflected in the medical practices of 
Avicenna and Averroes. The first Pharmacopoeias 
appeared during the Renaissance with a continuing 
record of applications until the present. 12 
The muds or sludges with curative and/or aesthetic 
purposes are preparations that have a solid part, (which is 
essentially of mineral origin and consists of clay with 
Table IV. De balneis Sancti Bartolomei, Rub V 
rillness cured in San Bartolomeo baths 1. 
debiles in iunctiris . . durities aut nodositas ... ac 
iunctarum .. . duritie genu .. . membra indurata, 
contracta [joint stiffnessl ... 
doloribus podagricis [gout] . .. 
Vulnera wounds & ulcera [plagues and ulcers] 
Scabiosis conferunt [scabies (Figure 6, Tav.56)] & 
u/ceribus [plagues and ulcers] 
Table V. De balneis Sancte Elenae. Rub VJ [Illness 
cured in Sant'Elena baths]. 
aegritudinis capitis [headache] .. . 
stomacho humido [ulcerative gastritis, secretory 
gastritis] ... 
hydropisi [hydropsy] . .. 
Confert iuncturis, & eas confortat, & prohibendo 
f/uxum humiditatum ad eas ... Paralysi ... Nervis 
humiditate repleris ... Spasmo .. caeterisque .. 
ex causa frigida & humida [pain and loss of joint 
function] 
Decoratio. [beauty spa treatments] 
serpigini [Herpes Zoster with a dermatomal 
distribution (Figure 1, Tav. 6)], albaras [vitiligo or 
other skin diseases with achromic cutaneous 
blemishes (Pityriasis alba, Pityriasis versicolor, 
Candida a/bicans etc.) (Figure 5, Tav. 61 )], 
scabiei [scabies (Figure 6, Tav. 56)] & maculas 
corporis superficia/es [skin discoloration] 
Table VI. De balneis Orthonis mantis. Rub VII 
[Illness cured in Monte Ortone baths]. 
hydropisi [hydropsy] 
do/ores antiquos [general pains] 
particular chemical composition and grain size), and a 
liquid part, generally consisting of mineral, thennal or 
marine waters. .bed 
In addition to the traditional applications descn 
above, several papers have been published in order to 
provide a scientific basis for traditional uses of mud/sludge. 
Nevertheless the mechanisms involved are multiple an~ 
complex so it is still difficult today to provide a clear an 
' fi ·a1 ffec~ comprehensive explanation for the bene c1 e 
observed. 
Toe main properties related to clay minerals are: . ul 
1. Adsorption capacity, due to the partic ~ 
distribution of the size of the clay particles. These are ID 
fact very small and once mixed with the thermal water 
can lead to the formation of colloidal systems or systems 
with micellar structure which favour the exchanges on 
the human skin surface. 
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Figure 1. Serpigine acuta. Alibert, Tav. 6. 10 
2. High ion-exchange 
capacity, determined by the 
spatial arrangement of polar 
compounds present in the 
spaces between the crystals of 
clay, which favours a 
continuous ion exchange 
between the thermal water, rich 
in ions, the clay and the skin. 
The distribution of the charges 
that it generates also facilitates 
the establishment of inter-
actions, physical-chemical (van 
der Waals forces) and 
electrostatic, which favour the 
passage of substances, such ~ 
L---Fi-.g-u-re-2-.-R_o_gn_a__, lipids and toxins from the skin 
to the clay. 
legitima o Vesciolosa. 3_ Plastic and rheological 
Alibert, Tav. 55.10 properties. The sludge used in 
,,_--=--~c-----.-.,,-, the mud, in fact, possess 
specific characteristics . . of 
viscosity and malleability, 
which affect the ability to retain 
water and to form a continuous 
film when applied to the skin 
surface. These properties are 
derived from the distribution 
and reduced size of the clay 
particles. 
4. Thermal properties. The 
mud/sludge for therapeutic 
and/or dermocosmetic use is 
characterised by a special 
ability to retain heat, preventing 
rapid cooling. This means that 
once applied very hot on ~e 
skin, they cool slowly, keepmg 
-.......__..::._~,.__~ _ _J the accumulated heat for a long 
Figure 3. Ematese 
Varicosa. A libert, Tav. 
58.10 
time and without causing 
damage and burns. 
The mud/sludge is applied 
directly to the skin in a thick 
layer of a few 
centimetres that, due 
to the particular 
distribution of the clay 
particles and their 
physicochemical 
properties, forms a 
continuous film 
capable of performing 
important beneficial 
actions. 
The action of heat 
plays a major role in 
the mechanisms that 
characterise the L-~----=:s.._ _ ___:: _ __, 
beneficial activity of Figure 4. Panno Lenticolare. 
the sludge. Indeed, the Alibert, Tav. 59_ 10 
application of hot~----------, 
sludge on the skin in 
the form of cataplasms 
(poultices), on zones 
of limited extension, or 
on large areas of the 
body, can be used for 
the treatment of 
dermatological disor-
ders (i.e. acne, 
seborrhoea, dermatitis, 
ulcers) or to reduce the 
pain and inflammation 
in the case of chronic 
rheumatic disorders 
and arthritis. 
When hot mud is 
applied, due to the heat 
and the action exerted 
by the occlusive layer 
of clay, there is initially L------"=------' 
an intense increase in Figure 5. Panno melonato. 
the rnicrocirculation Alib er 61 10 ert, 1av. . 
with intense hyper-
aemia and increased 
sweating. 13 This leads to 
a significant increase in 
hydration of the stratum 
corneum and a 
modification of the Lipid 
layers of the skin that 
promotes the exchange 
of substances. The rapid 
loss of water and 
electrolytes due to 
sweating determines a 
withdrawal of liquid 
from the interstitial 
spaces, which favours 
the removal of inflam- i__ _______ .......... ___. 
matory mediators, ~e Figure 6. Rogna Serosa o 
elimination of catabolites Canina. Alibert, Tav. 56.10 
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and reduces the stagnant fluid in the periarticular tissues, 
with consequent reduction of pain. In addition, the heat 
exerts a muscle relaxant action. When the treated surface 
is large enough, systemic effects also are observed, wi1? 
increased heart rate and respiration, release of anti-
inflammatory hormones (i.e. cortisol) and endogenous 
opioids (i.e. endorphins) with analgesic properties. 14·15 
Furthermore, the application of hot mud exerts an 
anti-inflammatory effect, with reduction of swelling and 
decrease of plasma levels of pro-inflammatory mediators 
TNF and IL-1 ~' which play a key role in inflammatory 
processes associated with rheumatic diseases. 1~ It is 
hypothesised that the lowering of the concentration. of 
inflammatory cytokines is due to a neuroendocnne 
reaction triggered by thermal stimulus. 
The effectiveness of the mud is not only due to the 
action of heat, but also the transfer of ions and minerals 
present in the thermal water through the skin. As has been 
seen, in fact, the essentially mechanical and thermal 
action exerted by the clay favours not only the 
elimination of molecules and ions that are adsorbed from 
the mud, but also the passage of several micronutrients 
contained in the thermal preparation, necessary for some 
physiological and metabolic processes. This has been 
demonstrated in several experiments by in vitro 
percutaneous absorption, in which it is seen that the clay 
promotes the transfer through the skin of chemical 
elements present in the thermal water in proportion to 
their concentration in the water itself. 17 
The thermal water used in the preparation of the mud 
has also an active role; it potentiates the action of heat and 
it reduces pain and inflammation in the joints. This has 
been demonstrated by a study in which hot thermal 
mudpacks have been applied to two groups of patients 
with osteoarthritis of the knee. In the experiment the mud 
was applied to one group directly on the skin, while in the 
second group a nylon film was applied between the skin 
and the mud so as to prevent the exchange of substances 
between the two. In both groups there was a significant 
reduction in pain and improved joint function, but with 
better results in the group receiving direct application on 
the skin. 18 
Furthermore, in a 1998 study, 55 patients suffering 
from psoriasis vulgaris were treated only with thermal 
products: waters, mud, and/or algae, except for bland 
emollients for xerosis. Treatment for brief periods (10 ± 
3 days) resulted in notable improvement. 19 
In another study, 74 patients with Clostridium difficile 
infection, were subjected to routine bathing practices 
which had, although limited, an efficacy in decreasing the 
burden of spores on skin. 20 The use of mud for skin 
application is highly reputed also for wound healing, i.e. 
for those injured by war. As indicated above, for example 
the mud ( fan go) from Battaglia, in the province of Padua, 
may induce positive effects by stimulation of 
metabolism, induced perspiration, and promotion of the 
absorption of pathological effusions; also pain is allayed 
and alleviated indirectly.21 
New aspects of health application: From 
tradition to innovation 
Taking advantage of what has been described in the past 
on the Euganean thermal basin, we have started a 
research project aimed at the development of a 'fango' 
featuring some of the qualitative aspects of mud from the 
Euganean basin, but one that could be adapted for a use 
at home to extend the beneficial effects obtained after a 
period of treatment at spas or as complementary 
treatments for pharmacological therapy of the problems 
described above. Our approach employs a 
'reconstructed' fango. For this purpose, standardised 
selected natural clays were used, mainly composed of 
alurnino-silicates whose chemical-physical charact-
eristics are equivalent to those from the Euganean basin. 
They allow the preparation of a fango with plastic 
characteristics, rheological and thermal specifications, 
standardised and easily controllable. This also allows us 
to answer to regulatory aspects necessary for a home use. 
In this specific case the clay is treated to render it suitable 
to the purpose of the application. In particular, it was 
mixed with hyperthermal-bromine-iodine water from the 
Euganean basin, stabilised and packed ready for 
application. Studies are still ongoing and we will report 
in due course a comparison with the effects of mud baths. 
Three different applications can be envisaged for such 
a reconstructed fango. 
1. The application of hot reconstructed fango for .~e 
treatment of chronic rheumatic disorders, osteoarthritis, 
spondylitis, fibromyalgia, and bone fractures'. w~e it is 
to be avoided in acute and subacute rheumatic diseases, 
heart disease, kidney and liver failure, tuberculosis, 
epilepsy and pregnancy. 
2. In acute diseases, for inflamed or congested areas, 
the application of cold fango is suggested, because the 
thermal properties of the clay-water mixture all~w the 
removal of heat from the area affected, by exerting an 
anti-inflammatory and pain reduction functio~. . 
3. Use in the dermo-cosmetic field, especially m the 
form of facemasks or body applications. The c~ay ~xerts 
a cleansing action the skin that allows the elimination of 
excess sebum and toxins, while the thermal "'.ater 
provides important tissue trace elements. The combm~ 
effects of thermal clay and water should be of benefit md 
22 · · 2J an the complementary treatment of acne, psonas1s 
dermatitis.24 
The amelioration of the microcirculation ind~ced by 
mud application is also applied in health spas_to unprov~ 
the cosmetic appearance of cellulitis, and thi~ approac f 
should be better fulfilled by home applicanon ° 
'reconstructed fango'. The results related to the a~ve 
mentioned 'reconstructed fango' are currently un er 
evaluation and will be presented in another paper. 
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Book Review 
Prescribed: Writing, Filling, Using and 
Abusing the Prescription in Modern 
America 
Jeremy A Greene and Elizabeth Siegel Watkins (eds) 
Baltimore: The Johns Hopkins University Press, 2012. 
Pp. x+329. £15.50. ISBN 978 142140507 0. 
Toe prescription lies at the very heart of modem 
pharmacy practice, symbolising in a tangible way much 
of the role of the pharmacist. It performs diverse and 
sometimes conflicting functions; on the one hand it 
serves as the means by which physicians convey their 
instructions regarding a patient's treatment to 
pharmacists; on the other it acts as a barrier between 
patients and their unrestricted access to medicines. But it 
also performs other functions: it is a demonstration of the 
clinical autonomy of doctors; a symbol of the 
subservience of other health professionals; and a political 
instrument by which governments control the availability 
of certain products of the pharmaceutical industry. And 
its ownership has been a matter of debate and negotiation 
over many years. 
Over the centuries the role of the prescription changed 
little, but new challenges emerged with the start of the 
therapeutic revolution in the late 1940s. This book 
focuses on the evolution of the prescription over the last 
60 years. All the authors are American and as indicated in 
the title the book has an exclusively American focus. It 
consists of an introduction followed by ten chapters 
written by medical historians. The different chapters 
focus on different aspects of the contested nature of the 
prescription and the different functions it has performed 
in the second half of the twentieth century. The chapters 
illustrate in considerable detail the problems of overuse, 
misuse and abuse of medicines, and the ways in which 
the prescription has been used to control them. 
Toe introduction sets the scene for the book; the editors 
explain that they 'use the prescription as a shorthand 
reference for a set of complex relations among the 
producers, providers, and consumers of medicine' . It also 
reviews the early history of the prescription up to the 
middle of the twentieth century before exploring the 
nature of the prescription in modem American. 
In Chapter 1 Nicholas Rasmussen explores concerns 
about the overuse of barbiturates and attempts by the state 
to regulate it. He treats the public debate around their use 
from the rnid-1940s to the late 1950s in terms of a 'moral 
panic'. He shows how the debate blurred the boundaries 
between addictive narcotics and mothers little helpers 
available on a doctor's prescription. In Chapter 2 Scott 
Podolsky considers problems resulting from the overuse of 
antibiotics, from the 1950s onwards. He shows how the 
focus shifted to the rational use of drugs following the 
widespread prophylactic use of antibiotics and the 
promotion of fixed-dose antibiotic combinations. He 
explores the process by which better control was eventually 
achieved following acrimonious discussions between 
doctors, regulators and the pharmaceutical industry. 
Dominique Tobbell considers the issue of brand 
substitution by pharmacists in Chapter 3. A problem arose 
in the early 1950s as a result of pharmacists needing to 
stock the very large number of different brands of the same 
drug being marketed; it was impossible for retail 
pharmacists to stock them all. Yet substitution was seen as 
an attack on the doctor's autonomy, and the combined 
efforts of the doctors and the industry led to most states 
passing anti-substitution laws. 
In Chapter 4 Elizabeth Siegel Watkins considers 
patient package inserts and their impact on the 
relationship between patient, doctor and pharmacist. The 
first patient package insert was for oral contraceptives in 
1970. Before that date, doctors controlled the amount and 
type of information that was revealed to patients about 
prescription drugs. Toe women's health and consumer 
movements of the 1970s lead to demands for patients to 
be given access to all available information. American 
pharmacists opposed the use of inserts, and were anxious 
to uphold the role of the prescription as a boundary 
marker between experts and lay people. 
Chapter 5 explores the issue of who has the right to 
write prescriptions. Julie Fairman notes how physicians 
in the United States felt besieged as nurse practitioners, 
pharmacists and physician assistants all tried to gain 
prescription writing privileges at the same time in the 
1970s and early 1980s. She presents a detailed case stu?Y 
of the struggles nurses had in state after state with 
doctors, pharmacists and regulators to win the right to 
write prescriptions. 
Toe theme of who has the right to prescribe is 
continued in Chapter 6, in which Judith Houck takes a 
feminist approach to well-women clinics. A clini~ was 
founded in California in the 1970s with the ann of 
providing well-woman health care free from medical 
oversight. In this situation the prescription had an 
ambiguous role. On the one hand it limited the extent to 
which lay persons could provide health care; on_th~ other 
sympathetic physicians wrote pre-signed presc~pnons or 
signed off a week's worth of prescriptions at a time. 
In Chapter 7 the focus shifts from who prescribes to 
· d to whether particular drugs should be restricte 
prescription only at all. Heather Munro .Prescott 
considers the campaign to make oral contraceptives and 
emergency contraceptive pills available. over the cou:;tert 
The possible dangers of oral contraceptives came to ghf 
in the second half of 1962 when the number of cases 0 
' p cott blood clots reported rose from 28 to 272. . res and 
explores how following changes to formulation . 
' · · tration guidance for use, the Food and Drugs Admims th IIl 
was eventually persuaded that it was safe to make e 
available over the counter. In doing so she shows h~ 
feminist grass roots activism helped to redefine e 
meaning of the prescription. . is 
Toe theme of different categories of drug regulatio~ 
continued in Chapter 8, this time in relation to e 
44 Phann Hist (Lond) 2014; 44 (2): 
prescribing of narcotics. Prescriptions for opioids in 
particular carry a social and cultural meaning as well as a 
legal one. Marcia Meldrum shows how they make both 
doctor and patient visible and hence expose both to the 
risk of stigma and marginalisation in society. She 
illustrates the difficulties doctors often had in negotiating 
the fine line between meeting patients' genuine need for 
opioid pain relievers and feeding their addiction. 
In Chapter 9 David Herzberg explores the role of 'scrip 
mills' in which Quaalude (methaqualone) became a 
notorious drug of abuse in the 1970s. The drug was 
highly addictive and special clinics were set up where 
addicts could obtain supplies. The chapter illustrates how 
an apparently simple question; 'what is the difference 
between prescribing and drug trafficking?' does not 
necessarily have a simple answer. Herzberg shows that 
prescribing can be a commercial transaction whether it 
occurs in a scrip mill or in a legitimate doctor's office. 
In the final chapter Jeremy Greene considers the 
afterlife of the prescription. Whilst the lifespan of the 
prescription is probably only hours or even minutes, 
Greene shows how over the last fifty years the vast 
quantities of prescriptions written and dispensed have 
been used to create huge systems of therapeutic 
surveillance, with important implications for both drug 
safety and marketing. Computerisation has allowed the 
automation of pharmacovigilance. In this chapter Greene 
illustrates the evolution of drug prescribing databases, 
and how the prescription has become a tool for market 
research; prescription databases are now big business in 
their own right. 
This highly readable book will be of considerable 
interest to historians of pharmacy. They will make a 
number of general observations arising from its 
publication: that a substantial number of eminent 
medical historians are now engaged in research on the 
development and use of pharmaceuticals; that much of 
this research examines contemporary practice, and 
certainly that within the last fifty years; and that much of 
this effort is focused on practice in the United States. 
The transformation of the prescription has been very 
different in different countries, as a result of differences 
in welfare, funding arrangements for medicines, and 
legislation. But in them all the prescription serves as a 
link between clinical practice and medical commerce, 
between doctor and pharmacist, and between pharmacist 
and patient. In most countries the recent history of the 
prescription is yet to be written. Those who take on this 
challenge would be well advised to take note of the issues 
raised in this important book and the way in which they 
are addressed. 
Dr Stuart A Anderson 
David Waldie (1813-89) 
Professor Harkishan Singh 
Panjab University, Chandigarh, India 
The year 2013 marks the bicentenary of the birth of 
David Waldie who gained prominence for the discovery 
of the anaesthetic properties of chloroform. He had an 
Indian connection where he was instrumental in starting 
chemical manufacturing for the first time; he died after 
spending 36 of his life span of76 years there. 
In August 1988 while examining the files of the Indian 
and Eastern Druggist at the Royal Pharmaceutical 
Society of Great Britain Library I came across an article 
on David Waldie' which aroused my interest for studies 
on him. I also kept an eye open for literature pertaining 
to Waldie during my search of archival material in 
general on the medico-pharmaceutical history of India. I 
located certain new references of interest and also 
obtained useful source material on him through 
correspondence with several institutions over many 
years. The West Lothian History Library, Linlithgow, 
Scotland supplied relevant material from the local 
newspapers.2 To get started on the writing the well 
known sources on the subject were studied.3"° 
David Waldie, the eldest son of Alexander Waldie and 
his wife Agnes Ford, was born in the Royal Burgh of 
Linlithgow, Scotland, on 27 February 1813.7 He had his 
early elementary education in his native town before 
proceeding to Edinburgh for his medical studies at the 
Royal College of Surgeons at the very early age of 14 
years; five years later he qualified as a surgeon obtaining 
the Diploma of the College in November 1831 . 
Thereafter he practised as a surgeon, apothecary and 
druggist at Linlithgow. 
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Waldie had an abiding interest in chemistry and 
became Fellow of the Chemical Society, London, in 
1843.8 Possibly it was his interest in chemistry which 
made him to give up practice as a surgeon and apothecary 
at Linlithgow in 1839 or 1840 and become a chemist to 
Liverpool Apothecaries Hall, later known as Liverpool 
Apothecaries Company.4.9,10 After several years at 
Liverpool he started feeling that it would be a slow 
process to get remunerative business there, so he 
accepted the post of a chemist at a firm (Malcolm & Co.) 
in Calcutta and left for India in 1853.3 
Based on information from major publications 
pertaining to Waldie and some fresh material I have been 
able to collect, the coverage which follows is categorised 
under the headings: Discovery of Chloroform Use as an 
Anaesthetic; Chemical Manufacturing and Analysis 
Work in India; Demise and Burial; and Waldie 
Memorials. 
Discovery of Chloroform Use as an 
Anaesthetic 
Developments leading to chloroform use as an 
anaesthetic are found in the articles cited here .3-6 
David Waldie worked on the preparation of 
chloroform. It was he who suggested to Sir James Young 
Simpson, gynaecologist, to try chloroform as an 
anaesthetic. Simpson produced wonderful results but the 
findings he projected did not give due credit to Waldie 
who in the first place had brought chloroform use to his 
notice. 
Waldie and Simpson were both born in 
Linlithgowshire. They studied medicine in Edinburgh 
during the same years and were friends.7 
At the Liverpool Apothecaries Hall Waldie prepared 
chloric ether, a spirituous solution of chloroform, in a 
crude manner by distilling alcohol with chloride of lime. 8 
He introduced an improved method of separating the 
chloroform and dissolving it in known quantity of spirit. 
Near the same time in October 1847 he had a meeting 
with Simpson about which he wrote in his own words: 
On occasion of a visit to Dr Simpson, when in Scotland in 
184 7, he spoke to me of his trials of various vapours, in his 
endeavours to discover something else than Ether, at that time 
employed to some extent for anaesthetic purposes, amongst 
others mentioning Chloric Ether, the chemical constitution of 
which he was evidently not aware 0£ This I explained to 
him, showing him that it was chiefly vapour of alcohol that 
would be inhaled, and advised to try the pure Chloroform, 
which appeared to me likely to be suitable. I promised also 
to prepare some as soon as I could return to Liverpool, and 
send him for trial. Unfortunately the laboratory of the 
Company had previously been destroyed by fire and was not 
then restored, so that I could not prepare it .. . 11 
Simpson did not wait for Waldie to send chloroform, 
but he himself had it prepared and tried it as an 
anaesthetic in obstetrics. He communicated the results to 
Edinburgh Medico-Chirurgical Society in November 
1847. 
investigations by Dilling3 and Dundee6 deserve a special 
mention. Dilling described D. Waldie as 'Prophet of the 
Anaesthetic Properties of Chloroform. ' 3 Based on his 
study Dundee wrote: 
Waldie clearly stated his part in the discovery and refuted 
claims to any honours not due to him. He never claimed 
priority over Simpson, although not satisfied with the amount 
of credit he got .. . '6 
About the Dundee's paper it has been said, 'probably this 
is the best account of the choloroform controversy'. 10 
Chemical Manufacturing and Analysis 
Work in India 
It is stated that: 
In 1853 Mr Waldie went to Calcutta (now known as 
Kolkata), being sent out by the firm Malcolm and Co. as 
experimental chemist. There he not only superintended the 
refining of borax and saltpetre at Goosery (Ghusury), but also 
carried out the manufacture of carthamim from safllower; the 
latter, however, was not pecuniarily successful. On Messrs 
Malcolm and Co. reliquinshing business Mr Waldie took 
over a manufacturing business at Duckinsore (Dakhineswar), 
and also practised as an analytical chemist. This business he 
afterwards removed to Bamagore (Baranagore), and 
eventually to Cossipore, carrying it on up to 1887, when he 
sold it to its present proprietors. 8 
It appears that the parent firm Messrs Malcolm and Co. 
in Britain deputed him to work at their unit in India and 
they possibly were already in the business of chemical 
manufacturing. For want of any other information on the 
company and otherwise, and later Waldie himself 
establishing himself as a successful chemical 
manufacturer, credit is given to him as being the first to 
start chemical manufacturing in India. 
According to Dilling, 
In 1853 he accepted the post of chemist to a firm (Malcolm 
& Co.) in Calcutta, and reached there on 13th May, 1853 ·:· 
the firm, Malcolm & Co., which seems to have been_ m 
difficulties, and in November, 1857, Waldie considers taking 
over a small chemical factory, started by a Dr Porteo~, 
probably at Bamagore (Baranagore ), and relinquishing his 
connection with Malcolm & Co .... he found the Barnagore 
factory too small and had transferred to new premis~ at 
Kasipur (Kashipur), where he founded the Coss1pore 
Chemical W orl,s .. . . 3 
A limited number of items were manufactured at the 
Cossipore Chemical Works. I have come across a :ague 
statement that around 1884 at the Economical Section of 
the Indian Court where there was a complete classified 
collection of indigenous drugs, D. Waldie exhibited 
'some of the chemical products, acids, ethers, etc. 
manufactured in his laboratory at Cossip~re. ' 12 . 1 The association of Waldie with Coss1pore Chenu_ca 
Works continued till 18878 or may be later till his passmg 
away as it is mentioned at an other place. 3 Subsequently 
it was named D. Waldie & Company. At ace~ stage 
Waldie had taken into partnership a young geolo_gist, ~ 
Criper, who expanded the business and shifted 
company to Konnagar. 13 
Several studies have been carried out which ensure a In a 1896 article it was stated 'There is only one 
positive place for Waldie as a discoverer . of the chemical works _ Messrs. Waldie & Co.,_ near ~cu~ 
anaesthetic use of chloroform. The m-depth and their principal production is in the mmeral acids. 
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According to a survey of industrial development of 
Bengal for the period 1900-1939 the three chemical 
industries named were Bengal Chemical and 
Pharmaceutical Works, Bengal Immunity Company and 
D. Waldie and Company, the latter being the pioneer in 
the chemical industry in Bengal. Is 
As well as a successful chemical manufacturer Waldie 
was also an accomplished analyst. He was a chemical 
expert to all merchants in Calcutta, analysing samples of 
shellac and other articles of the East India produce.3 His 
certificate was accepted throughout Calcutta. It was 
stated that: 
Between 1866 and 1867 he made extensive investigations 
into the character of the water ofHoogly River. He was able 
to prove that the water of this river was the purest that could 
be obtained. This result of his investigations was challenged 
at the time, but was later proved to be correct. Waldie was 
actively concerned with the purification of the Calcutta 
water-supply and in this connection did valuable work of 
great and lasting benefit to the community. 1 
On this theme I came across a reference to a publication 
by Waldie (1874), 16 while working at the National 
Library, Calcutta. 
Demise and Burial 
After coming to India in 1853 David Waldie lived in the 
country until he passed away on 23 June 1889.3,6 
Waldie continued to be busy with his vocation of 
chemical manufacturing and analysis, but he spared time 
to actively associate with the Asiatic Society of Bengal 
which had started as the Asiatic Society and was the 
oldest institution in India of learning in science and 
humanities. 17 The following extract from the proceedings 
of the July 1889 meeting of the Asiatic Society of Bengal 
recorded his demise and also put on record the particulars 
ofWaldie's association with the Society: 
The President said - I very much regret to have to announce 
the death since our last meeting of Dr D. Wal die, one of our 
oldest members of the Council. Dr Waldie joined the society 
in 1865 and had served on the Council since 1879, having 
been vice-president in the years 1884-1885. He was a most 
regular attendant at our meetings, and was always ready to 
further the work of the society in auditing accounts and 
giving his services on various committees. He published 
several papers in the journal and Proceedings, most of which 
were connected with the water supply of Calcutta, and the 
effective filtration of the Hoogly water during the rainy 
season, which has always been a difficulty. Before Dr 
Waldie came to India some forty years ago, he had been 
connected with Sir James Simpson, who was the first to apply 
sulphuric ether as an anaesthetic, and appears to have 
suggested to him the use of chloroform instead of ether, 
though our late friend and associate does not seem to have 
received full credit for his share in one of the most important 
discoveries of the age. A man of retiring and unassuming 
ways, we have had few opportunities of knowing the full 
extent of his scientific work, but as an analytical chemist and 
chemical manufacturer he undoubtedly did much to promote 
chemical science in this country. I believe he also did good 
service in connection with the establishment of libraries and 
institutes in the neighbourhood of his works at Cossipore and 
Dakhinsur (Dakhineswar). We shall miss his kindly presence 
here, and he will be regretted by many who know his worth. 18 
In a reference to the burial of Waldie at Calcutta it was 
stated:' 
a tombstone may be seen in the Scottish Burial Ground there 
bearing the following inscription: 
Sacred to the Memory ofDA YID WALDIE, eldest son of 
Alexander Waldie, and his Wife, Agnes Ford, Linlithgow, 
Scotland. Born 27th February, 1813. Died 23rd June 1889. 
Aged 76 years. 
Chloroform - One of God's Best Gifts to His Suffering 
Children. 
I requested a senior colleague of mine in the profession 
who lived close to the Scottish Burial Ground at Calcutta 
to check on the inscription on Waldie's tombstone; I was 
disappointed at his stating in the reply, 'It is near our flat 
but cemetery is a jungle now and it is abandoned. It was 
difficult to trace anything there ... ' 19 
As I was studying David Waldie, there arose a confusion 
about the place of his burial. I noted that in the oft-cited 
papers on Waldie by Dilling3 and Dundee6 the burial was 
put at the Howrah Cemetery at Calcutta. 
The doubt about the place of burial of Waldie now seems 
to be clearing in favour of his resting place being the 
Scottish Cemetery at Calcutta. The grave of Waldie has 
been located at the Cemetery, which like many is in a bad 
state of repair, and a scheme is afoot to restore it, along with 
2000 others in the graveyard 20 It may be noted that there 
is a scheme backed by the Royal Commission for Ancient 
and Historic Monuments and by the Kolkata Scottish 
Heritage Trust, headed by James Simpson, a leading 
conservation architect based in Edinbwgh. 
The Annet House Museum, Linlithgow, in May 2013 
organised a redisplay of the museum's Waldie exhibition, 
a key feature of which was a display telling of Waldie's 
journey to India in 1853, based on the diary kept by 
Waldie during his journey. 21 
Waldie Memorials 
The year 1913 marked the centennial of birth of David 
Waldie. In early 1913 a movement started for 
commemorating the occasion by Alexander Spence, 
MPS, of Leslie, Fifeshire, who was a native and ex-
Magistrate of the Burgh ofLinlithgow.1•6•7•18 In a ource 
it is mentioned that Alexander Spence and 'J. D. Nimmo, 
Chairman of the National Bank of India' started the 
movement together.3 In 1915, a bronze portrait 
medallion tablet with appropriate inscription was erected 
on the wall at 67 High Street where Dr Waldie had 
resided.7•18 
It seems that the first Waldie memorial was put up not 
in Scotland but in India. On 9 November 1913, prior to 
the monthly general meeting of the Asiatic Society of 
Bengal, a brass tablet in memory of David Waldie was 
unveiled, placed on the wall at the top of the main 
staircase bearing the following inscription,3 which has 
also been reproduced elsewhere: 1•6 
In memory of 
DAVID WALDIE 
Born in Linlithgow, Scotland, Feb. 27111, 1813 David Waldie 
was associated with the discovery, in 184 7, of anaesthetic 
properties of chloroform. Arriving in Calcutta I 53, he 
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became the pioneer of chemical manufacture in India. He 
was an active member of this Society for twentyfive years 
and served on the Council for ten years. Died in Calcutta, 
June 23ro 1889. 
Erected by Messrs D. Waldie & Co., in 1913 
Out of the references cited the memorial tablet 
illustration appeared only in Faraday's article; 1 this was 
a photograph by The Statesman, Calcutta, lent to him by 
Alexander Spence. 
Authors address: Professor Emeritus, Pharmaceutical 
Sciences, Panjab University, 1135 Sector 43, Chandigarh 
160022, INDIA; profharkishansingh@yahoo.co.in 
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Traditional treatises of pharmacy in Persian are divided 
basically in three main categories: 1 . 
1. Texts which specially introduce crude therapeutic 
materials e.g. MakhzanAladvieh2. 
2. Qarabadins which present recipes (traditional dosage 
forms containing various crude materials). 0xymel, 
Laooq and Abkama are such recopies which have been 
recently reviewed.3·5 The chapters of these texts were 
usually arranged in alphabetical order of either the names 
of dosage forms (Amal-e-Saleh)6 or based on the diseas~ 
types (Qarabadin-e Kabir)7 or body organs (Ala} 
Alamraz Farsi).s . 
f di 10ns 3. Comprehensive works composed o scuss the 
about crude drugs and remedy formulations, usually d 
first part of the volume being devoted to the fo~~r9 an 
the second part to the latter, like Ekhtiarat-e Bad1e1. 
Amal-e-Saleh: A Traditional Pharma· 
copoeia in Persian . . und 
Amal-e-Saleh, which contams rec1~es of compo ed 
pharmaceutical remedies (Qarabadm), was ~~ It 
alphabetically similar to current pharmacopoeias. . 
was composed of two parts: introduction and instruction 
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on the preparation of remedy formulations. The 
introduction describes different weighing systems, old-
fashioned scales and measurements alongside their 
equivalents. General methods of preparing crude 
materials are discussed in this part, e.g. distilling, curing 
and rinsing. The other part of the manuscript 
(Morakkabat) deals with preparation methods for 
compound remedies. Alphabetically arranged 
monographs in this part are composed of the remedy 
name, precise pronunciation of the name, synonyms in 
other languages, the reference of formulation, if any, 
therapeutic effects on different organs and body 
temperament, formulation and preparation method, 
potency and dosage, equivalent formulation and time of 
keeping the final product. For instance the monograph 
and its components for Squill Pill is shown in Figure 1. 
Beneficial and Practical Hints of 
Pharmacy 
Interesting pharmaceutical hints have been presented in 
Amal-e-Saleh. The followings are some examples. 
• Compounding: preparation of dosage forms using 
simple instruments, processing and using special vessels 
and tools. Medicinal oil extraction methods, medicinal 
smoke collection and preparation of aromatic distil-
lations. Zargaran reviewed such methods for pharma-
ceutical ancient tools. 11 
• Organoleptic descriptions of raw materials which are 
practically usable for quality control (reference 6, p. 
124). Similar organoleptic controls are still valid in 
current pharmacopoeias. 
• Sub lingual pills e.g. Hab albakhar (reference 6, p. 128). 
• Aromatherapy for mental disorders e.g. Shamom 
dosage form (reference 6, p. 288). 
• Medicinal belt, a kind of sustained-release dosage form 
whose annual replacement was advised (reference 6, p. 
132).6 
• Dosage adjustments according to the patient's age 
(reference 6, p. 240). 
Pronunciation 
Salehi: Author of Amal-e-Saleh 
Saleh Ibn Mohammad Ibn Mohammad Saleh Qaeni 
Heravi (Salehi) is little-known in the literature. According 
to Salehi's autobiography, his origin was the city of Qaen 
(centre for Qohestan state, now southern Khorasan, Iran), 
but he was born in Herat (a city of Khorasan, now 
Afghanistan) and lived in Bakhtar (now Balkh in Afghan-
istan). He compiled Amal-e-Saleh in 1180 AH/1766 AD 
containing an introduction and 28 sections, each of which 
includes several chapters. His two other medical works in 
Persian are Manzomeh, a book of medical poetry, and 
Tohfat-al-Saleheen, written about rnateria medica. These 
two titles are mentioned in Amal-e-Saleh. In addition to 
Salehi's Persian mother language, the scientific texts had 
been written in Persian in a part of Asia up to 1275 
AH/1858 AD when the Gorkanian kingdom ended in 
India; 12 therefore Salehi compiled his works in Persian. 
References and Authorities of Ama/~a/eh 
Salehi's work was mainly based on observation and 
examination of available data on natural remedies. The 
sources and layout of Amal-e-Saleh text are composed of 
• Ancient manuscripts (Persian, Roman, Greek, Egyptian). 
• Medieval manuscripts including: Meftah Al-teb, Sharh-e 
Asbab, Menhaj, Resale Qalbieh, Al-Havi, z.akhireh 
Kharazmshahi, mainly written by the Islamic era scientists: 
Qalanesi, Aqsaraei, Avecina, Abolfaraj, Rhazes, Jorjani, Ibn 
Nafis, Khojandi, Mokhtar Ibn Hobal and Hally Abbas. 
• Prophetic Hadiths, mainly their philosophy and ethical 
aspects. 
• Manuscripts :from European culture. Salehi reported 'black 
salt' :from European (Farangi) physicians, remedies :from 
Brakelsus and 'Mastic oil' :from Senaretus Algermani and 
Vaqerius drug compendium (Qarabadin-e-Vaqerius), two 
European pharmacists (see reference 13). 
• Directly learning :from mentors like Ibn Helale Ardebili. 
• Observation and examination of folk medicine and 
ethnopharmacological is.5ues during his journeys. Salehi 
quoted his personal experiences of treatment as 
anecdotes with details containing the patient's age, 
other languages names t. /... Remedy name 
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Figure 1. The monograph of Squill pill and its components :fromAmal-e-Saleh, a Persian Qarabadin (1180 AH/1766 AD). 
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gender and illness, treatment needed and its length. An 
example of this sort of case report is translated as follows 
(reference 6, p.140): 
A 6 year-old girl in Isfahan had been suffering from an 
unknown disease for which the treatment by most physicians 
had been unsuccessful for one year. She became pale-yellowish 
bearing high fever. Salehi reported he prescribed milk for 5 days 
and pill (3-5 issues) of Artemisia leaves plus pulverised 
pomegranate seeds at sleep time for 7 days. The patient easily 
defaecated 5-6 times a day containing worms. Her parents 
reported more than 120 worms and she became healthy. 
Paracelsus in Amal-e-Saleh 
Salehi reported prescriptions and remedies from a 
European (Farangi in Persian) chemist and pharmacist 
Berakelsus Farangi in Amal-e-Saleh e.g. 'Zolkhasiat 
elixir from Berakelsus Farangi' (seep. 76),6 'Oil of gold 
from Berakelsus Farangi' (seep. 207), 6 'Simple wheat oil 
prepared in the way of master of Alchemists Berakelsus 
Farangi ... '(p. 216)6 and 'An urolithic salt prepared by 
Hakim Berakelsus' (seep. 505).6 'Diuretic distill water 
compounded by Brakelsus . . . '(seep. 347).6 The history 
of science shows that Brakelsus Farangi, Yermani or 
Germani, mentioned in Persian works, must have been 
the German-Swiss Renaissance physician, botanist and 
alchemist, Philippus Aureolus Theophrastus Bombastus 
von Hohenheim (1493-1541 AD). He was known as 
Paracelsus. 14 Historians recognise him for the 
introduction of experiments and observations into 
medical treatment. Furthermore he founded the 
discipline of toxicology and is credited with the terms 
zinc (zincum), gas, chemistry and alcohol.4 As a 
physician of the early 16th century, Paracelsus fathered a 
new field called Iatrochemistry (Tebb-e Kimiaee in 
Persian). 15 The first one to explain the signs of syphilis 
thoroughly was Paracelsus. 15 Similarly Salehi has 
reported a compound for syphilis (Atashak-e Farangi or 
Afrangi in Persian) developed by Paracelsus. 
One Arabic translation of The New Chemical Medicine 
of Paracelsus is stored in the United States' National 
Library of Medicine (NLM), 1 entitled Kitab Al-Tzbb Al-
jadid Al-kimiyai Ta/if Barakelsus, by Salih Ibn Nasr Allah 
Al-Halabi Ibn Sallum (died: 1081 AH/1670 AD). This 
work is subdivided into four chapters (maqalat) and an 
addendum. The four main chapters are based on the works 
of Daniel Sennert; particularly the latter's Institutionum 
Medicinaepublished in Latin in 1611 AD. (1020AH). The 
addendum consists of an Arabic translation, much 
shortened, of the Basilica Chymica or Royal Chemistry by 
Oswald Croll, compiled and translated by lbn Sallmn 
entitled Alkimiya Al-Malakiyah. Two other treatises in the 
Islamic Parliament library of Iran are: an Arabic translation 
of Ketab Aljadid Alkimiaei Allazi Akhtara-o Brakelsus 
(The New Book of Chemistry invented by Paracelsus), 
Figure 3; and a Persian translation of Tebb-e-Kimiaee 
Berakelsus (The Chemical Medicine of Paracelsus) by an 
anonymous translator (1235 AH/1820 AD), Figure 4. 
Western-Eastern Bilateral Scientific 
Interactions 
Medical anecdotes inAmal-e-Saleh showed that Salehi had 
traveled throughout the Middle East to search for raw 
materials and new methods of treatment based on Persian, 
Afghan, Turkish, Arabic and Syrian heritages taught by 
passengers, merchants, hakims, immigrants and 
physicians. Moreover he had become familiar with Indian, 
European (Farangi in Persian), Touranian, Egyptian or 
Chinese medical heritages (Figure 3). 
Salehi was born in Herat and lived in Balkh therefore 
many of his medical observations belong to the Khorasan 
area, e.g. cure of arthritis in a Balkh ruler's wife. 
As mentioned before he cured a girl with intestinal 
worms during his residence in Isfahan and foundAntirn~ny 
stone, an antisyphilis remedy introduced by Farangian 
(manuscripts of Paracelsus) in his home city, Qaen (Iran). 
He quoted a story of the discovery ?f 
adulteration of Scammony that happened m 
Baghdad (Iraq). Furthermore, some of his 
experiences are from Syria where he was 
looking for Samake-e-Syda (a kind offish from 
Sidon with medicinal effects) (seep. 260).6 
The connection between Middle Eastern 
culture and Europe (Farang in Persian mainly 
means England, France and Portugal) is ~e 
result of Venetian connections to the Safavtd 
dynasty. 16 At least two arms of the Silk Road, 
originating from 'Eastern Room' _[Turkey, see 
fig. 5] and continued through Syn"7 ~ Iran, 
Afghanistan and China and by sea via .In~a, ~ 
be recognised. As is clear from the _distnb~~on 
pattern of cities and places that Salehi ha_d visited 
(Fig. 5), the direction matches the Islamic part of 
the land Silk Road , i.e. the road of cul~ 
communication, the road for raw rnaten hi 
transfer or the Spice Road. Though Sal~ 
Figure 2. The opening (right-hand side) and last (left-hand side) pages quoted experiences, raw materials or remedies 
of Amal-e-Saleh (Experiments of Saleh) lithograph version (1284AH/ from Byzantium, Khata (Tibet), Cyp111S, 
1867 AD) no. C-10. Medical museum of Shiraz University of Medical M Yi man Oman Europe, Touran 
orocco, e , , th 
Sciences. (CentralAsia)andlndia, he nevertravelled ere. 
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Figure 3. The opening (right-hand side) and last (left-
hand side) pages of an Arabic translation of Ketab 
Aijadid Alkimiaei Allazi Akhtara-o Brakelsus (The New 
Book of Chemistry invented by Paracelsus) by an 
anonymous translator, the copy was made in 1309 
AH/1892 AD by the scribe Taloee, no. 86191. Islamic 
Parliament library of Iran. 
, I 
Figure 4. The opening (right-hand side) and last (left-
hand side) pages of a Persian translation of Tebb-e-
Kimiaee Berakelsus (The Chemical Medicine of 
Paracelsus) by anonymous translator (1235 AH/1820 
AD), no. 85901. Islamic Parliament library of Iran. 
Conclusion 
This is the first report referencing Berakelsus in the old 
phannaceuti~al easte~ texts in Persian. Our :findings 
proved a bilateral mteraction between eastern and 
western pharmaceutical knowledge by land via the Silk 
Road, Cultural Road or Spice Road. 
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the National Glass Centre, The Washington Wetland 
Centre, or Beamish Mu eum. 
The main theme will be 'The Apotheca,y ' to 
commemorate the Apothecaries Act of 1815 but as 
the national commemoration of WW I continues until 
2018 papers or posters on either topic will be 
welcome together with contributions on pharmacy 
topics relevant to the North East and Sunderland. 
Paper or Poster titles to Shirley Ellis by the end of 
November please: shirleyellis@shirlellis.plus.com 
Book Notice 
Health care: A Postcard History of 
Twentieth-Century Attitudes and Practices 
A new digital-only release from John K.Crellin and 
Flanker Press 
Available from eBook retailers 
Ever since their early twentieth-century " olden Age", 
postcards on both sides of the Atlantic have recorded 
popular culture. Through humour, view of lll'ban and rural 
places, photographs ofindividuals, fantasy, adverti ing, and 
succint messages, they have documented art and 
entertainment, social events, commercial practices, refonn 
movements, political propaganda, and countless byways of 
society. 
In this book, John Crellin explores the entertaining and 
creative ways that postcards relating to health care 
reflected and reinforced attitudes towards keeping fit, 
self-treatment and health care practitioners. Filled with 
colour images of these postcards, Health care: A 
Postcard History of Twentieth-Century Attitudes and 
Practices provides an in-depth examination of the cards' 
history and culture of medicine. 
Due to the photo heavy nature of this publication, full colour 
ereaders, tablets or de ktop are recommended. 
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Drug-induced toxic epidermal 
necrolysis - described in 1887 
Axel Schneider1 , Axel Helmstadter2 
11nstitute of the History of Pharmacy, Philipps-
University, Marburg, Germany 
21nstitute of Pharmaceutical Chemistry, Goethe 
University, Frankfurt/Main, Germany 
A rather wide range of drugs is able to cause severe 
cutaneous adverse reactions. There is a variety of 
sometimes life-threatening mucocutaneous reactions 
including Stevens-Johnson syndrome (SJS) and Toxic 
Epidermal Necrolysis (TEN) which are regarded as two 
stages of a single disease. They are characterised by 
cutaneous erythema with blister formation of varying 
extent and haemorrhagic erosions of mucous 
membranes. SJS is characterised by skin detachment 
from up to 10% of the body surface area (BSA) while 
TEN, per definition, needs more than 30% skin affected. 
An overlap group of SJS/fEN has been defined with 
blisters and erosions between 10 and 30% of the body 
surface. 1 While Stevens and Johnson described the 
syndrome in the 1920s, 2 similar phenomena are also 
known as Lyell syndrome, referring to the British 
physician Alan Lyell (1917-2007)3 who described four 
cases in 1956.4 Two of these were related to drug intake, 
aspirin and phenylbutazone (Butazolidin). Lyell was 
fascinated by the topic and spent a great deal of his career 
on description and research on the subject. 5 This might be 
the primary reason for the development of this 
terminology although neither he nor Stevens and 
Johnson were the first in describing the reaction. It has 
been shown that the condition as such was already 
described much earlier without leaving traces in common 
terminology. Most authors refer to the report written by 
Gottfried Ritter von Rittershain (1820-1883), physician 
in a children's asylum in Prague, in 1878. He described 
in detail symptoms and the course of almost 300 cases in 
neonates with a mortality rate of approximately 50%. 6 
So initially the disease was called Morbus Ritter von 
Rittershain which was, for obvious reasons, hardly 
accepted by the medical community. At the end of the 
19th century, Jonathan Hutchinson also reported cases 
similar to those of Ritter von Rittershain, referring to 
newborn infants as well.7 Historians hypothesise that the 
condition was described even decades earlier: in the 
Middle Ages8 or in 1807 by the Viennese physician 
Joseph Plenck (1735-1807).9 Most of these authors 
described neonatal cases and were unable to determine 
the actual cause of the disease. In retrospect, it is assumed 
that the symptoms were caused by Staphylcoccus toxins, 
a viewpoint supported by the fact that the reports point to 
epidemic occurrence in certain hospitals. Nowadays this 
condition is called Staphylococcal Scalded Skin 
Syndrome (SSSS) and separated from TEN which is 
known as a rare but serious adverse drug reaction. 
Synthetic drugs, however, were rare in the time of 
Rittershausen and the neonates he described had - as far 
as can be seen from his publication - not received drug 
therapy before the symptoms developed. 
In this context it is worth noting that as early as 1887 
TEN was described in detail as a side-effect of one of the 
first synthetic drugs, phenazone (Antipyrin®). This 
compound was synthesised by Ludwig Knorr (1859-
1921) in 1883 and marketed as a febrifuge soon 
thereafter. 10 The Meister, Lucius and Bruning drug 
company, later known under the name Hoechst AG, 
distributed the preparation among a variety of physicians 
for test purposes and many literature reports about its 
effectiveness and also its adverse drug reactions were 
published in the late 1880s. Most physicians came to the 
conclusion that the drug had a reasonable benefit-risk 
ratio and the product was welcomed as a highly effective 
alternative to traditional methods of reducing elevated 
body temperature like hydrotherapy or substances 
erroneously regarded as generally useful febrifuges such 
as quinine. Life-threatening adverse effects were rarely 
reported. 
Eln elare11thllm.Ucher l+'all von 
Dermatltll, bervorgeruten dUJ"Ch 
Antlpyrblbehandlnng. 
Von 
Dr. B. Spitz (Brealau) 
Figure 1. Title of Spitz's publication. [A peculiar case 
of dermatitis caused by antipyrine treatment.] 
Figure 2. Baruch Spitz (1854-1932). 
54 Phann Hist (Lond) 2014; 44 (3): 
One highly remarkable exception is a publication by 
the Jewish physician Baruch Spitz (1854-1932) 11 which 
almost doubtlessly describes an early case of TEN after 
phenazone ingestion (Fig. 1 ). He reported on a 20-year-
old woman who had received Antipyrin in daily doses of 
1-2 g/day. After one week she developed a measles-like, 
confluent exanthema accompanied by oedema of the lips 
and eyelids. Two days later large blisters developed and 
epidermis came off the body in large swathes. As Spitz 
described the 'whole body' being affected, this clearly 
has to be regarded as TEN, not only a Stevens-Johnson 
syndrome. The patient suffered from severe pain and was 
unable to open her eyes; her body temperature was 
moderately elevated. In the end, however, the patient 
recovered slowly ad integrum. The author concluded that 
Antipyrin may have unpredictable dangerous side effects 
in certain patients and complained that these could not be 
predicted. 
Baruch Spitz (Fig. 2) was born in Kempen, a province 
of Posen (Kepno, Poznan, Poland), on December 31, 
1854.12 The Jewish name 'Baruch' means 'blessed'; he 
had received this name being the only surviving child of 
his parents. His father, Moritz Spitz (1818-1897) worked 
as a furrier. At the age of 9, Baruch moved to Breslau 
(Wroclaw) for higher education, and discovered his 
passion for antique language and literature. After having 
received his 'Abitur' [to leave school] he started to study 
medicine. He was appointed MD from Breslau university 
in 1879, 13 married Elise Honigmann in 1885 and soon 
thereafter became physician in the Breslau Jewish 
hospital (Fig. 3). Later, not being able to become medical 
director there, he opened a private practice in Breslau and 
eventually became 'Sanitaetsrath'. He died September 
11, 1932. 
Figure 3. Burgfeld, a very old street in Breslau. 
7 Burgfeld housed a branch of the Jewish Hospital, 
where B. Spitz was Assistant Physician [1882 Directory]. 
The given example shows that not only common, but 
also rare, ADRs of therapeutically used new chemical 
entities were already being reported in the 19th century. 
It needs also to be highlighted that Baruch Spitz clearly 
deserves the honour of being regarded as one of the first, 
probably the first, to describe a drug-induced TEN after 
treatment with NSAIDs which were a completely new 
class of drugs at that time. Today, NSAIDs including 
phenazone, which is still available, are known to cause 
TEN and warnings are included but classified as rare in 
their Summary of Product Characteristics. NSAIDs 
were, however, highest ranked in the list of drugs 
responsible for causing TEN. 14 Among the four patients 
described in Lyell 's initial publication, only one suffered 
from a severe drug reaction related to phenylbutazone. In 
his later years, the author himself admitted that what he 
had summarized as TEN most probably were three 
different conditions sharing prominent symptoms. 15 He 
suggested the term 'exanthematic necrolysis' for drug-
induced cases but, following the tradition of medical 
terminology, it would easily be possible to call it 'Spitz 
Syndrome'. 
Furthermore, it is interesting to see that such a rare 
adverse drug reaction was already described in the 19th 
century, long before any systematic approach to 
pharmacovigilance, before sophisticated clinical studies, 
and before the advent of medical statistics. The value of 
drugs was intensively discussed in meetings of the 
medical community and in journal articles which often 
also reported lectures presented to expert audiences. In 
the case of of phenazone (Antipyrin), for example, this 
led to an almost complete view of side-effects in a 
relatively short time. Standard textbooks about Adverse 
Drug Reactions (ADR) around 1900 already listed all the 
relevant side-effects, 16 including phenazone-induced 
severe cutaneous adverse reactions.17 It seems clear that 
common ADRs were recorded early, but as is shown 
here, this was even the case for the rare event of a toxic 
epidermal necrolysis. 
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Itching for a solution: How topical 
steroids became a standard 
treatment for eczema 
Elizabeth Nally 
Imperial College Medical School, London 
Introduction 
The discovery of cortisone has been hailed as the second 
most definitive moment of modern medicine after 
penicillin. Its story has been recounted numerous times, 
often encompassing rheumatic diseases, as it was in this 
speciality that cortisone was first used. 1 In 1948 Philip 
Hench, a physician at the Mayo Clinic, first treated his 
rheumatoid arthritis patients with cortisone. The results 
were extraordinary. One bedridden woman leapt out of 
bed and even attempted to dance.2 Steroid therapy soon 
revolutionised treatment of the so-called 'relatives of 
arthritis', particularly dermatological conditions such as 
eczema. This paper aims to show how the making of 
cortisone into the standard treatment for eczema 
fundamentally changed clinical definitions and practices, 
turning it into a chronically manageable disease. This 
redefinition had important consequences for the care of 
eczema but also for eczema-drug research, development 
and marketing. A stable market emerged, which rather 
than generating innovation, resulted in little modification 
of the treatment regimen. It will also aim to show why, 
despite the limitations of steroids, for the past fifty years 
cortisone has stood head and shoulders above any other 
treatment in the management of eczema. 
There is a substantial literature on the early history of 
cortisone use and production in Britain, but it focuses 
exclusively on rheumatic diseases. Viviane Quirke's 
detailed analysis of British cortisone manufacture in the 
1950s and 1960s examines the role of Glaxo as the 
market leader and the company's joint endeavour with 
the Medical Research Council (MRC) and Ministry of 
Health (MoH) to make cortisone more widely available.3 
Her account has gone some way to show how corti~~ne 
revolutionised medicine but her focus is the Bnttsh 
pharmaceutical industry, only using rheumatic disease to 
set a clinical scene for her cortisone story. She even 
concludes by stating that Glaxo's production of cortisone 
was 'largely an ad-hoe response to events, such as 
changing medical fashions' .4 She emphasises the huge 
market for topical steroids by the 1960s but does not 
show how this impacted on skin diseases. . 
David Cantor takes a political outlook on the penod, 
examining the years 1949-55 when the drug was first 
gaining momentum. s He places cortisone in a _post-
WWII context and explains how cortisone's early history 
in Britain is intertwined with that of the NHS. He too 
focuses on the rheumatic diseases, providing a detailed 
insight into how cortisone affected the speciality an~ the 
physicians working within it. As with Quirke, there 1s no 
discussion of the other conditions that were 
revolutionised by this 'wonder drug'.6 
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Despite the dramatic increase in prevalence of eczema 
during the second half of the twentieth century, its history 
has attracted very little attention. 7 This might be because 
historians of medicine have only just started to examine 
the history of chronic diseases. Mark Jackson makes 
passing reference to eczema in his history of allergy. 8 He 
presents the increasing trend in eczema prevalence and 
discusses the rise of hydrocortisone, only mentioning in 
passing the controversy that surrounded it. He mainly 
uses asthma to examine the increasing socio-economic 
impact of allergy after WWII and how pharmaceutical 
companies attempted to reap the benefits of this 'modem 
malady'. Whilst providing the most thorough analysis of 
allergy in Britain to date, Jackson does not examine 
eczema as a stand-alone condition. He fails to recognize 
how topical steroids, and their emerging controversies, 
changed the disease. Furthermore, he does not examine 
the role of British pharmaceutical companies in the shift 
from acute to more chronic diseases. These are areas that 
this paper hopes to study in greater detail. 
Eczema before steroids 
Approaches to the treatment of eczema have corres-
ponded to the changing understanding of the disease. 
Humoralist and diathetist physicians perceived eczema 
as an external expression of a systemic disease; thus 
oozing of the skin was considered beneficial, as it acted 
to clear toxic humours. At the first international Congress 
of Dermatology in Paris in 1889, Philippe Gaucher, a 
French dermatologist at Necker hospital in Paris, stated: 
the skin disease is in a certain way a safety. If one makes it 
disappear, the elimination of the toxins is suppressed and can 
produce internal disturbances.9 
These ideas began to be questioned at the turn of the 
19th century. Sir Malcolm Morris10, a consulting surgeon 
and lecturer at St Mary's Hospital and founder of the 
British Journal of Dermatology, denounced the ' laissez-
faire' treatment approach of the French whilst Sir 
William Wilson, 11 lecturer at Middlesex Hospital and 
Chair of Dermatology at the Royal College of Surgeons, 
argued that dermatologists were, in essence, neglecting 
their patients by allowing the disease to just run its 
course. 
British physicians were also becoming increasingly 
aware of the scale of the condition, declaring that it was 
by far the most frequent disease of the skin, with one in 
four dermatology patients presenting with a case of 
eczema. 12 Despite the growing trend, dermatologists in 
the 19th and early 20th century were quick to admit that 
there was no treatment to provide permanent relief of the 
incessant, eczematous itch. 13 They relied on a wide range 
of therapeutic options, taking into account both 
constitutional and local remedies, using them in an 
almost trial and error manner. 14 
Diagnoses of cutaneous diseases during the 19th and 
early 20th century were delineated depending on their 
primary lesion resulting in categories including 'porrigo' 
(scalp eruptions) (Fig. IA),15, 'lichen' ( kin eruption 
connected with internal disorder and mainly affecting 
adults) (Fig. IB)16 and 'eczema' (eruptions due to an 
external cause such as exposure to toxic chemical ) (Fig. 
JC) 17 which have all shown to be clinical precursors of 
the modem atopic eczema. 
In 1930, Josef Jadassohn, profe or of dermatology at 
Breslau University, spoke at the International Congres 
of Dermatology in Copenhagen and commented on the 
extreme confusion generated by the variety of diagnoses 
given to similar patients: 
nowhere have diagnoses in various university clinics varied 
so much as in this field - not to mention differences in 
nomenclature.19 
By the 1930s, pre-eminence was given to local 
treatments once it was understood that eczema was not a 
presentation of a systemic disease. In 1933, Marion 
Sulzberger, an American-born dermatologist who trained 
in Europe and returned to the US, famously coined the 
name 'atopic dermatitis' which linked the skin disease to 
allergy and eliminated any rationale for treatments of a 
systemic disease.20 The list of possible topical powders, 
lotions, pastes and dressings became exten ive yet none 
prevailed as a truly effective ymptom controller.21 
------------, However, the efficacy of 
these local treatments 
was limited This is 
evident by examining 
some of the extreme 
measures physicians 
were offering in an 
attempt to control scra-
tching, especially in 
children. AC Roxburgh, 
lead physician at the 
dermatological depart-
ment of St Barth-
olomew's Hospital, even 
suggested tying d1e 
hands and feet of the 
child to the cot 22 
Eczema before 
teroid was a di ease 
Figure 1. First representations of atopic dermatitis. A: Porrigo larvalis. B: Lichen agrius. C: 
Eczema rubrum. 18 
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defined largely in terms of its symptoms, and lacking a 
strong scientific definition based on a specific causal 
mechanism. The disease changed its presentation 
dramatically from day to day with exacerbations of the 
condition occurring sporadically. Sufferers desperate for 
any form of relief were targeted by advertisements for 
new remedies. For example, in 1913 The Times printed a 
series of announcements advertising the self-proclaimed 
'world's greatest skin remedy: Ecsolent compound'. It 
was described to 'speedily banish eczema' and was 
'strongly recommended by medical men.23 The clinical 
uncertainties surrounding eczema opened it to all manner 
of patent medicines and cures, and also cast doubt on the 
professional expertise of dermatologists.24 
Dermatologists recognised that with eczema there was 
a real lack of understanding resulting in no clear 
definition of the disease. In their Introduction to 
Dermatology, Norman Walker & George Percival, two 
distinguished British dermatologists, described eczema 
as a term 'which is a cloak of ignorance'.25 They found 
that it was often applied to any sort of eruption of the skin 
when the observer was ignorant to what the actual 
aetiology was. There was a clear necessity to differentiate 
cases from the umbrella term eczema and to search out 
the cause of this inflammation that affected an ever-
increasing population in Britain. 
Emergence of cortisone 
Hormones of the adrenal cortex (corticosteroids) were 
first investigated in 1929,26 but research momentum only 
gathered pace during the 1940s. In 1941 rumours were 
circulating that Luftwaffe pilots were taking the 
hormones to increase their oxygen capacity in order to fly 
at higher altitudes.27 Fear for the most part drove a large 
transatlantic research programme to manufacture steroids 
synthetically, even resulting in focus being shifted from 
other areas, such as penicillin. 28 The American pharmac-
eutical firm Merck was first to synthesise corticosteroids 
but production was not on a commercial scale and 
cortisone was first marketed at an astounding $1 OOO per 
gram. In 1948 Merck distributed nine grams of cortisone 
to Hench for his trial on rheumatic diseases. 29 Word of its 
success soon spread across the Atlantic where it was 
hailed a miracle drug. The Lancet described it as 'a 
therapeutic discovery of great irnportance'30 whilst The 
Times reported, 'it would be as important to arthritis as 
insulin was to the treatment of diabetes'.31 Opinion 
amongst British biochemists was uniformly pessimistic 
when asked whether they thought cortisone could be 
made affordable due to the difficulties in its synthesis. 32 
However, evolution of clinical research in Britain post-
WWII would allow British cortisone manufacture to 
become a reality. 
Cortisone in post-WWII Britain 
Clinical research in Britain was being transformed by 
two medical organisations: the MRC and the National 
Health Service (NHS). The formation of the MRC in 
1913 acted to shape a national system of medical 
research in Britain. Bryder argues that from its birth, the 
MRC prioritised research in the laboratory, deeming 
clinical research to be a poor match against the 'pure 
sciences' . 33 Cantor supports this view, pointing out that 
Sir Walter Fletcher, Secretary of the Council up until 
1933, believed medical research should not be in the 
hands of clinicians.34 However, a culmination of events 
in the 1940s finally allowed clinical research to prosper. 
The MRC-conducted streptomycin trial of 194835 is 
commonly regarded as the world's first randornizsd 
controlled trial (RCT).36 The timing was no accident. It 
coincided with the creation of the NHS in 1946. This 
combination of government funding for medical research 
and a health service where research on patients could be 
carried out proved to be a recipe for success, and allowed 
cortisone research in Britain to advance. 37 
British trials into cortisone and rheumatism first began 
in 1949. The MRC formed an advisory committee to 
promote research into the speciality, focusing specifically 
on the effects of cortisone. Further studies by Hench at 
the Mayo clinic showed that the drug could also manage 
many other diseases, particularly diseases of the skin. In 
August 1950 the Ministry of Health listed over ten 
conditions where cortisone was effective. The research 
programme was rapidly expanded38 and panels were 
appointed in ophthalmology, haematology and, most 
importantly to this account, dermatology.39 
The dermatology panel's first meeting was held in the 
offices of the MRC in 1951. The panel consisted of nine 
of the leading skin physicians in the country, led by J.T 
Ingram, lecturer in diseases of the skin at Leeds 
University and physician in charge of the dermatological 
department at Leeds Infirmary. 40 Their aim was clear - to 
investigate the use of corticotrophin (ACTH) and 
cortisone in the treatment of skin disease and to conduct 
clinical trials. Fifty grams of cortisone and twenty-four 
grams of ACTH were made available to their _re_search_by 
Merck and distributed accordingly. Upon deciding which 
conditions they wished to investigate, chronic eczema 
was top of their agenda due to its widespread prevalence. 
In December 1954 the panel published its first report 
on the dermatological applications of systemic cortisone 
and ACTH.41 The results were conclusive. The response 
of the eczematous reaction was dramatic, but once 
treatment was withdrawn, relapse was almost inevitable. 
A further study looked specifically at its effe~t on 
infantile eczema ( a debilitating form of the disease 
specifically affecting infants and young children). Of the 
eleven children treated, only three saw any form of 
improvement and two of these soon relapsed.42 The p~el 
recognised the limitations of systemic cortis~ne and Ill a 
letter addressed to the Minister of Health m 1953, F. 
Hellier, dermatologist at Leeds Infirmary and secretary 
for the MRC panel on cortisone and. ACTH, 
recommended against making the drug available_ for 
common skin complaints such as eczema, especially 
considering its short supply in Britain at the time.43 
Comparisons at this point can be drawn ~e~een ~: 
eczema and the rheumatism stories. After the 1lllt1al wa 
of enthusiasm about cortisone an air of scepticism arose. 
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A 1949 editorial in the Lancet ,---------::-----------------, 
approached the discovery with caution 
stating, 'a therapeutic discovery of the 
first importance, and it is one that 
arouses many speculations.' David 
Cantor describes two factors that 
undermined the portrayal of cortisone in 
rheumatic diseases during the early 
1950s; the first being the persistent 
shortages of the drug and the second 
being its potential to cause harmful side 
effects.44 These limitations could also be 
applied to cortisone's use in eczema. 
Redefining Eczema 
In 1952 a landmark event, attended by 
dermatologists from across the globe, 
returned to the international scientific 
calendar. The Tenth International 
Congress of Dermatology was held in .__ ___________ ...J.!!.. _ __.,L.._ __________ .J 
London, seventeen years since the last Congress in 
Budapest - a delay brought about by the Second World 
War.45 The President that year was Sir Archibald Gray, a 
British dermatologist held in high regard for securing the 
speciality's position in the field of medicine.46 
Of the three discussion topics, the first was, 
predictably, concerning cortisone and ACTH. Marion 
Sulzberger, now head physician at the New York Skin 
and Cancer Hospital and eminent figure of global 
dermatological research, presented findings that 
correlated with those of the MRC. He recognised the side 
effects yet his stance on using oral cortisone in chronic 
skin conditions such as eczema was not wholly negative: 
Because of the undeniably serious risks, some have said that 
such agents as ACTH and cortisone should not be used 
except in dermatoses which are ordinarily fatal. But I submit 
that physicians must never forget that there are diseases 
which do not endanger life, but ruin it.47 
The second discussion topic involved the pathogenesis 
ot: eczema. John Belisario, Consultant Physician for 
~1seases of the Skin at the Royal Prince Alfred Hospital 
m Sydney and founder of the Dermatological 
Association of Australia, compared a 'befuddled man 
studying an obscure problem to the philosophical 
detachment of a dermatologist contemplating an 
e~zema' .48 His remark highlights yet again the apparent 
difficulty in defining a chronic disease that can change 
dramatically from day to day. He argued that the lack of 
a unanimous concept had impeded progress in the 
condition. Donald Pillsbury, a physician at the 
Department of Dermatology at the University of 
Pennsylvania echoed his sentiment and explained that 
casual terminology had resulted in 'great bewilderment 
t~ the physician'. 49 Both attempted to classify the many 
~erent types of eczema. For example, Pillsbury used a 
sene_s of charts (Figure 2) in his presentation to show the 
relative role of factors which proved significant in terms 
of aetiology. It would be nai've to assume the timing of 
these two discussions was coincidental. The discovery of 
cortisone emerged at a pivotal point in the history of 
Figure 2. Pillsbury's charts aimed to show the various 
causes that had been discovered through recent re earch of 
each specific type of eczema, in this case atopic dermatiti , 
and their interplay. He even considered the psychological 
impact the disease. so 
medical research in Britain. Cortisone provided the 
catalyst for clinical trials into eczema and its treatment to 
take place and with it a demand to define the condition 
that had relied previously on subjective opinions. 
Moreover, efforts to define eczema were strengthened by 
the emergence of this radical treatment. The changing 
presentation of eczema meant that the effectiveness of 
cortisone treatment was difficult to evaluate. In order to 
establish whether it was having a true effect the disease 
required delineating. 
Topical steroids 
As dermatologists tried to define eczema more precisely 
in the early 1950s, cortisone researchers at the same time 
grappled with problems of using the new drug for 
common skin diseases, including eczema. Side effects 
reported by the MRC in cases of rheumatism included 
salt retention and severe depres ion and increased 
susceptibility to infection.51 J Walker, a medical doctor 
working for Glaxo, concluded in 1952 that cortisone had 
'very serious and yet incompletely undefined 
limitations'.52 However work continued on the drug in 
America and new analogues soon emerged from 
pharmaceutical laboratories. In the same year the 
introduction of topical hydrocortisone provided a major 
pharmacologic breakthrough for dermatotherapy. 
Sulzberger and Witten 's research proved it effective in six 
of eight patients with atopic dermatitis. 53 Hydrocortisone 
was welcomed as the naturally occurring, active 
hormone of the adrenal gland and so it was hoped that it 
would provide the solution to some of the problems seen 
with cortisone therapy. The MRC's dennatology panel 
began research into the ointment immediately. They 
performed a trial into its effects on various type of 
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Table 1. Response of different types of eczema to topical hydrocortisone treatment. 
'Cured' column refers to cases where the eczema has been caused by an external 
influence and removal has caused remission of the disease. 55 
cortisone, and its new 
analogues, more widely 
available in Britain. Back in 
1950 the MoH considered it 
imperative that companies 
start manufacturing the drug as 
soon as possible.59 However, 
the NHS was under consid-
erable pressure amidst 
concerns about the rising costs 
of drugs it provided. The 
Ministry found itself having to 
balance the two issues; 
stimulating cortisone prod-
uction whilst limiting its 
availability to certain hosp-
itals. 60 However, by 1954 
cortisone production in Britain 
began to stand on its own two 
feet. Although it still fell short 
of the minimum potential 
needs if all patients who could 
benefit from the drugs were to 
receive treatment, 61 British 
Disease Cured Improved Unaffected 
I .Infantile Eczema 1 52 26 
2. Exogenous & 7 7 8 
Contact 
3. Patchy, Disco id 3 8 0 
and Nummular 
4. Pomoholvx 5 8 5 
5. Seborrhoeic 19 29 9 
Dermatitis, Flexural 
Infective or Acute 
Neurodermatitis 
6. Atopic, Besnier's 26 32 15 
Prurigo, Lichen 
Simplex & Chronic 
N eurodermatitis 
7. Other Eczemas 8 15 3 
eczemas and the results were fairly conclusive. The 
majority of patients saw an improvement of their 
condition (Table 1) and, most importantly, side effects 
were negligible. 54 
By 1954 the MoH was pushing to make this treatment 
more widely available. The matter was discussed at the 
seventh meeting of the panel where it was concluded that 
'since there was no danger involved' they saw no reason 
to advise the Ministry to refuse or delay permission for 
manufacturers to put the ointment on the market. 56 
Despite the MRC panel's lack of concern about topical 
steroids, a letter between FHI( Green (MRC assistant 
secretary) and F Hellier in 1954 tells a different story. 
Hellier addressed the issue of making hydrocortisone 
ointment available to general practitioners (GPs), which 
the MoH was under pressure to carry through. 57 Hellier's 
tone is one of caution: 
Hydrocortisone ointment is only a suppressive agent and not 
a curative one. In consequence once a patient has started to 
use it and found it beneficial then very likely he will wish to 
continue indefinitely and so once a patient has been launched 
on a career ofhydrocortisone he may require it for months or 
even for the rest of his life.58 
He recommended against making the therapy available 
for GPs. Nonetheless, Hellier's decision appears based 
on economic considerations rather than on the adverse 
effects of the therapy. His worry is that demand for the 
creams will exceed supply. He states that many of the 
conditions would respond 'quite satisfactorily' to routine 
treatment with 'much cheaper remedies' . So what 
appeared to be limiting the availability of topical steroids 
at this early point in their history was not concern over 
side effects but their price tag. 
Hellier's concern about supply and demand of topical 
hydrocortisone was soon to become a distant memory as 
collaboration between the MoH and British 
manufacturers, particularly Glaxo, worked to make 
Worsened Total 
13 92 
0 11 
0 11 
1 19 
0 57 
5 78 
4 30 
production was now in excess of NHS requirements at 
the tirne.62 With the backing of the MRC panels, 5th 
December 1955 was set as the release date for cortisone 
to be made available to the public on prescription.63 
Topical treatment post 1955 
The release ofhydrocortisone to the open market and to 
GPs in 1955 was a major leap in the development of 
topical steroids as a standard treatment for eczema. Now 
that Britain had its own source of cortisone and 
hydrocortisone, the MoH no longer had to rely on 
expensive imports from America. Competition_ between 
companies on the price of the drugs acted to drive down 
the cost over the late 1950s. Glaxo, despite being the 
market leader in Britain, was under pressure from other 
companies in France (Roussel) and America (l!pjo~). In 
August 1956 Glaxo resigned to reducing their pnce by 
15% to match RousseI.64 The reduced price knocked 
down the barrier that had previously prevented 
widespread use of steroid creams for eczema. In J~uary 
1961, The Ttmes reported a further price cut in corttsone 
derivatives by Glaxo, the largest cut made by any firm 
since 1956.65 Harry Jephcott, chairman of Glaxo 
remarked in July 1952 that there would always b~ 
restraint placed upon the use of cortisone so long as it 
remained relatively expensive. 66 67 By the 1960s however 
it was clear that hydrocortisone's price barrier had been 
broken down. . . · d 1 
The combination of hydrocortlsone bemg WI e Y 
available through prescription and its affordabilio/ for:: 
NHS meant that people with eczema were usm~ 
creams much more readily. The rise of h~dr~corttso; 
also meant that research into topical steroids mcreas d. 
· ha By 1960 five different analogues of hydrocortl_sone ed 
been developed, many of them with mcreas 
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penetration and potency. 68 These more potent creams 
were placed on the market from 1960. 
The Topical Steroid Market 
Medical historians and epidemiologists have often 
characterised the post-war period as the moment in 
which developed countries went through a fundamental 
'epidemiological transition', from an age dominated by 
acute diseases to one dominated by chronic diseases. 
Typically, this has been explained as a natural 
demographic process. Yet, Jeremy Greene has argued 
that, in the United States, it was importantly facilitated 
and shaped by the massive expansion of pharmaceutical 
companies, who created new markets for drugs aimed 
specifically at chronic conditions.69 Not only did 
pharmaceuticals create new drug markets, argues 
Greene, they also created new diseases for their products. 
Mark Jackson has made a similar observation in his 
analysis of the role of the British pharmaceutical industry 
in shaping the identity, experience and prevalence of 
allergy.70 Like allergy, eczema also became an important 
new market for British pharmaceuticals. 
The rising epidemic of eczema during the second half 
of the twentieth century provided an important 
opportunity for British pharmaceuticals. Research 
carried out in 1984 looked at rates of reported eczema in 
children born in 1946, 1958 and 1970. Overall rates rose 
from 5.1% in children born in 1946, to 7.3% in those ?Orn in 1958 and to 12.2% in 1970.71 Figures compiled 
m 2003 suggested that this trajectory continued, with the 
Figure 3. Advertisement for Betnovate dating from 
1969. Glaxo used dramatic before and after photos to 
emphasise the effects topical steroids could have on 
eczema.75 
prevalence of eczema in Britain increasing roughly 
threefold between the 1970s and 1990s. n 
Responding to the growing demand for eczema 
~~~trnents, in 1957 Glaxo changed tactics and began to 
~t:Late collaborations with other companies. Their most 
unpo~t rel~onship proved to be with the American giant 
Schermg which led to their first novel medicine 
Betnovate.73 Betnovate was launched in 1963 and soo~ 
became the market leader in the treatment of eczema thanks 
to clever marketing by the company.74 (See Figure 3).75 
Between 1966-1967 Betnovate sales represented 36% 
of the group's pharmaceutical tumover.76 By 1969, sales 
of Betnovate had overtaken those of all Glaxos' 
antibiotics.77 Glaxo soon became the market leader in 
topical corticosteroids with the launch of Dermovate 
[ clobutasol] in 1973 and Eumovate [ clobutasone] in 
1975.78 
The exponential rise seen in eczema post-WWII 
occurred alongside the growth of the topical steroid 
market. Greene would argue that Glaxo's mutually 
constitutive processes of clinical re earch, clinical 
practice and medical marketing into topical steroids 
expanded eczema as a chronic disease causing more 
people to receive the 'eczema diagnosis' .79 However the 
rapid growth in the topical steroid market in Britain was 
not universally welcomed. 
The backlash against topical steroids 
For medical experts and regulators, the topical steroid 
market raised concerns about the appropriate use of 
treatments by GPs. Hellier had feared that GPs would 
prescribe hydrocortisone for every type of eczema even 
when it may not be wholly appropriate and that patients 
would demand treatment for all kinds of skin problems. 80 
With an open market for topical steroids, reduced cost 
and their availability to GPs, Hellier's fears appeared to 
come true. 
The initial enthusiasm and lack of caution in the use of 
topical steroids led to over-prescription and over-use. The 
creams were often applied over prolonged periods of 
time and the long-tenn unwanted effects of topical 
steroids became increasingly evident.81 A number of 
journal articles, first appearing in I 963, reported adverse 
skin changes that had occurred as a re ult of topical 
steroid use. Early reports described kin atrophy when 
topical steroids had been used regularly for months and 
years. One particularly shocking study pre ented eleven 
children who had been prescribed a potent fluorinated 
steroid for facial eczema. After months of use they 
presented with 'bright malar flush, mall superficial 
papules, pustules and scaling'. They termed it the 
'rebound phenomenon' (Figure 4).83 Patients would see 
deterioration with the steroid but it wouldn't be 
recognised by the GP so more would be prescribed 
causing a vicious circle. The aim of the publication was 
clear, to raise awareness of this horrific po ibility.82 
In 1976 J Kirby and D Munro, consultant dermatologists 
at St Bartholomew's Hospital, published an article 
describing atrophic effects even after hort-term use. They 
placed the blame with the pharmaceutical companie : 
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Figure 4. The so-called 'rebound phenomenon'. An 
acute exacerbation presented after use of topical 
fluorinated steroids. In this young girl there was 
markedly increased pustulation and scaling of the skin. 83 
The problem is magnified when clinicians are unsure of the 
skin-thinning potential of a new corticosteroid. Misleading 
and flimsy evidence, provided by some manufacturers to 
allay our fears, complicates the problem. For these reasons it 
is essential to examine the skin-thinning properties of a 
topical corticosteroid before it is widely used in clinical 
practice. 84 
The point these researchers make is a reasonable one. 
When the creams were first released there was little 
information about how to administer them, probably 
because no adverse effects were known so they were 
deemed of little danger. In 1967 writing for The Times, a 
professor at a London teaching hospital called for greater 
information to be provided to the prescriber. He 
highlighted the importance of education for the doctor on 
modem prescribing, especially with the magnitude of 
changes that had been seen in medicine since the 1950s. 85 
In response to the growing controversy, pharma-
ceutical companies developed ways to deflect criticism 
and improve the public image of topical corticosteroids. 
The eczema market was huge and loss of sales in these 
products would have had great financial consequences. 
Glaxo published practical guides in 1977 and 1978 
containing detailed information on Betnovate, 
Dermovate and Eumovate and how to prescribe them.86 
They also produced a film targeted at GPs titled 'Topical 
steroids in allergic and eczematous conditions' .87 
Despite the backlash, topical steroids still played a key 
role in eczema treatment. They enabled eczema patients 
to exert some sort of control over a condition that 
dramatically diminished their quality oflife. Hugh Jolly, 
consultant paediatrician at Charing Cross Hospital 
commented on steroid use in eczema for The Times in 
1975 when the side effects were well established: 
This is not the complete answer to eczema but used correctly 
it is the most valuable preparation in the doctor's 
armamentorium. Cortisone applied first as a lotion and later 
as an ointment can transform an itching red oozing skin in a 
matter ofhours.88 
Jolly stressed that as with any drug there were risks, but 
with correct use, topical steroids were highly effective at 
controlling eczema exacerbations, especially in children. 
However, a dramatic shift in public opinion had already 
occurred as a result of the few catastrophic outcomes of 
fluorinated steroid use in the 1950s. This view solidified 
in many people's mind causing a fear and avoidance of 
steroid treatment for years to come. 89 
Conclusion 
This study aimed to show how topical steroids 
transformed both the definition and management of 
eczema. Prior to their discovery, eczema was a chronic 
disease that lacked clinical criteria and effective 
treatment regimens, leaving patients struggling to 
manage the debilitating disease. The arrival of an 
effective topical treatment in hydrocortisone acted to 
revolutionise the condition, particularly in those suffering 
from severe forms of the disease. The emergence of 
topical steroids in Britain post-WWII occurred at a time 
of prosperity in clinical research allowing for greater 
understanding of the causal mechanisms of the disease. 
Le Fanu's story of cortisone is the classic one, in that 
corticosteroids revolutionised treatment of chronic 
conditions.90 However, for eczema, making steroids a 
standard involved more negotiation than the heroic story 
allows. Topical steroids were often mistaken as a cure 
when in reality they only suppressed the symptoms for a 
short period of time. After huge early enthusiasm, there 
was considerable backlash after the long term side effects 
of the more potent creams emerged. 
Yet, despite their misgivings, topical steroids remained 
a standard in controlling eczema, which dramatically 
increased in prevalence over the second half of the 
twentieth century. Focus had shifted away from acute, 
infectious diseases and now lay heavily with the 
increasing burden of chronic conditions. As Greene 
argued for the case in America, 'the expanding 
prevalence of chronic disease evident by 1950s offered 
the perfect opportunity to redesign the drug-dise_ase 
relationship' .91 Glaxo prevailed as leader of the topical 
steroid market in Britain. Their topical hydrocorttsone 
creams defined eczema through their effectiveness as a 
treatment, as a research tool and as a marketing vehicle.92 
Their ability to treat eczema, a previously unmanageable 
chronic disease, demonstrated the importance of 
pharmaceuticals to the lives of patients suffering with the 
condition. 
My research into this topic has highlighted the limited 
historical reflection on eczema, a condition that has seen 
an exponential rise in prevalence over recent decades. 
My research examined how topical steroids _chan~ed 
eczema in Britain whilst also taking into cons1derat10n 
the socio-economic climate surrounding a shift in ~sell:'e 
pattern from acute to chronic disease. However, this shift 
didn't just occur in Britain, so in order to further supp~rt 
the claim that eczema was defined by the topical ster01d 
market further study needs to be done to examine the 
disease in developed countries across Europe and further 
afield. 
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Why Did It Take So Long? 
Pharmacology in Pharmaceutical 
Education 
Trevor E Whaley MRPharmS 
Doncaster, South Yorkshire 
Pharmacology was introduced into the syllabus for the 
Pharmaceutical Chemist Qualifying Examinations in 
1950 in preparation for the first examination in 
Physiology and Pharmacology in June 1952. The subject 
had been purposely omitted from pharmaceutical 
education I in the early days of the Pharmaceutical 
Society and was not to be included for over a century. 
Earlier papers2 have attempted to follow the time-scale 
of inter-professional and political argument, legal 
enactments and other changes that affected the 
Pharmaceutical Society and which, therefore, resulted in 
~s situation. Such a view, however, is very restricted as 
1t does not allow for any exploration of the actual subject 
of pharmacology or for the consideration of any possible 
attitudes or opinions regarding it which may have 
supported, or opposed, the need for future pharmacists to 
be formally educated about the action of the drugs they 
were .dispensing or selling. It, certainly, does not explain 
why 1t took so long for the subject to be finally included. 
In 1839 the first volume of Dr Jonathan Pereira's 
Elements of Materia Medica was published. The author 
was a well established and respected teacher of medical 
students and intended his work to be an up-to-date text-
book for them. It included a study of the action and uses 
of medicines. In 1842 he was appointed as the first 
Professor ofMateria Medica at the School of Pharmacy, 
where the subject was effectively restricted to medical 
botany and pharmacognosy. 
Before looking specifically at the subject of 
pharmacology, it would be helpful to have a brief 
'overview' of some of the theories and ideas relating to 
medicine at the time. As we are aware, Dr Pereira 
published in 1839 and the Pharmaceutical Society was 
formed in 1841. Thus, the opinions brought forward from 
the previous century, together with those proposed during 
the interim years, were of particular importance. 
At the start of the century, doctors would rely on their 
knowledge of the patient and their observation of all of 
the symptoms manifested by the disease. Their aim 
would be to treat the symptoms and restore the natural 
balance of the body and, by so doing, bring the patient 
back to full health. An important part of this would relate 
to the patient's diet and environment which would be 
re~ated accordingly. However, they also had a very 
:,v1de variety of medicines which could be used to assist 
m the process. At this time drugs were expected to assist 
the restoration of the body's natural balance, but were not 
expected to specifically act upon, or cure, the disease. 
Preparations were available to reduce specific symptoms; 
among these were emetics, cathartics or purgatives, 
t~nics, expectorants, sialagogues (promoting salivation), 
diuretics, sedatives, stimulants and many more. To this 
list has to be added blood-letting, with or without the 
addition of drug treatment. 
By the end ?f the 18th Century, and into the early years 
of ~e 19th, ideas and theories were being expounded 
""'.hich move~ away from this 'whole body' concept of 
disease. In his Treatise on Membranes Bichat in 1799 
had proposed that disease affected the tissues of the 
organs of the body. However, it was not until 1839 that 
Schwann published a paper indicating that he had found 
cells in all animal tissues. This was followed by the work 
of Vrrchow in the 1850s developing the concept of 
cellular pathology, resulting in the publication of his Die 
Cellularpathologie in 1858. Thus, medical theory had 
slowly moved towards the realisation that disease 
affected the tissues and organs and, finally, that it was 
seated at the cellular level, which would, at least, open the 
p~~way t~wards the consideration of drug action being 
slfilllarly sited. However, back in the first four decades of 
the century, uptake of new ideas was very slow and it has 
to be remembered that no-one had any knowledge of 
how a medicine actually worked. 
. ~r Pereira made reference to this last point very early 
rn his own work. In the Preface he explained that he used 
the 'order of their natural-historical relations', based on 
external form and structure, to classify medicines. 
However, he made it clear that a classification based on 
their action and uses would be far superior, if it could be 
produced. Unfortunately, he considered that lack of 
knowledge of how medicines actually act on the body, 
the fact that 'scarcely two medicines give rise to precisely 
the same effects' and that different writers had widely 
divergent views as to the principal action for the same 
drug made this impossible. He supported this last 
statement by quoting several physicians and writers who 
had five different opinions regarding the principal action 
of opium and ten regarding that of mercury. It is notable 
that, at the time, the vast majority of drugs available to the 
medical profession were of vegetable origin, together 
with a number of chemical substance such as mercury, 
antimony, sulphur, iron etc. Thus, if he was unwilling to 
trust a classification based on their action and uses, then 
one based on their external fonn and tructure, which 
effectively involved a botanical clas ification of the 
plants involved, would appear to be a logical alternative. 
Unfortunately, acceptance of this suggestion doe not 
give any indication of how it was po sible for a number 
of eminent medical men to have widely differing views 
about the principal action of specific drugs. At this stage 
in the development of pharmacodynamics, which we 
now know as pharmacology, every action and use of a 
particular drug would be noted, including, in the case of 
poisons, their ultimate effect. To put this into context it 
may help to consider a specific monograph. Purple 
Foxglove has been chosen since, as seen later, there is a 
relevant reference to it in the first chapter of Dr Pereira 's 
work. Digitalis had been introduced to medicine as early 
as 1785 by Dr William Withering; a considerable amount 
of research had been done on it and it was in regular use 
in the form of powdered leaf, and as an infusion, tincture 
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and extract of digitalis and mixed with squill in Pilulae 
Digitalis et Scillae. 
An immediate observation is the considerable scope 
and detail of the monograph. The Physiological Effects 
and Uses cover almost eight pages3. In considering the 
physiological effects of foxglove he suggested three 
degrees of its operation; the first is that produced by small 
and repeated doses, mentioning all of the symptoms that 
it can produce. The use of the word symptom here is best 
explained by referring to a statement which appears early 
in his work", where he describes the means of ascert-
aining the operation of medicines by observation of their 
effects on man: 
In ascertaining the action of remedial agents on the living 
body, it is necessary that we examine their influence both in 
healthy and diseased conditions. For, by the first we learn the 
positive or actual power of a medicine over the body; while 
by the second, we see how that power is modified by the 
presence of disease. 
Returning to the monograph, it was noted that 
foxglove's influence over the circulation was not at all 
constant; in some cases the frequency of the pulse was 
increased, in others decreased, in some unaffected, but in 
a considerable number of cases it became irregular or 
intermittent. The observations and opinions of various 
other doctors are discussed before the point is made that 
if it be desired to reduce the frequency of the pulse, the patient 
should be kept in the recumbent posture. 
The physiology behind this statement is then explained in 
detail before 
I need scarcely add that the sudden change of position in 
those who are much under the influence of this medicine is 
attended with great danger, and in several instances has 
proved fatal; for, in consequence of the heart not having 
sufficient power to propel the blood to the head against 
gravity, fatal syncope has been the result. 
Also mentioned under this heading, again with much 
discussion and references to other doctors' experiences, 
is its cumulative effect, its diuretic effect and the 
increased flow of saliva it may produce. 
The second degree of operation of digitalis would be 
that associated with the use of too large or too long-
continued doses. Again, there are detailed and lengthy 
descriptions of the symptoms produced, before 
proceeding to the consideration that 'the quantity of 
digitalis that may be given to a patient without destroying 
life, is much greater than is ordinarily imagined' . He 
quotes a number of instances, not only of his own 
observations and treatments but also those of others. The 
usual adult dose quoted for tincture of digitalis is 10 
minims cautiously increasing to 40 minims and repeated 
every six hours. He cites his own experience of having 
seen 
twenty drops (minims) of the tincture given to an infant 
labouring under hydrocephalus, three times daily for a 
fortnight, at the end of which time the little patient was 
completely recovered, without one untoward symptom. 
He states that he has frequently given a drachm (60 
minims) three times daily, for a fortnight, without 
observing any marked effect. However, he reserves the 
highest dose quoted to a 'highly respectable practitioner' 
who has, for many years, been in the habit of 
administering the tincture 
to the extent of from half an ounce to an ounce (480 minims) 
at a time, not only with safety, but with the most decided 
advantage, as a remedy for acute inflammation, - not, 
however, to the exclusion of blood-letting, which, on the 
contrary, he previously uses with considerable freedom 
(presumably indicating that this would concentrate the 
effect). 
The third degree of operation is that resulting from 
fatal doses. All of the symptoms of poisoning by the drug 
are noted. 
The next section deals with the uses of foxglove and 
indicates the four main purposes for which it is 
employed. These are: to reduce the frequency and force 
of the heart's action; to promote the action of the 
absorbents (absorbing vessels); as a diuretic; and 
'sometimes on account of its specific influence over the 
cerebra-spinal system'. He lists seven diseases in which 
it is used, and adds an eighth various section. In all cases 
these are linked to the four main purposes listed, together 
with much discussion and reference to other authors. In 
its use in fever, for example, it reduces the frequency of 
the pulse (sedative action on the heart and circulation), 
but in relation to the other symptoms of fever it must be 
remembered that 'it is an agent which exercises a specific 
influence over the brain'. In the case of inflammation it is 
used, again, to reduce the frequency of the pulse. He 
notes the celebrity of foxglove as a remedy for dropsy 
and discusses its diuretic effect. He suggests it is 
'oftentimes serviceable' in hemorrhages from internal 
organs, and covers its use in diseases of the heart ~nd 
great vessels (sedative effect) in detail. Although quotmg 
numerous works relating to 'supposed' cures for phthisis 
(tuberculosis), he considers it of little, or no, value. 
However, in cases of insanity and epilepsy it may prove 
serviceable 'by repressing excessive vascular 
excitement' but its specific cerebra-spinal effects must 
also be considered. He finally mentions scrofula and 
asthma and refers the reader to a further author for other 
diseases relieved by the drug. . 
The monograph is concluded by listing the available 
preparations of foxglove, together with details of how 
they are prepared and their usual do~es, b~fore 
considering possible antidotes. These are basically aime.d 
at countering the symptoms of poisoning, since there 1s 
no known chemical that would be effective. 
Thus, every effect that the drug had on th~ body was 
considered as part of its action. The major difficulty, for 
the researcher with this 'all inclusive' method of 
acquiring kno;ledge, which was essential in forming ~ 
basic understanding of his subject, was the volume of~ 
that was available from so many sources. Every deta 
would be investigated, and it is quite apparent that anr 
reference to the modem concepts of 'side effects , 
'adverse reactions' or, even 'overdoses' would be totally 
misplaced. · r 
From the monograph, it would appear that a maJO 
action of digitalis is as a sedative due to its effect upon the 
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heart and circulation, but conversely, as a diuretic, it is 
also a stimulant, either by stimulating the action of the 
absorbent vessels, or by direct stimulation of the kidneys. 
It is also stimulant in its effect on the salivary glands in 
producing salivation. In addition to these two effects, 
there is also its direct effect upon the cerebra-spinal 
system. The cerebro-spinants appear as the first class of 
substances to be considered in the Physiological Classes 
of Medicines in the main work. In the grouping of 
medicines within this class the following appears5: 
The seventh group includes tobacco and foxglove, both of 
which are remarkable for their depressing influence on the 
circulating organs, in consequence of which they are 
denominated sedatives. When taken internally, in large doses, 
they give rise to nausea, vomiting, giddiness, feebleness and 
irregularity of pulse, fainting, convulsions and insensibility. 
Foxglove sometimes causes salivation. Both substances have 
been employed to reduce the frequency and force of the 
hearts action, and to cause diuresis. 
Thus, foxglove belongs primarily to the class of 
cerebro-spinants and Dr Pereira denominates it a 
sedative. However, in working towards this conclusion, 
there would have been those who had concentrated on its 
stimulant action as a diuretic or sialogogue, or on its 
antipyretic properties, or on its use as an antiphlogistant 
in inflammation and, of course, there were still those who 
were convinced of its usefulness in phthisis. 
Considerable discussion and argument would have taken 
place in deciding what its principal action actually was, 
and it is feasible that the argument was still continuing. 
It is hoped that taking the example of such a well 
known, well researched and :frequently used drug and 
placing this in the context of the wide variety of drugs 
that were available, together with the fact that no-one 
knew how they actually worked, could explain the 
widely divergent opinions quoted in the Preface and 
would support his reluctance to use a classification based 
on the action and uses of drugs. 
It can be seen from the foregoing that pharmacology 
was in its infancy. Dr Pereira was only one of a large 
group of researchers, internationally, who were restricted 
by lack of basic knowledge, but there is no doubting the 
intensity of their desire to acquire it. 
Returning to the pharmacy student of the day, he 
would still have to be fully conversant with the doses and 
practical uses of the drugs that he would be required to 
sell, compound and dispense during his working life. 
This knowledge would be acquired, as it had .b~n by 
those Chemists and Druggists who were orgarnsmg the 
new Pharmaceutical Society in 1841, during a long and 
detailed apprenticeship followed, for most, by a lengthy 
period as an assistant. Irrespective of the actions of ~e 
new Society, there was no indication of any maJor 
changes to this arrangement in the foreseeable future. 
It was Jacob Bell who first indicated that one of the 
major functions of the new Society would be the 
advancement of the art and science of pharmacy, and that 
if pharmacists concentrated on this they would have no 
need to encroach upon the practice of medicine: !he 
basic science underlying the preparation of medicmes 
and the purity of the finished product in pharmaceutics, and 
the specific nature of pharmaceutical chemistry would 
allow for the acquisition of accurate, factual knowledge and 
considerable opportunities for research. Similarly, as Dr 
Pereira indicated, if future pharmacists were to view the 
drugs they handled as items capable of providing 
opportunity for detailed knowledge and research, rather 
than considering them as simple articles of commerce, the 
wealth of information available in pharmacognosy and 
medical botany would be almost limitless. 
In terms of pharmacodynamics, research was entirely 
medically orientated and the possibility of arguing for the 
inclusion of any part of the subject in pharmaceutical 
education would come under the critical scrutiny of the 
medical profession who were determined to maintain 
strict boundaries between pharmacy and medicine. This 
point is exemplified, later, by the removal of the word 
toxicology, in relation to pharmaceutical education, from 
the 1852 legislation6, at the insistence of the apothecaries. 
It was very important, politically, for the chemists and 
druggists to organise themselves into a recognised 
Society, that could represent their interests, as quickly as 
possible. This would involve details o! their pr?po~ed 
aims, which would include future education. Cons1denng 
the urgency of the situation and the forceful stance of the 
medical profession, it would, nonetheless, be unwise to 
argue that this was sufficient reason for the spec_ific 
exclusion of pharmacodynamics or any subject 
fundamental to it, such as basic animal or human biology, 
from the formal education of those who were to be 
responsible for the compounding, selling and dispensing 
of medicines. 
Conversely, the factual knowledge that was available 
to them in pharmaceutics, pharmaceutical chemistry, 
medical botany and 'pharmaceutical' materia medica, 
compared to the theoretical nature of pharmaco-
dynamics, could see them become 'men of sci.enc~' 
within their own sphere of pharmacy and would mamtam 
the essential boundary with medicine. Their own 
knowledge of the apprenticeship style of ~d~~ation 
regarding the drugs they used, and the poss1b1lity of 
formal education expanding as pharmacy evolved, could 
have formed the basis for an argument that the inclusion 
of pharmacodynamics was not essential at ~at time. 
This possible argument could be ~am~ forward 
throughout the remainder of the 1800s 1!1ce, m terms of 
day to day practice, there were no maJ?r changes f?r 
pharmacists and the majority of ~~s available were still 
oflittle use. However, such an oplillon does not overlook 
the immense volume of work, which would have such an 
important impact on pharmacology, undertaken during 
the middle and latter half of the century. The use of 
nitrous oxide ether and, finally, chloroform as 
anaesthetics the awareness of cleanliness combating 
disease (e.g'. Florence Nightingale), John Snow tracing 
cholera to the street water pump in London, the 
contagious nature of puerperal fever being co~ed 
and, importantly, the work of Pasteur and Koch m the 
introduction of the germ theory, followed by the 
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introduction of antisepsis in surgery by Joseph Lister and 
the necessity of the Sanitary Act were all contributory. 
During the last decade of the century X-rays had been 
discovered, malaria had been shown to be transmitted by 
the Anopheles mosquito and in 1899 aspirin was 
introduced. By the turn of the century, Ehrlich had started 
his work in the field of chemotherapy. 
Whether the above argument is valid, or the stance of 
the medical profession was the only obstacle or even if 
simple indifference was the major problem, a situation in 
which pharmacy students were not required to have a 
formal education in animal biology, human physiology 
or pharmacology could not be maintained as the medical 
advances of the 20th Century unfolded. 
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Teaching Pharmacy in Malta 
'1676 - 1990s' Part II 
John Joseph Borg PhD 
Sliema, Malta 
Setting the Scene 
This second21 article continues the review of the 
milestone developments in Maltese pharmacy education 
from 167 4 to 1990s. The article also presents the analysis 
of the shifts in pharmaceutical education over the 
centuries. Chemistry and Practical Pharmacy were the 
subjects which were mostly emphasised over 300 years. 
Botany, and languages have been phased out, and 
subjects like Biochemistry and Pharmaceutics have 
found their place in the first year curricula. This might 
indicate that to keep abreast with progress made in 
pharmacy, the education of a pharmacist changed from a 
course which emphasised botany in 1676 to a course 
emphasising analytical chemistry, pharmaceutics and 
pharmacy practice, as today's modem pharmacy requires. 
The teaching of pharmacy in Malta 
throughout the Twentieth Century 
By 1921, the course of pharmacy was conducted over a 
period of three-years, on a triennial basis. It involved both 
theoretical and practical instruction, and, on successfully 
completing the course, candidates were awarded a 
Diploma in Pharmacy. 1 But a licence had to be issued 
before candidates could actually practise the profession. 
In order to obtain this licence a recommendation by the 
Medical Board was essential. In 1946 thirty-eight 
candidates who had obtained the Diploma in Pharmacy 
of the Royal University of Malta were recommended for 
the licence to practise the Pharmaceutical Profession. 2 
In 1936 candidates who wanted to enter the course of 
pharmacy' had to be in possession of a pass in _five 
subjects at matriculation level, which had to be obta~ed 
during the same examination session. The subJects 
required by the University allowing entrance to ~e 
course of pharmacy were: two of the followmg 
languages: English, Italian, Latin and French, and three 
of the following sciences: physics, chemistry, biology, 
and mathematics. 3 
The pharmacy course during the 1930s was integrated 
within the course of medicine,4 and the Pharmacy 
Department was part of the Faculty of Medicine and 
Surgery. During the first three years, pharmacy ~d 
medicine students studied the same basic subjects. ~e 
throughout the first year English, Italian, botany, phy~ics, 
zoology and inorganic chemistry, were all given 
importance. In the second year English, Italian, botany 
and materia medica were emphasised. 5 After 1936, 
physiology and bacteriology were added to ~e 
curriculum, 6 and during the third year, botany, matena 
medica and pharmacognosy were introduced. Throu~-
out this period, professor Fogarty was the English 
Language lecturer while professor Vella was the bo~Y 
and zoology lec~er, and professor Borg was the physics 
lecturer. It is important to note that in the 1932-36 course, 
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pharmacology was not a part of the cuniculum, with 
experiments being perfonned only in phannacy practice,7 
and not in chemistry or pharmacognosy.s 
Although the 1939 course was planned in the same 
manner as its predecessor, World War II broke out in the 
September of that year and the Chief Government Medical 
Officer ordered the pharmacy and medical students to 
discontinue their respective courses. Instead they had to 
take up nursing and all students were sent to St Aloysius 
College. Throughout the same period all University 
students were required to be trained as soldiers at Fort 
Ricasoli for three months, after which they were discharged. 
At this time, pharmacy students were required to stipulate 
during the first year whether or not they would be 
continuing their studies in order to become general 
practitioners. 1bis choice was made obligatory by the rector 
Professor Galea. 
During the above mentioned nursing course the annual 
examinations were still held, and many students fared badly 
because the syllabuses were not covered properly. 1bis 
resulted in a resit examination session being introduced 
According to J Ellul (today a retired pharmacist, and one of 
the students in the 1939 phannacy course), the subjects 
which were given great importance were: 'maths, English, 
rnateria medica (which was lectured by the Chief Medical 
Consultant Guzi Debono ), botany, pharmacognosy and 
pharmacology'. Apart from the theoretical aspect of pharm-
acy, students in the 1939 course had to practise in a pharmacy 
for two years. The pharmacy they had to attend could have 
been either government or privately managed But, unfort-
unately, the number ofhours that students had to practice was 
not stipulated in any statute, and the system was abused But 
at the end of the two years, the student was obliged to present 
a certificate relating to his perfonnance and capabilities, 
signed by the managing pharmacist of the pharmacy.9 
The first course to be opened after World War II was that 
of 1946. Once again it was planned in the same way as its 
predecessors. Apart from the fact that students could obtain 
a first Diploma in Pharmacy, and then continue to study for 
their MD degree, students were now given the opportunity 
to obtain a degree of Bachelor of Science (BSc). However, 
for students to avail themselves of this option, they were 
required to study chemistry and biology, as well as 
phannacology, in the phannacy course. 10 
The course which led to the Diploma of a 
Pharmaceutical Chemist (PhC), was finally abolished 
and replaced by the degree of Bachelor of Pharmacy 
(BPharm), in 1949. The course was now extended to 
cover a four-year period, with pharmacy practice 
extended over a two-year period at an approved 
pharmacy. Prior to this refonn, the University Statute of 
1943 had brought about important modifications in the 
curriculum, with more time devoted to the theory 
involved in Pharmacy. The period of practical training 
was reduced to one year. Following this, a provision 
requiring students to work at the pharmacy laboratory of 
the University for an average period of one-hundred-and-
twenty hours, to the satisfaction of the Professor of 
Materia Medica, was implemented. 11 
In the mid-sixties a preliminary course of science was 
established in order to prepare students wishing to enter 
any science related course at the University, for the 
standard of tertiary education. Consequently, an 
opportunity arose for students who did not obtain one 
Advanced level and therefore did not satisfy the entry 
requirements of the University but were in possession of 
Ordinary levels in chemistry, physics, biology, and 
mathematics, to enter University after satisfactorily 
completing this course. Since the preliminary course 
provided students with a sound scientific basis of 
knowledge, it did away with the necessity of courses 
having to provide this at their introductory stage. 
Prior to the introduction of this course, the educational 
system consisted of a series of matriculation classes that 
acted as preparation for students intending to enter 
University (these classes were attended for only a year). 
However, the science related classes ceased to be 
organised once the preliminary course of science was 
established. Towards the end of the 1960s, the 
preliminary course of science became the Part I course of 
the BSc cuniculum. 
1bis course was set in a flexible manner and certain 
extracunicular subjects were lectured to students wishing 
to take that subject as a major area in their academic 
training. Also if any student obtained an 'A' level in a 
science subject, he was exempted from the preliminary 
course of science, and could directly enter the first or 
second year of the academic course as required. Students 
who wished to enter the pharmacy course had to register 
for the preliminary course of science, and the following 
subjects were studied: mathematics, lectured by 
Professor Borg-Costanzi; physics, lectured by Dr B C 
Lewis; chemistry, lectured by Professor Farrugia and 
Professor Edwards; and biology. In the '60s regulations 
were laid down prohibiting students following the 
pharmacy course from continuing their studies to become 
general practitioners, or obtaining a bachelor of science 
degree. The entry requirements for the pharmacy and 
medicine courses were identical, and both opened 
biannually. 
During the late '60s the pharmacy course was set over 
a two-year period. Lectures were carried out in a small 
room on the ground floor of the Evans laboratory in 
Valletta, while chemistry lectures were carried out in the 
proper laboratory in the second floor of the same 
building. The number of students was usually around 
fifteen, and most foreign lecturers were amazed at this 
large number attending the pharmacy course. 12 During 
the late sixties (1967-8) students in tl1e first year of the 
pharmacy course had to study: pharmaceutical chemistry, 
pharmacognosy (lectured by Dr C De Luca) and 
pharmaceutics. During their second year, students 
studied: pharmaceutics, pharmacology (lectured by Dr 
Lanfranco), and pharmacognosy. All these lectures were 
supplemented by practicals. Practicals of pharmaceutics 
included the dispensing of medicinals. 
Pharmaceutical chemistry studied in those days 
consisted of organic and analytical chemistry (examples 
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included: UV spectroscopy, and gas chromatography) 
supplemented by examples relative to pharmacy, such as: 
alkaloids, quinidine, salicylic acid and other heterocyclic 
drugs. In pharmacognosy, students had to study medicinal 
plants, both in theory and in practice by carrying out 
experiments such as staining procedures, and observing 
plants under the microscope. 
Professor Borg-Costanzi was the University Rector in 
1968, and it has been said that he never had a very high 
opinion of the phannacy course, or of pharmacy in general. 
Instead, his favourite course was the BSc course which he 
had introduced during the sixties, and during those years he 
always did his utmost to increase the popularity of the BSc 
course. However, during the late sixties at the Academia 
Maltese (commonly known as the 'Polytechnic'), courses 
were starting to be delivered in chemistry and other science 
related subjects. Unfortunately, Professor Borg-Costanzi 
became obsessed with the idea of transferring the phannacy 
course to the 'Polytechnic' as it was his opinion that the 
phannacy course should not fonn part of the Faculty of 
Medicine and Surgery, but rather should be reinstituted at 
the 'Polytechnic' as a course leading to a certificate. This 
turn of affairs, was not greeted well by pharmacy students 
and a campaign was started by students, along with the 
Malta Union of Phannacists (whose president was Mr A 
Dannenia), and the Chamber of Phannacists (whose 
president was Mr W Felice) in order to increase public 
awareness of the importance of the role of the pharmacist in 
society. Prior to the start of this campaign, a number of very 
important meetings were held to discuss the situation and 
evaluate the methods with which the situation could be 
resolved. Taking part in these meetings was Mr Nonnan 
Fonnosa (who used to attend congresses held by the FIP 
abroad). Through his and Mr Dannenia's connections, 
professor Douglas Whittet (the English Chief Pharmacist in 
the 1960s) was brought over to Malta. Mr Emanuel 
Bezzina ( a member of parliament) also helped out. 
A 'Phannacy Week' exhibition was organised, and one of 
the exhibitions was held in the MITP building at the old 
University in Valletta. During this exhibition, students 
carried out chemistry experiments, and extemporaneously 
prepared different pharmaceutical dosage forms (tablets, 
sterile ampoules, etc) to show a few jobs that can be carried 
out by pharmacists. 
At the end of this 'phannacy week', a dinner (which was 
attended by the Rector) was organised. During this dinner, 
detenninant speeches were made by Mr W Felice, and Dr 
Whittet. Naturally, Dr Whittet's presence on the island must 
have impressed the Rector. It must also be added that the 
Commonwealth's University Association, which was very 
influential regarding innovations at the University of Malta 
(by providing financial aid in the fonn of scholarships), was 
embarking on a 'mission' to make Universities improve the 
standard of their phannacy course. These factors together 
made the Rector change his mind, and instead he embarked 
on a totally different project, one of which involved the 
improvement of the existing phannacy course by sending 
graduates abroad for further study at the University of 
London.13 The Rector's aim in such a manoeuvre was 
meant to ensure that, after this period of training, the 
graduate would become Head of the Pharmacy 
Department, but due to political reasons this did not occur, 
and Dr Jaccarini became the acting Head of the Pharmacy 
Department in the early 1970s. 14 
Between 1970 and 1977 the phannacy course was 
modelled on the traditional three-year British type of 
course. The minimum requirements needed to enter the 
course were two 'C' grades and one 'D' grade at Advanced 
level in chemistry, biology and physics. The course was 
based on four main pharmaceutical sciences: 
pharmaceutical chemistry, phannacology, pharmaceutics, 
and phannacognosy. Only a small percentage of the 
curriculum was taken up by the actual practice of 
pharmacy, which consisted of traditional operations such as 
compounding technology, posology, prescription 
calculations, and pharmacoeconomics (the latter was of 
particular importance at this time due to the growing 
concern about the rise in drug costs). No aspect of 
phannacy administration was introduced in the curriculum 
and so matters which would have increased the efficacy of 
drug therapy were left undealt with. Socio-medical topics 
such as sociology of medicine and phannacy as a 
profession were not included in the curriculum. 15 
In 1977 the Maltese government introduced the Student 
Worker Scheme. Students were required to work for six 
months of the year, and to attend lectures for the remaining 
six months. Students, already exempted from paying for 
their tuition fees at the University, could now benefit from 
an annually increasing remuneration donated by a sponsor. 
The aim of such a scheme was to provide a means by which 
the demand and supply of professional manpower needs of 
the country could be met. 
The 1976-1979 course of pharmacy was adapted to fit 
the new course structure, and students were divided into 
two groups, each alternating between the work and study 
semesters. The government acted as sponsor.16 In 1981, a 
discussion paper was presented to the government ?Y Dr 
Alfred Sant, who chaired a Committee17 set up to advise on 
the possibilities of restructuring the BPhann degree ~urse 
within the student worker scheme for tertiary education. 
The Committee proposed the following structure for 
the BPhann course: 
The course should be set into two sections; a Foundation 
. 1 
course, lasting one year and should cover. mathematJ.ca 
methods, chemistry, biology and physics; and an 
Orientation course lasting three years, which would be 
streamed into two overlapping categories pharmacy and 
technology. The pharmacy option wo~d C?ver: 
pharmaceutical chemistry; physiology and b1oche1D1stry, 
Pharmaceutics I and II· pharmacology, and pharmacognosy. 
' · 1 and The technology option would cover: pharmac~utJ.ca 
industrial chemistry; process technology; phys10logy and 
biochemistry; pharmaceutics I and industrial biology. 18 • 
On 17 January 1988, the Chamber of Ph~ac1s~ 
organised a seminar entitled 'Pharmacy Education lll 
Malta'. One major issue discussed that day was the 
Curriculum of the BPharm degree. The question of.the 
relevancy of the pharmacy course to the needs of society 
· · and the 
was kept in mind throughout the dis~~s10.ns, and 
pharmacist was evidenced to have a distmctive role 
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was deemed indispensable for his/her contribution 
towards health care. Consequently, the notion that 
pharmacy education should be a process that introduces 
theory by demonstrating its practical relevance, was 
maintained throughout the discussions, and a number of 
important conclusions and recommendations pertaining 
to the pharmacy degree curriculum were reached. The 
final workshop recommendations were as follows: 
The course must be based on the following three divisions:-
a. Pharmaceutical sciences 
i. Pharmaceutical Chemistry and Analytical Chemistiy 
ii. Synthetic and Natural products 
iii. Pharmaceutics 
b. Pharmacy practice and psychosocial pharmacy 
i. Pharmacy Practice 
ii. Managerial sciences 
iii. Psychosocial and legislative aspects of pharmacy 
c. Clinical pharmacy and biopharmaceutics 
i. Pharmacology 
ii. Clinical Pharmacy 
iii. Physiology and Biochemistry 
iv. Biopharmaceutics and Pharmacokinetics 
v. Disease. 19 
To date, although most of the above recommendations 
have been implemented, the 1994-1998 pharmacy course 
was felt to be lacking in communication and personal skills, 
especially in the psychosocial sciences. Furthermore, no 
lectures on the different types of research methods relevant 
to undergraduates have been intrcxiuced yet. The 
advantages of such studies would lie not in their theoretical 
aspect, but in the practical hints they would provide 
students with, helping them to achieve the set objectives of 
the projects being carried out (whether chemical, analytical, 
social, closed-ended versus open-ended formal or informal 
interviews, and questionnaires). 
Another point worth mentioning regarding pharmacy 
education is that since 1988, the Pharmacy Department of 
the University of Malta has been organising symposia on 
research carried out by both undergraduate and 
postgraduate students ( cf Appendix XIl). Also, since 1981, 
continuing education lectures have been organised by the 
Chamber of Pharmacists. These lectures have covered 
topics ranging from novel pharmaceutical developments to 
pharmacokinetics, and pharmacy practice. It is of note that 
m 1987 the student worker scheme was discontinued and 
students pursued their studies without any interruption. To 
~ompensate for loss of wages, the government of the day 
introduced the payment of stipends to full-time students. 
T_rends in pharmacy education. 
Smee the establishment of the School of Anatomy and 
Surgery in 167 6, it has been observed that it was necessary 
to increase the duration of the pharmacy course. However, 
documentation available shows that the pharmacy course 
had been set over two years for 224 years. 
At the beginning of the twentieth century the pharmacy 
course was modified to a three-year course, and remained 
so till the 1980s, when it was extended to cover a four-year 
period ( cf Table 1 ). In 1995, the addition of another year 
extended the undergraduate course of pharmacy to a five-
year duration. 
The need to increase the duration of the pharmacy course 
may be explained by the fact that, with the increase in the 
information and the progress witnessed in the 
pharmaceutical and medical professions, the modem 
pharmacist came to require a sound basic knowledge in a 
wide spectrum of subjects which were becoming 
increasingly essential to his expanding role. Consequently, 
it became a physical impossibility to achieve the 
increasingly demanding objectives of pharmacy studies 
within the time limits of the original pharmacy course. 
Duration 17th C 19thC 1900-79 1980s-
of Course 1994 
2 years ../ ../ 
3 years ../ 
4 years ../ 
Table 1. Duration of the pharmacy course throughout the 
Seventeenth, Nineteenth and Twentieth Centuries. 
Various modifications have occurred within the 
pharmacy curriculum since 1676. The ubjects tudied 
during the respective pharmacy courses during the 
seventeenth, nineteenth, and twentieth centuries have been 
presented in Table 2. 
The data show that botany was a core subject for more 
than two-hundred-and-fifty years (as it had repeatedly been 
included in the curriculum throughout the first-, second-
and third-year courses). It twas hen phased out of the 
pharmacy course during the late 1940s, as a probable result 
of the decreased utilisation of crude drugs by the 
community pharmacist in extemporaneously preparing 
medicaments. 
Materia medica bas also been phased out of the 
curriculum since the mid- l 930s. Documentation available 
indicates that materia medica had been introduced into the 
pharmacy course by 1676. Although this subject was 
important, it was dropped out of the first-year courses as 
from 1838. However, it was an integral subject throughout 
the second-year courses in the nineteenth century. 
Materia medica consisted of lectures on the 
formulation and use of active ingredients (u ually 
obtained in the form of crude drug ). o, materia rnedica 
can be said to have contained topics today studied in 
industrial pharmacy (like do age formulation) , pharm-
acology (the side effects of drugs) and pharmacognosy 
(the extraction of crude drugs). 
According to the documentation available, Natural 
History has never been a core subject in the pharmacy 
curriculum. In fact, it is only documented to have been 
included in the pharmacy first-year curriculum in 1838, 
and was removed by 1887. English and Italian were 
included in the pharmacy curriculum from 1887 unti I the 
late 1940s. However, they never formed part of the 
second-, third- and fourth-year curricula. Latin, Physics 
and Mathematics, on the other hand, were only included in 
the first-year curriculum throughout the 1930 and '40s. All 
these subjects were introduced to provide a sound basi for 
other subjects studied at a tertiary level of education. 
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Table 2. Subjects studied during Pharmacy courses.* 19 
Period 17th C 19th C 20th C 
Subjects 1st year 1st year 2nd year 1st year 2nd year 3rd year 4th year 
Botany ,/ ,/ ,/ ,/ ,/ ,/ 
Materia Medica ,/ ,/ ,/ 
Natural History ,/ 
English ,/ ,/ 
Italian ,/ ,/ 
Latin ,/ 
Physics ,/ 
Maths ,/ 
Practical Pharmacy ,/ ,/ ,/ ,/ ,/ ,/ ,/ 
(Extemporaneous Preparations) 
Practical Chemistry ,/ ,/ ,/ ,/ 
Pharmaceutical Chemistry ,/ ,/ ,/ ,/ ,/ ,/ ,/ 
Organic Chemistry ,/ ,/ ,/ ,/ 
Analytical Chemistry ,/ ,/ ,/ ,/ 
Anatomy ,/ 
Physiology and Biochemistry ,/ ,/ 
Mathematical Methods ,/ 
Pharmacognosy ,/ ,/ ,/ 
Pharmacy Practice ,/ ,/ ,/ ,/ 
Microbiolo2:v ,/ ./ ,/ ./ 
Pharmacology ,/ ,/ ./ 
Pharmaceutics ,/ ,/ ,/ ./ 
The information available regarding Practical Pharmacy and third-year courses since 1835. This indicates that 
( extemporaneous preparations) indicates that this subject chemistry has always been considered a :fundamen~ core 
has been given special importance throughout the centuries, subject in pharmaceutical education, and it is the basis upon 
and although it is documented that it did not form part of the which a holistic understanding of drugs depends. . 
cuniculum during most of the nineteenth century, it found However, subjects like Anatomy, Mathematical 
its place in the cuniculum once again in 1889. Throughout Methods, Physiology and Biochemistry, have only lately 
the seventeenth century, practical pharmacy ( extem- been introduced into the first-year pharmacy course. In fact, 
poraneous preparations) was performed in the dispensary Biochemistry and Physiology were introduced into the 
of the Holy Infirmary (see Part 1),21 but from 1889 to date, cuniculum in the late 1940s, and Anatomy and 
practical pharmacy has been performed in the laboratories Mathematical Methods in the 1970s. To date, 
of the University of Malta. Apart from the preparation of documentation shows that these subjects have become 
extemporaneous dosage formulations, pharmacy students integral parts of the first-year cunicula, with only 
since 1889, have been asked to attend a community Physiology and Biochemistry included in the seco~d-year 
pharmacy, and during the 1930s and '40s students also had course. The reason why these subjects have ~cqurred so 
to obtain a certificate signed by the Managing Apothecary much importance, is that they are b~ic to the 
of the community pharmacy being attended by the student. understanding of other core subjects emphasised to date, 
Unfortunately, lack of documentation cannot elucidate if such as Pharmacology and Pharmacokinetics. 
this latter practice was maintained throughout the 1950s, Data available show also that Pharmacognosy was 
'60s and '70s. It was reintroduced in the 1990s. introduced in the cuniculum during the 1970s. However, 
According to the documents consulted, it can be seen that although it was given importance throughout the first- ru_id 
chemistry and its respective disciplines (like organic and second-year course in the 1970s, it has today f~und its 
analytical chemistry) had been included in the first-year mainstay as a core subject in the third-year curnculum, 
pharmacy course from 1676 to 1995, and in the second- Pharmaceutics (including Microbiology) is documented to 
72 Phann Hist (Lond) 2014; 44 (3): 
have been part of the curriculum since the 1970s and is 
nowadays considered a core subject. 
Pharmacology (including Pharmacokinetics) is another 
core subject, forming part of the second-, third- and fourth-
year curricula. It was introduced only in the late 1970s. 
General Pathology and Behavioural Sciences, on the other 
hand, have only recently found their place in the second-
year curricula. 
Conclusion 
A fairly clear picture has emerged regarding the changes 
that occurred within the Maltese pharmacy course over the 
centuries. However, no documentation has been located 
that attests to the level of education attained in the 
respective subjects from 1676 to 1920. For example, it is 
known that the chemistry studied throughout the first 
quarter of the nineteenth century was mainly inorganic and 
organic, but no evidence of the study of mechanisms of 
reactions has been found. Although no direct evidence was 
found to answer this question, the author postulates that the 
standard must have been very high, as Professor J Borg's 
extremely detailed book Descriptive Flora of the Maltese 
Islands in 192'!2° was used by many students studying 
Botany at University. 
Authors address: Dr John Joseph Borg PhD , 8, No 40, 
Dingli Court, Howard Str, Sliema, SLM 1751, Malta; 
Phone: +356 21333072;john-joseph.borg@gov.mt 
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The Pitcher Plant: a 'traditional' 
remedy? 
John K. Crellin 
St John, Newfoundland, Canada 
'The plant in any situation is a very great curiosity. '1 
Introduction 
(i) Newfoundland's introduction of the decimal currency 
150 years ago occasioned the island's first one-cent coin 
featuring a wreath of the pitcher plant and oak leaves; (ii) 
Sarracenia purpurea, abundant in the bogs of New-
foundland and Labrador, became the provincial floral 
emblem in 1954; (iii) the plant has been described as 
'symbolic of all that Newfoundlanders are'; and is the title 
of the newsletter of the Newfoundland Wildflower Society; 
(iv) a recent flurry of emails requesting signatures for the 
British Save Our Herbal Medicine campaign. 
A sesquicentennial, current herbal practices, and Newf-
oundland pride prompted this critical appraisal that 
develops brief notes on the insectivorous Sarracenia 
purpurea published in the early 1990s.3 While 'pitcher 
plant' is the best known common name, it applies to all 
Sarracenia species as do a host of others, for instance, 
huntsman's cup, Eve's cup, side-saddle plant, trumpet cup 
and flytrap that fascinate sleuths of the origins of common 
names. 
In a 2008 Pharmaceutical Historian article, 'Traditional 
Use' Claims for Herbs: The Need for Competent Historical 
Research,' I questioned (i) the limited time span of usage 
accepted by jurisdictions to justify a label of 'traditionally 
used' (eg, 30 years under EU regulations, and 'two 
generations' in Canada), and (ii) the limited number of 
references, at least two in Canada, to justify a claim.4 I also 
stressed the importance of appraising a range of primary 
sources to find patterns of evidence sufficient to move 
beyond anecdote to what can be described as collective 
anecdotal knowledge. 
This account looks at the therapeutic claims for 
Sarracenias, indigenous to North America mostly to the East, 
as follows: (i) current and recent, (ii) from the seventeenth 
century to around 1850, (iii) from then until the early 1900s, 
(iv) and, lastly, summruy and comments. The long time span 
raises questions on what is required to fulfil one definition of 
'traditionally used,' namely that it be 
ba.5ed on the sum total ofknowledge, skills, and practices ba.5ed on 
theories, beliefs, and experiences indigenous to a specific culture, 
used in the maintenance ofhealth, as well as prevention, diagnosis, 
improvement, or treatment of physical and mental illnes& s 
Current and recent references 
Among widely-used 'authoritative' websites, the Natural 
Medicines Comprehensive Database ( consumer version) -
the oft-consulted PDR [Physicians' Desk Reference] for 
Herbal Medicines is a key reference - states that S. 
purpurea ( no reference to other species) is used [orally] for 
digestive disorders, particularly constipation, urinary tract 
diseases, as a diuretic, a cure for smallpox, and to prevent 
scar formation.6 WebMD and the Dartmouth-Hitchcock 
Norris Cotton Cancer Center websites are two to repeat 
essentially the same information. 7 
Figure 1. Sarracenia purpurea L. subsp. purpureci 
Readers who mistrust conventional medicine's 
negativity toward herbal medicine might well overlook 
such cautionary comments in the entries as 'unproven', 
'obsolete' or 'lack of credible supporting evidence', all the 
more so on reading the present tense ('is used') as current 
information. Moreover, encouraging claims about 
Sarracenia's medicinal value are readily found. For 
example, as an antiviral based on a series of case histories 
and bolstered by reference to a 2012 scientific paper, 'In 
Vitro Characterization of a Nineteenth-Century Therapy for 
Smallpox', which in turn supported its laboratory findings 
using monkey-pox virus by citing only positive, not 
negative, nineteenth-century reports (see below) on 
Sarracenia therapy for smallpox. 8 
Aside from the Internet, innumerable books since the 
1960s cater to popular interest in herbal medicine. 
However, only a few notice Sarracenia, mostly as a 
stimulant to 'appetite and digestion', with an occasional 
nod to the earlier reputation for smallpox without irnpl~g 
current usefulness.9 Although this hints at little interest .m 
Sarracenia, Mrs Grieves Modem Herbal deserves special 
mention. Although first published in 1931, it joined the 
popular herbal books of recent decades through a 1971 
reprint and a Web version. It has been viewed .as 
authoritative even though the information on therapeutlcs 
mostly lacks evidence of first-hand experience. She wrote 
somewhat positively that the principal value of S. purpurea 
'appears to be in torpid liver, stomach, kidney and _uterus 
complaints', and that it had been introduced as a specific for 
smallpox by 'North American Indians with great success, 
saving life and even the unsightly pitting'. _Sh~ was 
presumably referring only to smallpox when adding some 
homeopaths confirm the value of the remedy, but that 
allopaths do not appear to be successful'. 10 
Leaving aside popular books, always to be evaluated ~o~ 
slavish copying, the oral record can also establis 
'traditional' usage. Caution is again needed. It cannot be 
assumed that the following statements apply to every 
medical use recorded at one time or another with regards to 
specific groups in society: 
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A span,e record reflects loss of information rather than loss of use 
or 
Given the stubbornly conservative value of folk culture, it is 
expected that a significant element of continuity will be present 
concerning uses of medicinal plants. 11 
Reports can fail to differentiate between, an informant's 
recollections of, say, a 'Grandmother's remedy' and on-
going usage. Moreover, they can be fiustratingly 
inconsistent. In South Carolina a decoction of S. minor was 
said to be in 'current use' in the 1960-70s applied 'warm on 
skin rash or eruptions', but the plant did not feature in a 
compilation published a few years later. 12 
Figure 2. Clusius ' illustration reproduced in Gerard' 
Herbal/. 
Caution also applies to interpreting aboriginal 
information, even if sometimes, as with Sarracenia, 
traditional use might seem relatively strong.13 Of special 
interest is knowledge among the Mi 'kmaq people of Nova 
Scotia because they used it for smallpox in the 1860s (see 
below). A 1993 account of Mi'kmaq remedies noted that 
the water trapped in the 'trumpet' of S. purpurea was a 
magic elixir, and that the plant had been used to treat 
tuberculosis, kidney ailments, and indigestion. 14 However, 
these are recollections (not necessarily current usage) 
though at least a persistent thread of Mi 'kmaq interest is 
reflected in oral testimony (2013) of chewing the dried root 
to treat a sore throat, in line with its long recognised Indian usage of the plant as an effective treatment for 
smallpox. Unfortunately, the claim is not supported by the astringency.15 
author's documentation. 19 
1600s to c. 1850 If the smallpox treatment had become generally known 
While the sensory properties of astringent plants like during the 1700s, it is swprising, given the considerable 
Sarracenia once rationalised most uses, the spottiness of interest in aboriginal knowledge at the time and the many 
the pre-1850 Sarracenia story offers no indication of a outbreaks of the dreaded disease, that travellers/ naturalists 
generally known medical reputation. While, for instance, who were likely to have heard about it omitted it from their 
both the majestic and influential herbals of John Gerard publications, as did major reference works. Examples 
(1633) and John Parkinson (1640) reproduced Carolus include Mark Catesby, Peter Kahn (who was well aware of 
Clusius's 1601 illustration (identifiable as a Sarracenia, Sarrazin's reputation), and William Bartram.20 Clearly, 
likely purpurea) under the name 'Hollow leaved Sea neither Sarracenia's carnivorous nature nor horticultural 
Lavender' (Figure 2), they recognised it as a novelty. enthusiasm over potting the plants aroused general interest 
Indeed, Gerard said he included it to encourage others to in medicinal properties. Even during the first half of the 
find it and investigate its properties. Strikingly, however, 1800s only an occasional medical reference ~as been 
both authors grouped the plant with others that ~ere found, for instance, S. purpurea as a strong decoctton of the 
'astringent or binding' to be used for the 'collicke, root used by the 'Red Indians' (Mi'kmaq) of Newfound-
strangurie, and Dysentaria' (Gerarde) and for 'the land to treat spitting of blood and other pulmonary 
stornacke, the spitting ofblood likewise, and the abundance complaints; no analogous reference appeared in medical 
of womens courses' (Parkinson) - all akin to later botany texts or in the annotations in we! I-known floras. 21 1n 
recommendations for Sarracenia spp. 16 Not long view of the later availability of Sarracenia, factors such as 
afterwards, John Josselyn in his New England Rarities limited habitats (bogs and marshlands), naturalisation 
(1674),17 in a relatively clear reference to S. purpurea as failures in Western Europe, and better known and well-
'Hollow Leaved Lavender', opined: 'I wonder where the established astringent/bitter alternatives only played a ~mall 
knowledge of this plant hath slept all this while.' S~ce he part in this lack of interest, though may~ _they exp!~ the 
included it under 'Bums and Scalds' one can sunmse that failure to circulate such Sarracenia titbits as placmg a 
Josselyn recognised the astringent properties, hence a pitcher on a fire to boil the water trapped inside.22 
suggestion that it was also useful for 'fluxes.' 1850s to early 1900s 
The unusual botanical features of Sarracenia (a great The Sarracenia story changed dramatically during the 
'curiosity') attracted many naturalists/botanis~ .. In lSSOs to '60s, a time of constant exploration, both 1~ and 
providing probably the first detailed botanical descnptton, overseas for new remedies. The spotlight began with an 
supported by specimens sent from Quebec to French 1849 pa~r by pp Porcher on the medical use of S. jlava '.1°d botanists, physician Michel Sarrazin (1659-1734)_ ~as S. variolaris for dyspepsia, though he reached a much wider 
honoured in the genus name. Sarrazin's d~ptton readership with his 1863 Resources of the Southern Fields 
included no medical information, only __ noting the and Forests, a book that, in seiving the uth during the 
pungency of the plant. 18 Yet a recent tantalismg acco1;1Ilt American civil war became widely quoted for many years.23 
attributes him as having successfully confirmed nat:Ive ' 
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In both publications Porcher was at pains to s1re.5s that claims 
to relieve symptoms of dyspepsia came from many 
infonnants, including physicians, in whom he had 'the 
highest confidence'. Thus he offered a sense of collective 
anecdotal knowledge. He also supported the claims by 
reference to the 'astringent, bitter, tonic properties' and by 
suggesting the plant restored balance in stomach acidity. 
Although these claims were also later attached 
indiscriminately to S. purpurea, this species gained the 
headlines in the early 1860s as a smallpox treatment. 
Initially, two physicians in Nova Scotia indicated that it was 
an infallible remedy used by local 'Indians' . One claimed 
that, after his trials, he became 'convinced of its astonishing 
efficacy'.24 Another physician, promoting it in the august 
pages of The Times (1863), reported on eleven successful 
cases among troops stationed in Wmdsor. 'This remedy I 
consider a boon to the public' .25 
This was soon challenged and the intense controversy 
that ensued during the 1860s was set against a backcloth of 
a growing questioning of the value of individual clinical 
observations, even small series of cases. Coupled with this 
was concern over premature public announcements. The 
British Medical Journal, for instance, responded harshly to 
The Times report:26 
An honourable member of the profession, contrary to all 
medical logic and sane medical observation, drew violent 
conclusions from antecedents which in no kind of way justified 
them, and then rushed into the public prints, exciting and 
inflating the anticipations of the public, and causing thereby 
serious annoyance to the profession as well as eventual grievous 
disappointment to the expectant public. 
Conventional medical follow-up 
The controversy soon lost steam on both sides of the 
Atlantic, but lingered on against a background of anti-
vaccination movements and a search for new treatments. 
Medical textbooks, even American, on rnateria medica and 
therapeutics - intended primarily for medical students and 
young physicians - if not ignoring the plant, noticed 
smallpox only occasionally, while reporting briefly on tonic 
properties, especially for dyspepsia (though it fared poorly 
amid the intense competition from other such preparations). 
On the other hand, reference books such as Dispens-
atories and medical dictionaries, if not druggists' 
forrnularies and handbooks, at least noted it if only as a 
footnote to the medical arrnamentariurn. Sometimes this 
demanded updating.27 For instance, Remington's 1918 
edition of the Dispensatory of the United States of America, 
aside from listing constituents, only included, without 
follow-up, seventy-year-old information on therapeutic 
uses:28 
According to F. P. Porcher, the roots of Sarracenia jlava L., and 
S. variolaris Michx., have long been used in the Southern 
United States in dyspepsia, and are tonic, laxative, and diuretic. 
Earlier reference works at times joined criticism of the 
positive verdicts on Sarraceni.a and smallpox. The 1868 
edition of Wood and Bache's Dispensatory of the United 
States of America reported:29 
We have no hesitation in expressing our conviction that the 
apparent efficacy of the remedy was simply owing to its 
employment in the cases of modified small-pox ... either 
through vaccination or a previous attack. 
And the 1879 National Dispensatory, a successful 
competitor to Wood and Bache, offered a prophetic 
comment. After noting that positive smallpox treatments 
were not confirmed by experience, he added that, 'like 
other errors, it required some time and tabor to destroy.'30 
(The author would have been interested to read a letter in an 
1891 Newfoundland newspaper that still cited the above 
Times article as positive evidence of the value of aboriginal 
knowledge.)3 1 
Physicians during the last half of the century could also 
turn to medical botany texts though these, too, generally 
offered cursory and inconsistent infonnation on 
therapeutics, as did the offspring pharrnacognosy texts. For 
example, L Johnson's Manual of Medical Botany of North 
America when quoting Porcher's report on S. flava and 
variolaris added S. purpurea as also possessing the 
properties of a bitter tonic and stornachic for 'dyspeptic 
conditions'. 32 He ignored smallpox, while Robert Bentley, 
in his 1882 A Manual of Botany, felt it necessary to again 
stress that 'extensive trials in the hospital in this and other 
countries' found the rhiz.ome, rootlets and leaves of S. 
pu,purea to be 'entirely useless'. 33 
Home medicine books at the time, written by 'MDs' and 
generally reflecting conventional medicine, also failed to 
offer a consistent message. Indeed, one of the few to 
mention S. purpurea offered therapeutic uses - St Vitus's 
dance, convulsions, tremors, nervous affections - out of 
line with those commonly listed.34 
An alternative life 
If medical texts, a mirror of basic medical education, were 
essentially dismissive of Sarracenias, at least purpurea had 
another life through two schools of medical thou~t, 
homoeopathy and, notably in the USA, Eclectic practice. 
During their heyday until the early twentieth centul?', bo~ 
schools, which attracted many physicians initially tramed m 
conventional medicine, had a mission to reform medicine. 
Homoeopathy in the 1860s added fuel to the smallpox 
controversy. Although in 1864 and 1867 Edwin Hale, ~ne of 
its pioneers, acknowledged that Sarraceni.a was not qwte the 
sovereign smallpox remedy as claimed, he promoted further 
investigation by republishing positive smallpox results from 
conventional practitioners along with favo~le hoi:noo-
opathic evidence.35 The same, somewhat confusmg, ~ of 
positive homoeopathic and conventional expenen~ 
appeared elsewhere, as in Millspaugh's Sarracenlfl 
monograph of 1887 helping to establish :firmly the ~lant as a 
homoeopathic remedy.36 Given homoeopathy's reli~~ on 
provings, often historical, and their theoretical undetpllll11ll~ 
it is unsurprising that purpurea remains in the homoeopathic 
arrnamentariurn with some preparations currently accepted 
by regulatory jurisdictions.37 . . 
Eclectic practitioners (the name reflected therr ect~c 
use of therapies) had a strong disposition toward ~t:anl~ 
remedies, especially those native to North ~enca. It 15 
thus telling that Sarraceni.a, while a recogruse:d ~edy, 
never became well-established in Eclectic practice. Finl~Y 
Ellingwood in his American Materi.a Medica, TherapeutlCS 
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and Pharmacognosy (1915) stated that purpurea has 'as 
yet, no established place in therapeutics' .38 It was omitted 
from other key Eclectic texts and met ambivalence in 
others.39 Its reputation for smallpox, however, did not die. 
When Ellingwood added that Sarracenia had been used 
with good results for 'zymotic disease' - eg, scarlet fever 
and measles as well as smallpox to modify their character, 
shorten their course and prevent sequelae - he repeated 
extrapolations to other contagious diseases initially raised 
in one of the first promotions for smallpox.40 
Ellingwood was also repeating information on a label for 
a commercially manufactured Sarracenia 'Specific 
Medicine', a type of medicine discussed below (Figure 3).41 
It was marketed primarily to Eclectic practitioners and 'said 
to powerfully antidote the poison of contagious diseases -
smallpox, lepra, measles, &c'. 
While the literature suggests that demand for Sarracenia 
was never high, even among homoeopaths and Eclectics, 
various pharmaceutical companies included it their 
catalogues, maybe acquiring the raw material from influential 
Shaker herb businesses. Shrupe & Dohme in Baltimore were 
doing so by 1870 when they listed a fluid extract of purpurea 
with the remark: 'considered useful in the treatment of 
srnallpox'.42Proprietary preparations were another aspect of 
the medical market place. A successful one, Aimar's 
Sarracenia or Fly Trap Bitters, was sold by Charleston 
druggist, GW Aimar, who was likely influenced by the 
Charleston 'Sarracenia authority', physician Frederick 
Porcher. After Aimar invited physicians in 1858 to give his 
preparation a trial, it survived well into the 1900s ostensibly 
for 'Dyspepsia or Indigestion, Nervous Weakness, 
Costiveness, General Debility, &c.' (Figures 4a & 4b ).43 
Closing comments 
Even though Sarracenia has not been licensed as 
'traditionally used' by any jurisdiction, the discordant and 
disjointed trail of information, not uncommon for many 
better established botanicals, raises general issues to be 
considered when evaluating traditional claims. 
All ten references on Health Canada's 'partial list of 
recommended references to support traditional use 
claims' are used in this article unless they made no 
mention of Sarracenia.44 It is noteworthy that half of the 
references reflect Eclectic medical thinking. Indeed, 
Health Canada's subtitle for the references, "Traditional 
Herbal (Eclectic) Medicines," prompts a question 
whether or not this seeming conflation of Eclectic 
practice with traditional medicine is justified. Various 
issues deserve reflection. 
One is whether listed uses in Eclectic materia medica 
texts always capture therapeutic experiences found with 
preparations such as decoctions of Sarracenia likely used 
in conventional practice. Many Eclectic practitioners 
used manufactured preparations classed as 'Conc-
entrated' (many known as 'resinoids') or, as came later, 
the more widely used 'Specifics', mostly tinctures, but 
stronger than those in conventional practice. The 
Sarracenia Specific Medicine label shown in Fig. 3 was 
one of many Specific preparations marketed by the L!oyd 
company and appreciated for their consistent quality.45 
Such products were said to be favourites 'with numbers 
of physicians, and all have been established by clinical 
observation in disease expression' .46 
'Disease expression' referred to the specific symptoms 
associated with a particular disease as indicated in the 
following quotes from the Eclectic literature: 
it is a fact that disease has definite expression, which may be 
studied and learned, so that having learned the language of 
disease, we have a certain guide in diagnosis;47 
and 
the Specific Medicines are not commended to cure diseases 
by name, but to serve the medical profession desiring to use 
specific or definite preparations to meet pecific symptoms in 
disease expression, 
or, as often expressed, symptoms in a 'pathological 
condition '.48 Yet, while it was appropriate to make clear 
that botanicals relieved symptoms, information possibly 
-
; "1~~2'1~Mr,._ ___ _ 
SARRACENIA. 
480 GRAINS TO FLUID OUNCE. 
ABSOLUTE ALCOHOL 
llffl••aa. ati-11111:1Z•lff111,, ... 
Figure 3. Fae imile of main part of label of a 
preparation marketed by Lloyd Brothers. 
a. W. AJMAB, 
.. 
--
.....,....._o.i.c-w,·w, 
~ure 4a. Advertisement, G.W. 
Fig. Airnar, Charlestone, South 
Carolina. 
Figure 4b. Airnar' Sarracenja or 
Fly Trap Bitters. 
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based on experiences with a single product need to be 
carefully evaluated, especially if the therapeutic uses are out 
of step with other information. After all, precise 
manufacturing details, even the part of the plant employed, 
were not publicly disclosed. Consider, for example: 
(i) Theoretical considerations cannot be discounted in 
listed symptomatology. In some cases, rather than 
empirical clinical observation, 
the relation has been established by proving the remedy on 
healthy persons, and determining by this its quality of action, 
and its affinity for special parts. This is the homoeopathic 
method .. . But this is also the physiological method; for, the 
influence of a drug having been determined, as to its quality 
and selection of special organs, parts or functions for its 
action, the agent is employed when such action is required. 49 
(ii) Despite the commercial success of Specifics and 
claims that their symptomatology was backed by 
extensive experience, practitioners could rarely relieve all 
symptoms presented by a patient. Outcomes could reflect 
a particular regimen and other variables affecting 
therapeutic outcomes. It is also worth noting that 
translating Eclectic teachings into everyday practice was 
not easy for inexperienced practitioners, for instance 
when textbooks linked a botanical specifically to a 
disease label (as in conventional medical books) without 
reference to symptomatology. 
(iii) The favourable disposition of Eclectics toward 
botanicals, especially native remedies, can be another 
issue when evaluating Eclectic literature. On one level, 
confidence in botanicals encouraged challenging 
questions about conventional medical views. John 
Scudder, a leading figure in the Eclectic movement, for 
example, essentially asked whether conflicting results in 
the Sarracenia smallpox controversy resulted from 
differences between fresh and dried root. As he said, 
When fresh, it is bitter and astringent, having a somewhat 
pungent impression on the fauces. The specimens I obtained 
had no taste.50 
Yet, on another level, the danger also lurked of 
cognitive biases linked to a mind-set of reforming 
conventional medicine that opened the door to dismissing 
contrary opinions (a charge also to be levelled at 
conventional medicine).51 Eclectics, with an eye on 
theory, even notions of a drug possessing vitalist forces, 
might take a less than critical approach to the clinical 
assessment of, say, a Specific Medicine at a time when the 
level of acceptable 'experience' was changing. One might 
wonder about the strength of the clinical experience 
behind a formula in John King's American Eclectic 
Obstetrics (1871 ). This included pwpurea extending its 
tonic reputation to stimulant action on the uterus: 
an infusion of the leaf, or root, is also efficacious in 
amenorrhoea, dysmenorrhoea, or other functional 
derangements of the uterus, connected with [its] sluggish or 
torpid condition.52 
All in all, by using Health Canada guidelines it would 
be possible to selectively excerpt statements from two of 
their references to support 'traditional' usage of 
Sarracenia ( cf. Ellingwood and Grieve). However, 
appraisal of a wide range of information ( and lack of 
information) in the wntmgs of different schools of 
medical thinking make this questionable, even for 
dyspepsia. It questions the use of a minimum of two 
references to meet Health Canada's own definition of 
basing traditional usage on 'the sum total of knowledge, 
skills, and practices based on theories, beliefs, and 
experiences indigenous to a specific culture'. Consistent 
patterns of information, ranging from conventional 
medical thinking to domestic or folk medicine are needed 
before deciding if a recorded use has a reasonable 
probability of a consistent action. 
·---~ Figure 5. Canadian stamp (1966) recognising Newfound-
land with the province's coat of arms, one of many stamps 
from around the world to feature a Sarracenia. 
The pitcher plant has long been viewed as a curiosity, a 
curiosity occasioning stamps (Fig. 5), coins and ephemera 
beyond Newfoundland. Curiosity, too, has created poetry 
and perhaps helped to sustain a low level of medical interest 
that, from time to time, has thrown up uses out of charac~ 
with accumulated information such as for diabetes and pa1D 
syndromes; one injectable product for pain manag~~t is 
particularly striking-a commercially marketed distillate 
from S. purpurea that initially (1930s) was a ~ of 
amines based on the 'flies, ants, mosquitoes, etc., which are 
trapped, digested and assimilated with a subsequent 
conversion of protein material into amino compounds'. 53 
The 'curiosity' long surrounding Sarracenia ex~~ds 
beyond the carnivorous appetite into a byway of medic~ 
plant history, but one that prompts reflection on just what 1s 
meant by 'traditional'. 
Author ' address: 115 Tucker's Hill Road, Portugal Cove, ~t 
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Book Review 
Newfoundland Drugstores: a history. John K. 
Crellin. Published by Flanker Press Ltd. Canada, 
2013. Pp 209. ISBN 978-1-77117-282-0. Price 
$19.95 
John Crellin has written this history of drugstores in 
Newfoundland from the Victorian era to the present. 
Drugstores in the 1800s were the equivalent to the 
Chemist and Druggist in the British Isles and were 
regulated in the same way. There was, however a strong 
connection to American pharmacy and products sold 
were of English, American and, to a lesser degree, 
Canadian manufacture. Some of the products included 
Sand Soap for dirty, oily, fishy hands, Bulls' Grease, used 
in the same way as Bears' Grease for strengthening the 
hair, and Florida Water which was a mixture of Lavender 
Water and Eau de Cologne that became very popular 
during the Prohibition Era in the USA as it contained a 
high proportion of alcohol. The most famous Newf-
oundland product was Cod Liver Oil from the local 
fisheries. In 1914 American-style soda fountains were 
introduced. 
Until 1949 Newfoundland was under British 
jurisdiction. Canadian Confederation put pharmacy in 
Newfoundland under Canadian legislation. New 
narcotic and food laws were introduced and the 
drugstores were modernised. 
The paperback is 23cm x 15 cm x 1.4cm. There is an 
Index at the back and copious endnotes at the end of each 
chapter. Black and white illustrations are numerous. . 
The history of pharmacy and drugstores m 
Newfoundland is very similar to that of Britain. The 
difference is the range of products sold and the way th~t 
the local needs influenced the development. John Crellin 
gives us an informative and easy-to-read insight into 
these factors. 
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The pharmaceutical use of Lapis 
Lazuli in the Ancient East 
Dr Christopher J. Duffin 
Sutton, Surrey 
Technically, lapis lazuli is a rock, since it is made up of an 
association of several different minerals. 1 The main 
component is lazurite, an alwninosilicate belonging to 
the feldspathoid sodalite group of minerals and 
possessing a somewhat varied composition. Its 
distinctive intense marine blue to violet blue colour (with 
lighter blue and green varieties also known) means that it 
has sometimes been confused with the copper carbonate, 
azurite, especially in older literature. It is typically 
metamorphic in origin, the bulk of geological 
occurrences being related to the contact metamorphism 
of limestones, dolomites and evaporates. The rock has 
been the subject of several brief overviews.2 Historically 
significant deposits were located in Badakhstan (northern 
Afghanistan and referred to in 13th century accounts by 
Marco Polo), Pamir (Russia), the Atlas Mountains (North 
Africa), Latium, Vesuvius and the Albano mountains 
(Italy). Significant quantities of the rock were probably 
produced in Iran during the 13th and 14th centuries, 
according to some medieval Arabic sources. Extraction 
was carried out by means of fire-setting, right into the 
early 19th century.3 Lapis lazuli was highly valued in 
Mesopotamia and the Mediterranean region as a 
decorative building stone, a symbol of dignity, in various 
ritual and magical contexts, in votive offerings, as royal 
gifts and tributes, and as stones in a wide variety of items 
of jewellery.4 It was also the base material for the 
production of the artists' pigment, ultramarine,5 and used 
in the dyeing of cloth. The intense blue colour is believed 
to be a function of the complex chemistry of the various 
oxides of sulphur in the crystal lattice. 6 
The objective of the present paper is to examine, for the 
first time, the historical use of lapis lazuli as a 
geopharmaceutical material. Further papers in this series 
are intended to trace the use of lapis lazuli within the 
western European and Arabic medical traditions until its 
elimination from the materia medica at around 1750. 
Ancient Egyptians 
Traded with Afghan suppliers, probably via Turkey, lapis 
lazuli was employed by the ancient Egyptians from pre-
dynastic times onwards for the production of beads, 
scarabs, amulets and other small objects, as well as a 
colouring agent.7 It seems that colours were deeply 
symbolic; the blue oflapis lazuli was associated with joy, 
delight and tranquillity - it was the colour of heaven.8 
Used extensively in the tomb of Tutankhamun (18th 
Dynasty pharaoh reigning from circa 1332- 1333 BC), 
lapis lazuli was used for the eyebrows, eyelids and kohl 
marks on the death mask of the young king whilst a lapis 
substitute, Egyptian Blue, was used for the decorative 
stripes on the nemes or headcloth of the gold mask, and 
also to provide the inlay on the plaited false beard. This 
use of the authentic lapis emphasises a connection with 
the eyes in Egyptian culture. 
Egyptian medical writings are mostly found on stelae 
(stone or wooden blocks) and ostraca (shards of pottery 
or clay tablets), as well as specialised medical papyri. 
Amongst the latter, the Ebers Papyrus, now held by the 
University of Leipzig, is the most extensive. The 20m-
long scroll contains 110 pages and was supposedly found 
between the legs of a mummy in the Assassif area of the 
Theban necropolis on the East bank of the River Nile. It 
is believed to date from 1534 BC, having been written 
during the reign of Amenhotep I, second pharaoh of the 
18th Dynasty. Two recipes in the papyrus refer to the use 
of lapis lazuli in treatments of the eye.9 Recipe 378 
recommends 'real' lap is lazuli (i.e. not the Egyptian Blue 
synthetic glass equivalent) mixed with green and black 
eye paints or 'kohls' (based on malachite and galena 
respectively), crocodile dung and two rather obscure 
herbal components in a milk base. The mixture was 
applied to the outside of both eyes to 'eliminate stasis of 
water', a condition believed to be cataracts. Recipe 390, 
this time to ' eliminate blood vessels in both eyes' 
(presumably dilated conjunctiva! capillaries or 
conjunctivitis) recommends applying a 'ductile dough' 
comprising equal parts of green and black kohls, lapis 
lazuli, ochre and honey to the eye surfaces. 
A limestone ostracon at the Metropolitan Museum of 
Art (New York) contains a prescription for hysteria 
comprising lapis lazuli, 'green stone' (malachite), a 
fumigant ('Ki-bu'), one herbal component ('Ssyt') and 
raisins, all mixed together in a jug ofwine. 10 Hysteria was 
supposedly caused by internal movement of the uterus. 
According to Plato (circa 428-348 BC), 
The womb is an animal which longs to generate children. 
When it remains barren for a long time after puberty, it f~ls 
wroth, it goes about the body, closing the tissu~s for the arr, 
stopping the respiration, putting the body mto extreme 
dangers. 11 
The resulting characteristic and uncomfortable 
sensation of having a mass embedded in the_oeso~hagus 
or trachea (globus hystericus) is a psychological disorder 
allied to anxiety, and still little understood today. 12 
Assyrians 
The kingdom of Assyria (late 25th century--605 BC) was 
located in the area of present-day northern Ira~. The 
capital city of the Neo-Assyrian Empire _was ~m~v~~ 
situated on the opposite bank of the River T1~s. 
present-day Mosul, and razed to the ground by bes1e~~ 
Medes and Babylonians. Towards the end of 1 
existence Nineveh was home to the famous library of 
Ashurbartipal ( 685-circa 627 BC), the last of the _Neof 
Assyrian strong kings. Excavation of the mound-rums 0d 
Kouyunjik begun in 1847 by Sir Austen Henry Layar 
(1817-1894) yielded (in 1849) a collection of betwee~ 
20 OOO and 30 OOO cuneiform tablets from Ashur 
bacipal 's library,' the bulk of which made their way to _th~ 
British Museum. Amongst these is a range of medic 
texts, first studied by Reginald C~pbell Thomps: 
(1876-1941 ). 13 Here, lapis lazuli 1s recommend 
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crushed in curd or ghee (an unclarified butter) as an eye 
ointment in cases of ocular complaints caused by 'the 
Hand of Ghost'. 14 
One tablet (K.4120; Fig. I) also blames dazzling of the 
eyes on Hand of Ghost, and prescribes lapis lazuli plus a 
mixture of other geological and herbal ingredients, finely 
crushed together on copper and applied continuously to 
the eyes as an ointment in 'suet of the kidney of a black 
ox' . 15 
Amongst the various remedies for oral complaints, one 
cuneiform tablet recommends the amuletic use of lapis 
lazuli, hung on a thread around the neck, together with 
similar beads of cinnabar, iron oxide and alabaster. 16 'If 
the hand of a ghost seizes on a man, and his ears sing', the 
recommended treatment was to crush lapis lazuli 
together with myrrh, powdered arsenic, 'green stone' 
(perhaps verdigris or malachite) and, bound together with 
cedar oil, use it to anoint the ear lobes as well as inserting 
it into the ear itself in order to effect a cure·17 Together 
with another 26 stones, including magnetite, carnelian, 
coral and jasper, lapis lazuli was recommended for 
'emplacement of the intense pain of hand of ghost', and 
if bound to the site of the pain, alleviated the symptoms. 18 
If powdered lapis lazuli, haematite, plus a range of other 
stones and botanical ingredients (many of the identities of 
which are currently obscure) were continually rubbed in 
a solution of oil upon the temples, neck and eye sockets 
of a patient whilst reciting an incantation which is 
translated as 'The pointing of the evil finger of mankind', 
disease was guaranteed to be removed. 19 
The combination of incantation with the magico-
medical employment of lapis lazuli, (together with a 
range of other geological and herbal ingredients) was 
also used in cases where a frightening array of symptoms 
indicated that 'a roving ghost' afflicted the patient. The 
symptoms included pain in the breast, scalp and temples, 
roaring in the ears, numbness, shortness of breath, 
depression, chills, a crushing sensation in the chest, 
shortness of breath and persistent vomiting; the patient 
was perceived as specifically being under the Hand of 
Marduk, the somewhat capricious Babylonian deity who 
was deemed to exercise control over humanity.20 The 
rather complex incantation, recited whilst holding the 
patient's hand (which held a representative figurine) and 
prostrated before a specially consecrated potter's pit, 
invoked Ea, the Sumerian and Akkadian God of creation 
and father to Marduk, to exorcise the sufferer from the 
influence of the God.21 
Ancient Indian sources 
The Rasaratna Samuccaya is a 13th century alchemical 
treatise from the late Tantric Period, named after the 
Hindu and Buddhist scriptures produced at the time. 
Written by Vagabhatacarya, this work explains the 
preparation and properties of mineral drugs.22 The best 
quality lapis lazuli is taken to be that showing flecks of 
associated iron pyrites, also known as 'golden fly'. One 
possibly contemporaneous description of the r~k 
recounts that 'lapis lazuli must be regarded as genUllle 
and auspicious, which is without white flecks, is blackish 
+. K.4Jl0, 
s. 
I 
10, : 
Figure 1. Figure 1. Assyrian cuneiform tablet (British 
Museum K.4120) from the library of AshurbanipaJ at 
Nineveh (circa 620 BC), after Campbell Thompson 
(1923, plate 12 fig. 4). 
or dark blue, smooth, heavy, pure, shining and like a 
peacock's neck'. 23 Incorporated into the specialised eye 
ointment, 'suma ', lapis lazuli was prepared by boiling in 
a mixture of cow's urine, lemon juice and salts prepared 
from various herbs for a period of six hours in a 
specialised earthenware pot (Dau/a yantra). 
Alternatively, the lapis lazuli could be oxidised to a red 
colour by a complex process involving mixing and 
grinding with sulphur and lemon juice, fashioned into the 
form of a tablet which was dried in the sun before being 
fired seven times in a specialised arrangement of two 
conjoined clay pots. This could then be used to treat 
'aggravated bile' , haemorrhoids, tuberculosis, jaundice, 
coughing and 'illnesses produced by humors of mucus 
and wind'. Furthermore, a paste or 'pishthi' could be 
made for the treatment of dysuria, tuberculosis, jaundice, 
coughs, haemorrhoids, diabetes, insomnia, restlessne 
and neurosis. This involved grinding the stone with apple 
juice for a period of 14 days, stirring the mixture for three 
hours per day for three successive day , allowing the 
mixture to settle and then pouring off the supernatant 
apple juice. After drying and a further period of grinding, 
the paste was taken orally with honey, rose petal jam and 
murabba (a sweet jam pickle) of Indian Goosebeny 
(Phy//anthus emb/ica, formerly Emb/ica officinalis).24 
Generally referred to as Riijiivartah, lapis lazuli also 
has the following synonyms: Niliisma, Nrpapalah, 
Suvamadhiitu, Riijiidr1 and Avarta-manih. In Ayurvedic 
medicine, it is traditionally believed to alleviate problems 
in each of the three humours or doshas . Based heavily on 
the Rasaratna Samuccaya cited above, plus the 13th 
century Dhanwantari nighantu and the 17th century Raja 
nighantu,25 it is commended as having rejuvena?1_1g, 
nourishing, appetising, digestive and aphrodisiac 
qualities, and employed for urinary disorders, 
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tuberculosis, haemorrhoids, anaenua, hiccough, 
vomiting and even alcoholism!26 
Chinese and Tibetan sources 
Geopharrnaceuticals figure strongly in Traditional 
Chinese Materia Medica27 but, possibly rather 
surprisingly, references to lapis lazuli are quite sparse. 
Liu-Ii is taken by some authorities to refer to lapis lazuli, 
whilst others think that the name applies to rock crystal 
(quartz).28 Those identifying it and its synonyms as lapis 
lazuli indicate that the powdered mineral, or water in 
which the stone was dipped, was used to cure fevers and 
inflammation of the eyes. 
One of the most venerated of the Tibetan Mahayana 
Buddhist pantheon is the Medicine Buddha, Bhaish-
ajyaguru Vaiduryaprabha, or the Healing Master of Lapis 
Lazuli Radiance. Represented pictorially in the 
distinctive deep blue of lapis lazuli, wearing the robes of 
a monk and sitting cross-legged holding a myrobalan 
stem in one hand, he is revered as the source of the 
Tibetan healing arts, embodying the teaching of the Four 
Medical Tantras. These tantras are ascribed to the 
teaching of the Lord Buddha at the age of 72, and one 
tradition holds that they were translated into Tibetan by 
Vairocana during the 8th century AD. An alternative view 
is that the Tantras were gathered together and presented 
by Yuthong Yonten Gonpo II (1126-1202), one of a 
family lineage of royal court students and practitioners of 
traditional Tibetan medicine. Derived from this historical 
base, lapis lazuli is known by a number of synonyms in 
Traditional Tibetan Medicine, and esteemed for curing 
cases of poisoning, disorders of the lymph and leprosy. 
According to one text, it is even able to cure grey hair! 29 
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'What the Dickens!' The Out-patients 
pharmacy at the Middlesex Hospital, 
London 
Norma Cox 
VVandsworth,London 
In 1979 I was the staff pharmacist in charge of the out-
patients department pharmacy at the Middlesex Hospital, 
London. The out-patients department was in a brick 
building in Cleveland Street. (See figure 1 ). It was a 
separate building from the main Middlesex Hospital in 
Mortimer Street. The out-patients department and the 
main Middlesex Hospital were connected by a myriad of 
underground passageways that allowed the movement of 
people, supplies and trolleys along narrow tunnels. 
Figure 1. The out-patients department of the Middlesex 
Hospital in Cleveland Street. 
The out-patients pharmacy was underground, beneath 
the out-patients building in Cleveland Street. Patients 
called in for their medicines, after seeing the consultants 
and registrars in their clinics in the out-patients block. 
The pharmacy had a reception area with seating for 
patients to wait. The dispensary led from the reception 
area. There was an area within the dispensary for the staff 
to have their tea-breaks and lunch. I don't recall where 
the toilet facilities were. I left this position at the end of 
1979 and thought little of the place except for nostalgic 
memories with contemporaries. 
I knew that the Middlesex Hospital had become part of 
University College Hospital NHS Trust in 1994.1 The 
Trust had sold the Middlesex Hospital site for housing, 
offices and retail outlets to fund the University College 
Hospital Private Finance Initiative. 1 The Middlesex 
Hospital was then demolished in 2008 after anger and 
outcry.2 Worse still, the new building works had been 
delayed and only the hospital's listed Chapel remained 
intact in the middle of a building site.3 
In 2013 I visited the Middlesex Hospital site in 
Mortimer Street and found building works well 
underway, with completion dates predicted for 2014. I 
walked along Cleveland Street towards the Middlesex 
Hospital out-patients department expecting to find 
demolition or building works. To my amazement the 
out-patients building was still there. The perimeter wall 
was boarded by a wooden fence and workmen were busy. 
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Figure 2. The building in 2013. 
The quadrangle at the front of the building, between the 
two projecting ends, where the ambulances used to wait, 
looked the same (Figure 2). 
There is a campaign to save the Middlesex Hospital 
out-patients department.4 The building has been 
identified as an original workhouse. It was built on the 
old pauper burial ground for St Paul's Church, Covent 
Garden in 1775-78. More importantly, it is likely to be 
the model for the workhouse described by Charles 
Dickens in Oliver Twist. 5 Dickens lived in Cleveland 
Street for two periods of his life, from 1815 to 1816 and 
1828 to 1831 . This information came to light when a 
medical historian, Ruth Richardson, researched the old 
workhouse in an attempt to save it from demolition. She 
made the discovery of a calling card used by Charles 
Dickens to gain employment as a short-hand writer. His 
address on the card was 10 Norfolk Street, but this street 
does not exist anymore. Using old maps, the address 10 
Norfolk Street was found by Ruth Richardson to be the 
same as 22 Cleveland Street. He had lived and grown up 
nine doors from the workhouse. The Blacking factory in 
Chandos Street, where he was forced to work as a child 
while his father was in prison, was a few streets away. 
The threat of the workhouse must have terrified him. 5 
The efforts of Ruth Richardson have resulted in the 
Grade II listing of the Cleveland Street workhouse on 3rd 
March 2011.6 She contacted Mr Dan Calinescu of the 
Toronto branch of the Dickens Fellowship, who had a 
copy of the Charles Dickens calling-card. The 
Fellowship has financed a blue plaque on the house at 22 
Cleveland Street, which was erected on the 8thJune 2013 
to show that Charles Dickens had lived there.4 
The appearance of the workhouse has remained 
basically unchanged since 1788, as evidenced by the 
account of Dr Joseph Rogers, Medical Officer of the 
workhouse in 1865 and the description in the survey of 
London in 1949.5 It is one of three remaining Georgian 
workhouses in London. It was originally known as the 
Strand Union workhouse, later the Infirmary for the 
Central London Sick Asylum, and from 1865 it was 
known as the Cleveland Street Infirmary and then the 
Cleveland Street workhouse. It became part of the 
Middlesex Hospital in 1927 and remained as the out-
patients department of the Middlesex Hospital until 2005. 
The dire conditions in the Cleveland Street workhouse 
were reported in the Lancet in 1865.7 In 1866 Charles 
Dickens wrote to Dr Joseph Rogers, the Medical Officer 
at the Cleveland Workhouse, praising his campaign for 
reform. 8 The article in the Lancet may have influenced 
the passing of the 1867 Metropolitan Poor Act. 7 A recent 
article by Ruth Richardson, states that there are 'plans 
which envisage the destruction of everything but the 
listed building'. 9 
So the building I worked in was immortalised in Oliver 
Twist and will be preserved. 
Authors address: norma.cox6333@grnail.com 
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Knowledge of burn wound healing: 
the heritage from Traditional 
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The traditional pharmacy of Persia is based on n_w:nerous 
ancient manuscripts written by the elites of medic~e and 
pharmacy. These references which belong to different 
centuries (mostly from the 9th to 19th century) represe~t 
vast information about pharmaceutical and therapeu~c 
knowledge. Studying these works could be valua?le ID 
revealing the hidden parts of the history of science, 
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especially pharmacy and medicine. Also, modernisation 
of the methods of treatment and the majority of 
fonnulations seems to be possible. It is obvious that 
setting ancient experiences besides recent studies makes 
pharmacists and physicians more powerful. This review 
aims to introduce traditional knowledge about different 
treatments for burn wounds which has been extracted 
from various Persian manuscripts. 
Introduction 
The discovery of fire by humankind seems to be the first 
step in a huge progress toward simple industries and other 
initial examinations; 1 however, man experienced the 
undesirable effect of fire on his body, i.e. bum wounds. 
While he was extremely exposed to nature, some nature-
related events like sunburn, or burns due to lightning, were 
inevitable. So the smart creature started searching for 
solutions to the problem. Medicinal herbs and minerals 
were the most accessible options to relieve his injuries.2 
Ancient scientific treatises written by physicians in each 
civilisation prove their awareness of natural products' 
therapeutic effects. Traditional medicine in China, India 
and Egypt suggests various wound healing agents working 
with different mechanisms.3-5 Nowadays researchers 
worldwide are trying to restore this worthy knowledge to 
life by examining primeval concepts and ideas through 
modem methods.6 Most of these studies account for the 
initial stages of new drug discovery.7 Ancient medicinal 
manuscripts from Persia contain extensive infonnation 
about different wound categories, various wound healing 
agents, their mechanism of action and compound 
formulations efficient on wounds. This review aims to 
extract the knowledge of burn wounds treatment from 
ancient medicinal treaties of Persia including simple and 
compound fonnulations, modes of action and a brief 
statistical report about their effects and usages alongside 
the categorisation of burn wounds according their depth 
and origin. 
Study method 
Three main categories in ancient medicinal and 
pharmaceutical manuscripts were studied: 
• simple medications, 
• compound formulations, and 
• therapeutics. 
The information of materia medica (simple 
therapeutics) containing the origin (herbal or mineral), 
the herbal part used, the temperament, and mechanism of 
wound healing they are involved in, was extracted from 
Makhzan-al-adviehB and Tohfat-al-Momenin. 9 Two 
encyclopedias of dosage fonns, Qarabadin kabir10 and 
Qarabadin Salehi11 were searched for compound 
formulations. Special chapters in Tibb Akbari12 and 
Sharh al-asbab va al-alamat13 presented wound 
categories and therapeutic guidelines of burn wound 
healing. The keywords for searching were Persian and 
Arabic terms for burn, burn wounds, blistering, fire, hot 
water and hot oil. 
The next step was finding the scientific names of the 
mentioned materia medica and modernised terms for 
old-fashioned mechanisms of wound healing. Different 
attachments and appendices of newly rewritten works, 
like Kitab al-Asrar, 14 Al-Mujaz fi al-Tibb, 15 Ketab al-
saydana16 and Useful plants and drugs of Iran and Jraq11 
offer exact scientific names of materia medica, o they 
were used besides recent sources. 18-19 
Results 
Different kinds of burn wounds have been described in 
the ancient scientific literature. While various sources 
can cause burn wounds, specialised treatments have been 
suggested.12 
1. Wounds caused by fire are either mild (without blister) 
or moderate (with blister) to severe. Suitable herbal and 
mineral treatments will be discussed. This categorisation 
is almost similar to the modem division of burn wounds 
according to severity. 1 
2. Burns after touching hot oils. A combination of egg 
white and olive oil i recommended. 
3. For burns due to hot water ( calds), using vari us 
kinds of refrigerants like cold infusion of ash r olive i 
essential. 
4. If lightning cau e a burn, it may be treated imilarly 
to burns by fire. 
5. Toxic substances make erurn eparated from blood. In 
these cases cupping is used, and then vinegar ointment is 
advisable. 
6. Sunburns are likely to happen for sensitive skin. In 
such cases topical fonnulations made of vinegar or 
camphor are suitable choices. 
7. If alkaline agents cause a burn on the tongue, 
mucilaginous blond Psyllium and almond oil will 
remedy the side effects. 
Some factors had to be considered while electing the 
medications. First of all, the pre cribed formulation 
should be adjusted according patient's gender and 
temperament. Mild desiccants (to keep the wounds dry) 
are preferable for females and severe desiccants for 
males. The next point to be con idered is the patient' 
diet. Foods containing meat and ugar ought to be partly 
limited, since they produce fre h bi and w und 
healing will be delayed. Any inf ccti n in the wound ite 
will interfere with the healing proce s, o anti-infcctivcs 
are vital in uch cases.13 
More than 60 wound healing agents are uggested by 
ancient Persian textbooks; of which three--quarters 
originate from plants (Table I)_ and the remai~der arc 
minerals (Table 2). Obviously different mecharusms arc 
responsible for their effects and the following definitions 
were extracted from ancient manuscripts. 
(a) Anti-bleeding: avoids bleeding from wound site, so 
increases healing rate. 
(b) Anti-blistering: avoids eparation of watery liquids 
from blood. 
(c) Anti-infection: remove any kind of infection or 
avoids penetration of infection. 
(d) Anti-inflammation: tops or inactivates the inflam-
matory proce . 
(e) A tringent: causes con triction of wound. 
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If;)'pmCVJ11 p,rforaJJDA Leaf; Aeml part Ha,ifariqOU11 3 3 • • • • • • 
1-'lioma alba l.&f ( cooked in lntec) Hl11IO <l 2 aot mmtioned 
Lepidm. sa1in1111 Aerw part (in vinegu) Hor/ 2 2 not mmtionecl 
Lila C01ttlitiart L Lm' Root (cooked in S11S1J11 2 2 I 1 • 1 1 • 1 I 1· • I I • mU'nil) 
=-
Mah·a zyl\-mris l.&f (in oli.e oil) Kltobba.i l 1 DOt mmtianed 
Mo,wspp. Lu£ (in olive oil} Tout ? ? ? ? not mmtianed 
Mmaspp. Fruit peel (llh) Mou:. ::::0 :::() 2 • • • • • 
,\(mus co11u,0111is Le.£ (.alcoholic As I 2 • • • • 
ext=t)/ 
Fruit (cooked in wine) 
Narci:isu.s tazma Root Narju <3 <3 • • • 
OcUIIIIIII basiJiclllfl Le.£ Hamalw111 1 1 • 
Olsa n.roptUQ Fruit (miripe) Zit 1 )< • 
J)i,gs...., _ LuD' Root nHI S1J11Dbm 3 3 • • • • 
P~'lft/VIIT Lu£ La.anolltaml 2 2 • • • • • • 
P'larizml.. ori,nJDJi.r Lu£ (dried),' Trunk .Dolb -*• ... • • • 
billk (llb){ Fruit 
Porodaca olRIIIO Auw pazt(m l'Ose oil) Baqlato/Jiom 3 2 • • 
qa 
&.a""""1;scm1 Flowu! Flower in oil Vard••· 1 2 • • • • • • • 
ah111ar 
S-hcar11t,nt Lm Khaman 2 2 • • • 
Scahio.a an..-,ui.r Extim .\lamitha 2 2 • • • Snv,tni\'11111 1«111nmr Auwum Abro1111 l 1 • • 
S,s- iltdictmi .SttcilOil SlllfUmi I 1 • • 
Sol-"' ""711J11 Fruit Enabo-.salab 2 2 • • • • 
r-mlfa/1/ca Dritd ltaf' r,,,1,, I 2 • • • • T TlllfODOlfOII JlTOlllVU LuD~ Lahiat-ouu 2 3 • • • • • • 
T,i,o,,,,Ua/o-lfl· utd Holb, 2 2 • • • 
J'ro«MIII 
Jtf.lldlt Prodllct or Khall 2 J • • • • • ftrm:uitation 
Table 1: Herbals suggested for bum wound healing in ancient Persia and their individual infonnation (scientific and 
common names/part used/temperament/mechanism of healing). 
* According to scientists' belief, each substance is rated with opposite qualities including wannth a~d coldness, 
wetness and dryness. The least degree is O which shows equilibrium of opposite qualities and the highest 
degree is 4, with 1, 2 and 3 in between. 23 These degrees are related to different compounds existing in herbals 
or minerals. (Various compounds are responsible for different temperaments.) 
**The temperament mentioned belongs to the original substance, not its ash. 
*** The exact degrees have not been found. 
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Mineral Traditional Advised Temperament Characteristics which activate process of 
(*=main name formulation wound healing or lessen the burn effects 
compound) 
hot cold wet dry a b C d e f g h i J k 1 1n n 0 p q 
Tln-e - * * • • • • • • - Qimoulia 
*2PbC03.Pb(OH) Esfidaj - 3 3 • • • • 
* Al.K(S04)2. l 2H Shabb solution in 2 3 • • • • • 
20 water 
*Borate salts Melh-e in olive oil 2 3 • 
bouraqi 
Euspongia Esfanj in vinegar 1 2 • • • • 
officinale L. 
*Fe203 Shadanaj - 1 2 • • • • • 
(Haematites) 
*HgS Zanjefer/Sh in oil & wax 2 2 • • • • 
angaif 
Ink Medad/ in vinegar or 2 2 • • • 
morakkab water 
Nacra per/arum Sada/ ash in <l <l • • • 
eggwhite 
Ovum( shell) Baiz - 2 2 • • 
*Pb304 Osranj in rose oil or <3 3< • • • • • • • • 
olive oil 
*PbO Mordasanj - 1 3 • • • • • • • • 
*Sb2S3 Ethmed/ in animal fat 2 3 • • • • • • 
Kohl 
Slaked lime Keis in lard (pig ::::() ::::() • 
fat) 
*Zn2C03 Eqlimia - ? ? l< • • • • 
Table 2: Minerals used for burn wound healing in ancient Persia and their individual information (main compound and 
common names/advised formulation/temperament/mechanism of healing) 
* While the minerals existing in nature are not pure, the main omponent of the mineral is shown with a star. 
? : No information about the temperament was found. 
::::0: shows the equilibrium of different qualities (warmth and coldness, wetness and dryness) 
(f) Attenuant: Medications with mild warmth of 
temperament able to attenuate the substances aggregated 
in the wound site. 
(g) Debridement: removes dead or damaged tissue 
from a wound. 
(h) Desiccant: keeps wound dry. 
(i) Detergent: stimulates viscous substances and expels 
them from surfaces. 
G) Discutient: the hot temperament of some 
medications makes attached substances separate and then 
expels them in gaseous form. 
(k) Maturant: ripens the aggregated sub tances and 
facilitates their elimination. 
(I) Pain calmative: controls pain. 
(m) Promote healing: increases healing rate. 
(n) Refrigerant: causes feeling of coolness. 
( o) Softener: makes the wound site smoother. 
(p) Tissue adhesive: joins the edge of wound. 
(q) Tissue expander: causes tis ue growth and fill 
wound. 
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Name of compound Components Proportion of Usage consideration 
formulation components 
White ointment10,11 Esfidaj SU Preparing patches saturated with this 
Camphor 3U formula is advisable. 
Yellow Wax 4U 
Sesame oil IU 
Camphor ointment1o Rose oil ISU Oily phase should be melted first, then fine 
White Wax 4U powders added. 
Camphor IU 
Esfidaj IOU 
Esfidaj ointment10 Powdered Esfidaj 2U Mixmg should be done slowly. 
(prescribed by Avicenna) Olive oil 2U Should essentially be stored in clay or glass 
Purified vine~ar IOU containers. 
Burn lotion11 Boureh Armani IU The powders should be added little by little 
(=NaC03, NaHC03) in order to homogenisze preparation. 
Lawsonia leaves IU 
Myrrh lU 
Rose oil NM 
Lotion for pain relief1 1 Lens esculenta NM Lentilsand rose flower should be cooked. 
Rosa damascene NM It is essential that mixing the fine powders 
Esfidaj NM and homogenising be continued for long 
Barley flour NM time. 
Rose oil NM 
Table 3. Samples of compound formulations suggested for burn wounds according to Qarabadin books. 
U: Unit(s), NM: not mentioned. 
60% 
percentage of miner.ails or herbals haring mentioned characteristic 
Figure 1: Ancient knowledge about burn wound healing (usage of herbal and mineral according their characteristics)._ 
The statistics are based on data in Tables 1 and 2. a: anti-bleeding; b: anti-blistering; c: anti-infection; d: an~-
inflammation; e: astringent; f attenuant; g: debridement; h: desiccant; i: detergent;}: discutient; k: maturant; l: pam 
calmative; m: promote healing; n: refrigerant; o: softener;p: tissue adhesive; q: tissue expander. . . 
For example 60% of all introduced minerals have anti-bleeding effect, while 27% of herbals show this charactensnc. 
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Discussion and conclusion 
This study, using extracts from ancient Persian 
manuscripts, proves that these works have been written 
by physicians qualified in wound healing. They were 
experienced in selecting suitable healing agents 
according to the source or cause and depth of burn 
wounds. More than 60 plants and minerals have been 
suggested that work through different mechanisms. The 
majority of recent articles supported this knowledge. The 
extract of Lawsonia leaf inhibits the growth of micro-
organisms, and fresh crude extract of Portulaca results in 
collagen fibre formation, so both of them accelerate the 
healing process. 19-20 Boswellia resin has anti-
inflammatory and antimicrobial effects which indirectly 
improve wound healing.21 Despite these and other 
convincing reports, many of the therapeutic agents 
mentioned have not been studied yet. Such data can be 
the first step in new drugs design through in viva and in 
vitro researches. In the case of minerals, their toxicity 
may cause concern, but various methods of 
detoxification have been addressed in manuscripts which 
can be evaluated through modem chemical methods. 
Minerals are more efficient in tissue adhesion and 
expansion, bleeding control and debridement, according 
to Figure 1; therefore the majority of compound 
formulations were made with them and they are capable 
of healing severe and deep wounds. 
Herbal formulations are suggested for mild and 
superficial burn wounds. 
Although this review portrays the glory of 
pharmaceutical knowledge in ancient Persia, some 
practical aspects could be beneficial for people 
worldwide. 
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The Pars Collection: a window into 
the past 
Dr Holly Crossen-White 
Research Fellow, School of Health and Social 
Care, Bournemouth University, UK 
A recent study that sought a 'missing' history of drug-
taking during the early twentieth century involved the 
analysis of some volumes from the Pars Collection. The 
Pars Collection is a complete set of prescription books 
from a pharmacy that traded as Pars and Co. Ltd. in 
Bournemouth between 1876 and 1978. As familiarity 
with the content of the volumes grew the value of the 
prescription books went beyond how many times 
particular drugs were dispensed on any one day. These 
books conveyed a 'story' about the customers who 
visited the shop and through them life in Bournemouth at 
the tum of the twentieth century. In addition, an 
unexpected finding was that the evidence from this 
source could be related to other evidence extracted from 
The Times regarding drug consumption during this 
period. 
Overview of the study 
The focus of research was upon people who chose to 
regularly take drugs in the early twentieth century. This 
was a group of people likely to have left little trace of 
their lives for future generations to find. At the tum of the 
century their self-regulated drug consumption would 
have drawn little attention, they may have been 
considered morally weak by others1 but it was a private 
matter. However, during the first decades of the twentieth 
century drug consumption came more to public attention, 
which resulted in the Defence of the Realm Act (DORA) 
Regulation 40b. This meant that those who self-regulated 
their consumption of drugs were from 1916 committing 
an offence and thus they naturally sought anonymity to 
avoid prosecution. In essence, the early twentieth 
century is a key period in the history of drug-taking as 
effectively the social status of drug-takers was 
transformed overnight. It was the impact that DORA 
Regulation 40b had on the lives of drug-takers which was 
the focus of this study. 
However, to discover the experiences of drug-takers 
living through this period of great change would be a 
difficult task. It was necessary to think about how other 
historians had approached topics where there was a 
scarcity of evidence. A key strategy for this type of 
research is to look at archive material in different ways or 
to 'read against the grain'.2 Hobsbawm3 highlights how 
'reading against the grain' is employed in the practice of 
grassroots history. He indicates that grassroots historians 
work from the assumption that records created for one 
purpose may in fact accidentally have captured 
information that provides vital insight to another issue. 
Thus, for grassroots historians sources only emerge as 
such 
because someone has asked a question and then prospected 
desperately around for some way - any way - of answering 
it. ... There is generally no material until our questions reveal 
it. (p271). 
In this study, accidental capture was the most likely 
source of evidence and it was important to consider all 
the potential sources where accidental capture could have 
occurred. At the tum of the twentieth century individuals 
purchased their prescriptions and, as the property of the 
customer, these could be presented at a pharmacy when 
the owner chose to. Evidence from articles published in 
The Times during the period indicated that using a 
purchased prescription repeatedly was one way regular 
drug-takers obtained their drug of choice. Therefore, 
prescription books were one option that might help trace 
regular drug-takers during the early twentieth century. 
Prescription books are a rarely used but valuable 
historical source.4 They have been used previously to 
analyse prescribing and professional practice during 
specific eras.5 Reading about the content of prescription 
books raised the question; might this source hold hidden 
evidence that could be revealed through a different 
analytical approach? 
The starting point for 'prospecting' prescription books 
was to review what was recorded in these sources and 
whether there was a standard format. Establishing this 
would help assess the consistency of the evidence over 
time and whether it was possible to trace personal 
consumption during an extended period of time. 
Prescription books from several archives were reviewed. 
This process indicated that records rarely extended over 
a longer period either because volumes were missing or 
because the condition of the books was too poor to read 
all the entries. Also there was no standard approach to 
recording what the pharmacist dispensed. However, 
when the Pars collection was traced the quality of records 
stood out as exceptional and thus this source was focused 
upon by this study. 
Another key source used in this study was The Times 
digital archive. From searches of this source 359 articles 
were identified and included in the study. These articles 
reported drug-related incidents that occurred between 
1900 and 1922. Their content revealed a great richness of 
evidence and when this was compared to the analysis of 
Pars prescribing records it was possible to see similarities 
and links between the evidence provided by the two 
sources. 
Background to Pars and Co Ltd. 
In Bournemouth today older people still refer to ~~ 
Comer because the pharmacy was a key landmark within 
the town. It attracted attention due to its exotic window 
displays which at the tum of the century included rare 
items such as natural sponges from the Mediterranean.
6 
It also had an unusual frontage which was curved. The 
shape was due to the shop :fittings which dated back to the 
Regency period. These were transported from London to 
Bournemouth when the pharmacy first opened in 1876 
and the shop front modified to accommodate ~em. 
When the shop closed the interior went to the Ironbndge 
Museum. The 124 prescription books found at the shop 
were preserved also and sent to the Science Museum 
94 Phann Hist (Lond) 2014; 44 (4): 
Library, London. Compared to other prescription books 
considered for inclusion in this study the Pars Collection 
is outstanding. On a practical level the condition of the 
volumes used for this study (1890-1922) was very good 
and the ink entries remain clear and readable. In terms of 
information the content is very detailed and meticulously 
recorded. There is also evidence that entries were cross 
checked and amended when incorrect. In addition, the 
pharmacist made comments against prescriptions such as 
'Do not repeat'; however, on occasions the dispenser did. 
It is due to the care taken by the staff that these volumes 
are able to 'speak' about life during the period. 
The customers of Pars and Co. Ltd. 
The dispensing of three specific drugs ( opium, cocaine and 
heroin) was focused upon in this study. These drugs were 
most commonly dispensed to female customers. The 
entries in the Pars records gave little clue to the background 
of these female customers but given the profile of the shop 
they needed to be reasonably affluent. The entries for male 
customers indicated that there were military connections 
and searches of UK census records revealed many had 
served overseas for example, India or South Africa. 
The Pars records included the addresses of customers 
and this gave another clue to their customer base. The 
entries indicated that a significant number of customers 
were visitors staying in hotels. Some were regular 
visitors over the period but many were not. Dispensing to 
a person unknown to the pharmacist was in breach of the 
law at the time. However, it appears that this was 
overcome by dispensed items being collected by hotel 
staff or local nurses. The recurrence of customers at 
particular times of year also indicated that the regular 
visitors came for particular periods, not always in the 
summer but at other times. Possibly this relates to the 
mild winter climate of the area. 
Bournemouth was also associated with the enter-
tainment industry particularly through the Russell-Cotes 
family who were strong supporters of the arts. The family 
entertained many theatre stars of the day at their home 
and their hotel, The Royal Bath. The combination of 
health benefits, celebrity appeal and excellent rail links to 
London made Bournemouth a fashionable escape from 
the capital. As Pars & Co. Ltd was considered to be an 
'up-market' retailer it is likely that many of the visitors 
listed in the shop's prescription books were probably 
affluent Londoners. It seemed that the records had 
captured an interesting group that were probably quite 
affluent and included both residents of Bournemouth and 
visitors to the town. 
Analysis of the Pars Collection 
Initially, the study aimed to analyse th~ ~ars 
Collection by looking at all dispensed prescnpt10n_s 
during 1890 and then alternate years from 1900 until 
1922. The records for 1890 were used as a base year 
from which to look at the trends in prescribing during 
the later period 1900 to 1922. To look at the level of 
prescribing during the period the number of pages per year 
and the average number of entries per page were recorded 
and used to estimate how many prescriptions the premises 
dispensed in each year analysed. Figure I shows the 
estimated number of prescriptions dispensed at Pars 
between 1890 and 1922. 
fig,.,, 1: £,.1ima1od "LIT'l:er al pr=ri'FtilJ-.. dispor-...d b'f Pm i. C., 
Ltd.1890-1922 
The analysis of the prescription books focu ed on the 
dispensing of prescriptions that contained one of three 
specific drugs, opium, cocaine and heroin. 7 ub equent 
analysis of these prescriptions howed that female 
customers were much more likely to be dispensed the e 
drugs in most years with the exception of I 908 when 
male dispensing almost matched that of female 
customers (see Figure 2). 
_...v.-~, ~ : .f, , I, 
From comparing dispensing trends by gender the male 
peak in 1908 occurs when di pensi~g to f~male i_ al _o 
falling. The reduction in femal~ d1spen 1-!1~ bcgms. m 
1904 with a decline in pre cript1on contammg cocame 
and then in 1906 there is al o a fa ll in both opium and 
heroin. However, among male customers there is the 
n,tl:U•~P'""'l.t1 •mr•h,,h"t J1 .1Q U 
: ! 9:, 19:0 1~ni .!lC• 1, 0, . !.'C~ 1110 t cti . , •• 1• 1,; 19 .I i::c •:; 
Pharrn Hist (Lond) 2014; 44 (4) 95 
.'U 
reverse trend. Dispensing to male customers of opium 
rose from 1902 and then increased very sharply after 
1906 while cocaine rose from 1902 and heroin from 
1904. A key question was therefore: why was male 
prescribing the converse of female trends within that 
period? Figures 3 and 4 show Pars dispensing by drug 
type for males and females over the period. 
Marked variation in dispensing by gender seen in 
Figures 3 and 4 raises the question: why should there be 
such trends? The probability is that people with similar 
conditions should receive similar medications, so 
prescribing should likewise be similar. It seems unlikely 
that within the same period that males and females living 
in Bournemouth had completely different conditions or 
illness that would require totally different prescribing 
patterns. The most interesting pattern appears in the 
prescribing of heroin (see Figure 5). 
When looking at Figure 5 the context is relevant. 
Heroin had only recently come on the market (1898) and 
the period shown includes the First World War when the 
population would have been significantly altered with the 
enlistment of younger males. There may also have been 
problems with the supply of drugs due to wartime sea 
blockades8 which could have influenced prescribing. 
Figures 6 and 7 show the dispensing by gender for opium 
and cocaine over the same period. 
A feature across all the drug types is the trend during 
the war. During this period customers of Pars and Co Ltd. 
were likely to have been either female or older males. 
The pattern of dispensing which occurs within this period 
suggests that either females and older males take similar 
drugs or the supply of drugs impacted upon what could 
."U 
:0 
_.,. t,I .... I tf' 
be dispensed. Several features make the first assumption 
quite plausible. Across the data it is possible using the 
evidence from The Times to see points where dispensing 
behaviour fits with reaction to events that relate to either 
females or younger males. . 
As the customers of Pars would have purchased therr 
own prescriptions and paid for consultations with their 
doctor there is the possibility that they did have some 
influence over what they received. Looking first at female 
dispensing; the sharp decline in cocaine dispensing in 1902 
could be a reaction to incidents during 1901 and 1902 
involving cocaine and females. During July 1901 the 
deaths of two well-known actresses occurred. Each died 
from an overdose of cocaine. 9 The second incident in early 
1902 was a civil case involving a regular female drug-taker 
who took a range of drugs including cocaine. 10 Her state _of 
health was very poor at the time of the trial and her family 
had her declared insane to place her in treatment The case 
was extensively reported in The Times. In addition from 
1906 there is a fall in all female dispensing across all drugs. 
This fall coincides with the sale of the first barbiturate, 
Verona! (barbitone] marketed in 1906. 11 This was, in !906, 
an unrestricted drug that could be bought ~thout 
prescription. Given that the pattern of female dispensmg for 
heroin when it was first marketed it is possible that females 
were switching in 1906 to Verona!, the new 'trendy' drug. 
Modem research indicates that female drug consumers ai;; 
much more sensitive to market change than mal~d 
Therefore, this movement from one drug to another w~ h 
fit with female behaviour. Also, the larger study of w c 
this piece of research is one part found that female drug-
takers were more risk avoidant. As Verona! was a non-
restricted drug it meant that any purchases would go 
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unrecorded, which would be preferred by female 
customers, and thus provide another reason why females 
might have switched from heroin to Verona!. 
Lastly, in terms of female dispensing patterns, during 
December 1918 a very prominent female actress died, 
allegedly from a cocaine overdose. 13 Again in the Pars 
dispensing records there is a fall in the number of females 
receiving prescriptions containing cocaine. From the 
legal proceedings after the actress's death, evidence 
suggests that she also took heroin and had started doing 
so sometime in rnid-1918. Other reports of heroin-taking 
suggest that heroin consumption may have become more 
common among female drug-takers from around 1918. 
This female preference seems to continue into the 1920s. 
This is a female trend mirrored in the Pars records. 
Looking at male dispensing, their professional 
background could hold a clue as the entries in the 
prescription books suggested some male customers had 
a military background, with many having served 
overseas. Therefore, one theory on the rise in male 
prescriptions after 1902 is that these males were veterans 
returning from the Boer War. Possibly they were settling 
in the town because of its promotion as a health resort or 
maybe they were visiting on holiday. Articles from The 
Times indicate that some veterans from this conflict had 
become dependent consumers of drugs while on active 
service in South Africa. Drug-taking veterans of the Boer 
War were noted in reports until around 1912. Many were 
associated with morphine and some cocaine. Morphine 
cannot be traced in the Pars records, but a likely substitute 
drug for morphine would be opium, the dispensing of 
which is rising from 1902. Therefore, rising male 
dispensing at the shop could be a reflection of a trend for 
drug-taking among returning Boer war veterans. 
In addition, the theory of a link between conflict and 
male drug-taking fits with other dispensing data from the 
shop. This shows that male dispensing rose again after 
1918, which coincided with demobilisation. In this 
period, there is also a sharp rise in prescriptions issued to 
males that contain cocaine or heroin. Again, evidence 
from The Times links First World War veterans to drug 
dependency, mainly cocaine but occasionally heroin. 
However, the reporting in The Times during the early 
1920s strongly associated younger males with cocaine, 
and the sharp rise in Pars dispensing of cocaine to males 
would fit this pattern. 
On balance the way that trends could be linked to 
events within the period both for males and females does 
seem to suggest that the customers of Pars did appear to 
have some influence over the drugs they accessed. 
Whether this influence was due to some people self-
regulating their drug consumption either occasionally or 
on a regular basis can only be speculation. However, the 
regular appearance of some names for repeat 
prescriptions does point in this direction. 
Conclusions 
When the analysis of the Pars collection began it was 
unclear what would emerge; the process was very much 
about 'prospecting' around for traces of drug-takers. 
Given the period and the potential control the public still 
had over their drug consumption, pharmacy records 
seemed a potential source for accidental capture of 
regular drug-takers. However, exploring the Pars 
Collection revealed much more, some of which was 
unexpected. The process of discovering a 'missing 
history' highlighted how important it was to set these 
records back into the period in which they were created, 
not just considering the legal context but the wider social 
elements of day-to-day life. The process also demons-
trated how the :findings reached may not exactly 
correspond to the initial questions set but that continued 
questioning or 'reading against the grain' during the 
analysis is very important to the outcome of the research. 
If there is constant questioning, then as this study 
shows, the content of pharmacy records can go far 
beyond professional practice. So prescription books 
should not be seen as lone ources but important piece 
of evidence that when connected to other very different 
sources can help reveal much more about the public ' 
consumption of drugs. 
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The medical use of earths and minerals is probably as old 
as the history of mankind. Particular types of clays and 
earths are still being used worldwide as therapeutic 
agents in the folk medicine of different countries. From 
the 19th century, the medicaments included in countries' 
pharmacopeias whose exact pharmacological activity or 
the chemistry of their active components was not known 
gradually decreased in number, despite their popularity 
among patients. With today's analytical armamentarium 
it may be time to reconsider returning some of those 
compounds to pharmacopeias. By using modem 
techniques in the past two decades, researchers have 
studied the active components of healing clays and their 
pharmacological properties. Many of them possess 
valuable therapeutic properties which could be used in 
modem medicine in pharmaceutical dosage forms. Our 
knowledge about the medical substances that our 
ances_tors used through centuries could be used today as 
an evidence base for further clinical and pharmacological 
research. 
One of these substances is Armenian bole. In this work 
~e ~tudied the historical perspective of its therapeutic use 
m different countries. Also a sample sold in the market in 
Iran was purc?ased and X-ray diffraction analysis was 
performed on 1t to find out its chemical composition. 
Introduction 
From the 19th century until today one can observe that 
the number of substances in the pharmacopeias that have 
marked pharmacological properties and known active 
co~ponents has increased. On the other hand despite 
their popular use the number of substances and galenical 
compounds whose pharmacological actions were not 
understo?d at the time decreased in pharrnacopeias.' 
!o?ay w1~ the advances of analytical techniques maybe 
It _is possible to revise our traditional knowledge and 
bnng the forgotten medicaments which were once 
popular back to our pharrnacopeias. A group of these 
substances are medicinal clays and earths. 
The use of minerals for medicinal purposes dates back 
to prehistoric times. The first report of the use of 
medicinal earths and minerals goes back to ancient 
Mesopotamia (2000-3000 BC). The use of these 
substances could be traced in medical documents 
throu~hout the history ?f different great civilisations such 
as China, Egypt, P~rsia and_ Greece.2 Dioscorides (first 
century CE), mentions 99 morganic substances in his 
Materia Medica book which is 10% of the number of 
substances he listed in this book. Hippocrates (4-5th 
cen~ BCE\ men~o~s nine minerals in his writings as 
medicaments. Med1cmal earths have been categorised in 
the books of medieval Muslim and Iranian scholars.4 In 
the medical books of Ibn al-Sina [Avicenna] such as his 
Canon (980-103 7 CE), the pharmacological action of 
several clays and minerals are explained.s Also Rhazes 
(865-925 CE) mentioned medical clays in his books such 
as Al-havi. He wrote a book about the use of different 
clays and mud known in Latin as Dissertatio quod Lutum 
translaturn Contineat Utilitates. 6 The Muslim 
Andalusian scientist Ton al-Baitar (1197-1248) mentions 
eight kinds of medicinal earths, including Armenian 
earth (Armenian bole), which was considered as a 
medicament administered both externally and intemally.4 
Medicinal use of Armenian bole through 
history 
The medicinal use of Armenian bole (also known as 
Bolus Armenus) could be traced back to Ancient Greece. 
This famous medicament is described as the red clay 
found in the mountain caves of ancient Armenia.2 This 
earth also was found abundantly in Persia. It was brought 
from the Persian Gulf to India, where the local 
practitioners prescribed it as an astringent and to balance 
the state of the four humours of the body in cases of 
malignant fever.4 It is a soft clay, greasy to the touch, 
strongly adhering to the tongue and very fragile. 
Armenian bole usually has a yellowish brown color, and 
sometimes a fine flesh red [4]. 
In the Canon of Ibn al-Sina [Avicenna], the Iranian 
scholar of the 11 th century, the so called 'Tin e Annani' 
or red Armenian bole is considered as a well known bole 
which is somewhat dusty and red in colour. It was used 
by the jewellers to impart colour to gold. As for i~ 
medical properties it was said to be a styptic drug and this 
would give it a highly desiccant property. The oral intake 
or the topical application of it on the affected part was 
considered useful in cases of plague. It also states in the 
Canon that Armenian bole prevents the spreading of 
organic putrefaction and that Red Armenian bole has a 
wonderful (healing) effect on wounds and ulcers. It w~ 
used to treat catarrh and was considered useful m 
stomatitis. Ton al-Sina also used Armenian bole in the 
treatment of haemoptysis and also to dry up pulmonary 
ulcers. He also wrote in the Canon that this clay was a 
remedy for dyspnoea caused by catarrh. It was al~o used 
in case of intestinal ulcers and diarrhoea.5 In his book 
Al-Havi or The Liber Continens, Rhazes has written th~t 
this earth in some cases can be used to cure tuberculosis 
and that this earth is an excellent remedy for wet 
wounds.7 In many traditional pharmaceutical Iranian text 
books a monograph about Armenian bole could be found 
(Figurel). 
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Figure 1. Page of an 18th century Iranian book (Makhzan 
al-Adviyeh) which contains part of a monograph on 
Armenian bole. 
Ottoman physicians knew this earth as an exotic and 
expensive medicine.3 Armenian bole was used in European 
medical formulations as well. An example is a prescribed 
powder owned by William Hill of Ormskirk, Lancashire in 
the eighteenth century. This formulation was used to 
prevent rabies in cases of dog bites. At the time 'The 
Ormskirk Medicine' was a famous remedy in many parts 
of England. A packet of this formulation is available in the 
Wellcome Historical Medical Museum. The precise 
formulation of this preparation was revealed in 1777 by 
Heysham as: powder of chalk (half an ounce), Armenian 
bole (three drachms), allum (ten grains), powder of 
elecampane root ( one drachm) and six drops of the oil of 
anise.8 Armenian soil was one of the substances mentioned 
by the Swiss physician Titus Tobler in the mid nineteenth 
century as a medicament.3 The pharmacopoeia which 
contained the at the time so-called out-of-the-way remedies 
until 1895 was the French Codex. One of the formulations 
in it was the electuaire theriacal, which included fifty-eight 
ingredients, among which was 'terre sigillde' (Armenian 
bole ). 1 Despite its elimination from pharmacopoeias the 
medical use of Armenian bole in the folk medicine of 
different cultures has continued. There are documents 
showing that in the 20th century Armenian bole was used 
as a therapeutic agent in the Levant region for the treatment 
of dysentery, bleeding, skin allergies and leishmaniasis .. 
Today in the folk medicine of Iran this bole is still being 
sold in the local market for skin disorders. 
For this study a sample of Armenian bole was purchased 
from a local shop in Shiraz and analysed by X-ray 
Diffraction (XRD) for its chemical composition. 
Crystal identifications were performed by an X-ray 
powder diffraction (XRD) analyser system (Xpert- MPD, 
Philips, The Netherlands) operating at the Co Ka 
wavelength of 1.7889A, 30 mA, and 40 kV. Step size was 
0.02°/s. Calcite (CaC03), Quartz (Si02), Gypsum 
(CaS04,2H20), Muscovite (KAhSiJAIOw(OH)2), 
Dolomite (CaMg(COJ)i, Haematite (Fei03) and Chanosite 
(F~Sii0s(OH)4) were found to be the main mineral 
components of the Armenian bole sample. 
Conclusions 
Traditional medical books from different countries can 
provide good information on the lists of drugs of our 
ancestors and clinical trials through history. Armenian bole 
is an iron-containing clay which was used historically to 
treat wounds and ulcers in different countries. Over time it 
was eliminated form pharmacopoeias because its chemical 
composition was not known. The last pharmacopoeia 
which contained Armenian bole was the French Codex of 
the late nineteenth century. 1 Because of advances in 
analytical methods in the last two decades, researchers have 
tried to explain the scientific backing for the different 
properties of earths and clays. Today we know that there are 
documented cases of healing clays. 9 Their medical effect on 
wounds is primarily due to their small particle size, so they 
have a vast surface area and an adsorptive property.9 On 
their surface they possess high concentrations of ions. 
Medieval physicians used Armenian bole to prevent 
organic putrefaction spreading and to treat wounds and 
ulcers.5 In recent years research has shown that iron-rich 
minerals could be used to treat Bumli ulcer, which is an 
infectious ulcer caused by Mycobacterium ulcerans. Some 
iron-containing clays have shown antibacterial activity. 10 
The Armenian bole sample that we tested contained 
Haematite which could explain why it was used to treat 
wounds. Ibn al-Sina used Armenian bole to treat intestinal 
ulcers and diarrhoea. 5 Today there are studies performed on 
the beneficial effects of clay minerals in gastrointestinal 
illnesses. The proposed mechanisms of action for their 
medicinal effect on GI problems are the adsorption of 
microbes, viruses, or their toxins, on the surface of the 
clays. It is also proposed that clays can modify the mucus 
lining which would reinforce natural defences of the gastric 
tissue. Other health benefits of clays could be supplying the 
nutritional minerals (e.g. Fe, Cu).9 Clays have been 
analysed recently as excipients in anti-tuberculosis solid 
dosage forms. 11 The use of this clay as an anti-tuberculosis 
medicament has been reported in the history of various 
countries. With its known chemical composition research 
could be performed on its pharmacological activity and the 
mechanism of action of the healing properties. Also the 
chemical component responsible for these actions could be 
determined in future studies. Armenian bole is a good 
example of the medicinal clays and earths u ed throughout 
history in different parts of the world. 
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Book Review 
Views and Reviews 2 By Harkishan Singh 
Bangalore, India: Association of Pharmaceutical 
Teachers of India, 20 12, pp. 300 (hardback price r550/-, 
£5.50). 
This is the second compilation of the writings by 
Harkishan Singh, profes or emeritus at Punjab 
University. Whilst the first compilation brought together 
articles published between 1954 and 2007, this one 
bring together contributions publi bed in journals and 
books during the period 2008 to 20 l l. The book contains 
a total of23 pieces on a range of topics, varying in length 
between just over a page and thirty-four pages. 
Inevitably there i now a ignificant amount of 
r petition of material included in ingh 's previou 
v lumc . notable feature of the current one is that, of 
the twenty-three ontribution , no fewer than sixteen are 
biographic of men (but no women) who have made 
significant ontribution to the development of phannacy 
in India. However. virtually all have been the subject of 
previou works by ingh, appearing in the various 
Pharmaceutical Historian Back Issues 
volumes of his Builders and Awareness Creators of 
Modem Pharmacy series. In this volume they occupy the 
longer chapters and constitute the bulk of the book. 
The book nevertheless includes the occasional less 
familiar contribution. There is an interesting piece on the 
role of colonial commercial travellers in India, and 
another on the development of a National Forrnulary of 
India (NFI). This was spurred on by publication of the 
British National Formulary in 1949. The first NFI was 
published eleven years later, in 1960, with new additions 
appearing in 1966 and 1979, after which there has been 
no further revision. Singh provides an illuminating 
analysis of the reasons for the delay and why no further 
editions of the NFI have been forthcoming. 
Two of the contributions offer an historical perspective 
on different aspects of pharmacy practice in India. The 
first, a wide-ranging review which includes pharma-
copoeias, the pharmaceutical industry and profiles of 
pioneers, relates to modem pharmacy in India; the 
second to pharmaceutical education and pharmacy 
practice. However, again these largely go over ground 
covered in much greater depth in his earlier volumes on 
these topics. 
For the most part the book brings together articles that 
have clearly been the result of meticulous research and 
analysis. But this compilation also includes the 
occasional opinion piece from Singh which offers a 
glimpse into the sometimes murky world of 
pharmaceutical politics in India; some of his historical 
pieces are disappointingly short, such as that on 
pharmaceutical heritage. 
The final contribution, and one of the longest, is the 
text of a lecture Singh gave at a workshop on 'Science in 
India in the Twentieth Century', sponsored by the Asiatic 
Society in Kolkata. Its title is 'Pharmaceutical 
developments during the British period and in 
independent India.' However, again it largely goes over 
ground extensively covered by Singh himself elsewhere. 
The book ends with an appendix in which Singh 
provides an abbreviated biography of himself. He lists 
the po itions he has held, the awards and honours he has 
received, other professional and academic recognition , 
hi teaching and research experience, his publication , 
and finally his discovery of a drug. It is perhap a fitting 
way to round off a long and productive career. 
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